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During hepatic disease the liver has the unrivalled ability to regenerate, by activating 
mature hepatocytes which can divide and thereby reconstitute the functional liver 
mass. However in the context of chronic hepatocellular disease the liver can 
regenerate from an endogenous population of hepatic progenitor cells (HPCs). The 
mechanisms which are involved in the activation and differentiation of these HPCs is 
not fully understood. 
 
To investigate whether there is a differential signalling requirement in HPCs 
acquiring a biliary versus hepatocellular fate we established in the laboratory two 
models of chronic liver damage and regeneration, one of which causes hepatocellular 
death, and results in infiltrating HPCs regenerating hepatocytes, and a second which 
causes biliary blockage and death, resulting in biliary regeneration. 
 
Here we describe how during biliary regeneration the Notch signalling pathway is 
highly expressed and activated. HPCs cells are consistently associated with a 
myofibroblast niche which expressed the ligand Jagged-1 at high levels. We have 
modulated the Notch signalling pathway in both a co-culture system and our models 
in vivo to demonstrate that Notch signalling is important in the specification of 
biliary cells, and that inhibition of this pathway both in vitro and in vivo results in the 




During hepatocellular regeneration we have found that the negative repressor of 
Notch signalling Numb is highly expressed in tandem with a low expression of the 
Notch pathway. We suggest that Wnt signalling maintains Numb within these HPCs 
at a high level and that this, along with stimulation of a hepatocellular programme 
allows HPCs to exit from a biliary fate and assume a hepatocellular phenotype. 
Finally we have found that macrophage ingestion of debris promotes the expression 
of Wnt, and that ablation of these cells results in a phenotypic switch between HPCs 
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The Global Burden of Liver Disease 
Chronic liver disease is associated with high morbidity and mortality worldwide. The 
WHO ascribed a DALY of 37,760/100,000 people in 2004
1
 and in the UK liver 
disease is the 5
th
 biggest health burden; whilst the top four are decreasing liver 
disease is increasing exponentially
2
. Currently alcohol and chronic viral hepatitis 
serve as the main drivers of this disease and it is predicted that in excess of 3% of the 
global population are living with liver disease, with regions in which viral hepatitis is 
endemic within the population
3, 4
. The socio-economic burden of liver disease is 
rising, and currently the only curative option for end-stage liver disease is liver 
transplantation however donor organ availability has remained static whilst the 
requirement for transplant has increased, and as such many patients die whilst 




As the burden of liver disease is growing globally it is important to define the 
mechanisms which function during this pathological process and devise strategies 
which promote both liver repair and regeneration during chronic and acute damage. 
During these processes the liver mass is damaged, scar is deposited, and cells are 
activated in order to regenerate and restore the site of damage
6, 7
. Moreover 
regeneration of the adult liver is associated with a large degree of inflammation 
which may play an important role in appropriate cellular activation. These processes 
together should be considered during hepatic damage and regeneration as 
investigation into these mechanisms may identify novel targets and could deliver 
positive clinical outcomes during disease 
8, 9
. A step towards such emerging therapy 




disease and identify novel pathways which could be targeted in a therapeutic 
manner
10
. Further to the potential clinical impact of studying regeneration in the 
liver, this system provides a unique model of solid organ regeneration with a definite 
contribution from both mature parenchymal tissues as well as adult hepatic 
progenitor cells (HPCs). Critically therefore, control of hepatic regeneration may 
define specific cellular mechanisms underpinning adult progenitor cell proliferation 
and lineage specification in other solid organs. 
 
Adult Liver Architecture 
The adult liver is the largest mature organ of the body, and has a central role in 
homeostasis and metabolism of numerous compounds including many 
pharmacological drugs. The adult liver consists of sheets of parenchymal epithelium 
known as hepatocytes, which are the key metabolic and enzymatic site of the liver 
(Figure 1.1). These sheets are surrounded not by a basement membrane, but by a 
heavily fenestrated endothelial layer known as the hepatic sinusoidal endothelium
11
. 
Closely associated with the sinusoids are numerous phagocytic monocytes, such as 
macrophages. The sinusoids are separated from the hepatocytes by the space of Dissé 
which contains ECM components and stellate cells which in their resting state 
express intermediate filament Desmin and GFAP
12
. However in response to disease 
Stellate cells differentiate into activated Myofibroblasts, up regulate alpha-smooth 
muscle actin (αSMA), which can be used to make these activated cells. 
Myofibroblasts are responsible for the de novo synthesis of collagen rich extra 








The liver parenchyma can be divided into functional subunits known as acini which 
consist of both portal and venous circulation, as well as terminal braches of the 
biliary tree. The acini lie within periportal Zone-1 of the hepatic parenchyma and are 
associated with portal blood flow however a nutrient and oxygen gradient is 
established across the parenchymal hepatocytes from a high oxygen tension in Zone-
1 to a low oxygen tension in Zone-3 which is anatomically located  close to the 
central vein. In the adult liver this nutritional and oxygen gradient is maintained 
through portal and venous blood flow and is responsible for maintenance of zonation 
across the hepatic parenchyma. Reversal of blood flow results in reversal of zonation 
within the parenchyma and as a result the functional regions of the liver are lost or 
poorly defined. Interestingly during ontogeny non-circulating factors are required for 
correct liver zonation including ECM deposition, and Wnt signalling
14, 15
 indicating 
that the ontogeny of liver zonation exists differently to the maintenance of hepatic 
zonation in the adult liver. 
 
The adult liver is infiltrated with a large network of bifurcating ducts which consist 
of polarised epithelium known as cholangiocytes. These vessels begin at the bile 
canaliculi; small vessels formed between the membranes of hepatocytes
16
. Canaliculi 
filter into the canals of Herring – the terminal branches of the biliary tree which lead 
into larger bile ducts and ultimately exit into the duodenum. The biliary epithelium is 
capable of both bile salt and water transport
17-19
and maintains the flow of bile within 









Figure 1.1 – The micro architecture of the liver 
The adult liver consists of two main epithelial cell types, cholangiocytes and 
hepatocytes which are organised into the bile ducts and hepatocyte plates 
respectively. Between plates of hepatocytes are layers of fenestrated endothelium 
which are the constituent components of the sinusoids. Residing within the sinusoids 
are macrophages, other monocytic and dentritic cells. The hepatic sinusoids are 
adjacent to the space of disse. Stellate cells and during disease, myofibroblasts occur 
within these spaces, and are responsible for the de novo synthesis of extra cellular 
matrix during normal turnover and during disease. This complex cellular and 
acellular environment is fundamentally dynamic, and during both disease 
establishment and epithelial regeneration the different hepatic cell types must interact 




Regeneration in the Adult liver 
Due to the primary function of the liver it is subject to both acute and chronic injury, 
as such the liver must be able to tolerate these damaging processes. To cope with 
these events the liver has evolved a two-tier regenerative mechanism by which it can 





During normal homeostasis the adult liver has a basal proliferative rate of approx 
0.5% of hepatocytes in cycle at any one time; furthermore the parenchyma is 
remarkably quiescent with a cell life of 200-300 days
20
. Compared to tissues such as 
the intestine or testis, the liver is remarkably quiescent; however a healthy adult liver 
can regenerate completely from a partial hepatectomy of up to 75% and can activate 
mature hepatocytes and cholangiocytes to regenerate the complete liver within seven 
days
21
. Furthermore post transplant the liver has a remarkable homeostatic plasticity 
which allows it to grow or shrink depending on the body size of the recipient, again 
highlighting diverse activation of proliferation or apoptosis depending on the 




In many tissues, including brain, skin, testis, intestine and bone marrow cells are 
regenerated from a resident tissue stem cell
24-28
. These cells must satisfy certain 
characteristics: longevity, self-renewal, asymmetrical division and mulitpotentiality 
and translatability are all criteria which must be met in order for a cell to be 




in the literature. There is little compelling evidence in the field that the hepatic stem 
cell has been identified, and the field is muddied by multiple reports with insufficient 
or partial validation of ―hepatic stem cell‖ phenotype
10, 29, 30
. What is known though 
is that there is a mature regenerative component in the liver, and an immature hepatic 
progenitor cell which is capable of regenerating both hepatocytes and 
cholangiocytes
31, 32
 – which for the continuation of this work will be called a Hepatic 
Progenitor Cell (HPC). In rodents these progenitor cells are historically known as 
Oval Cells (OCs) and are likely to be a transit amplifying population, rather than a 





Intriguingly the mature parenchymal components of the liver fulfil some ―stem cell‖ 
criteria. Large scale hepatic resection results in the mitotic activation of hepatocytes 
and cellular compensatory hypertrophy which within two cell divisions which can 
regenerate the hepatic parenchyma
34
. Importantly it appears that these proliferating 
hepatocytes from donor animals result in clonal patches when transplanted into a 
recipient liver. The ability of hepatocytes to divide and repopulate the liver was 
initially demonstrated by the incorporation of adenoviral β-galactosidase which was 
administered a limited dilution, and was only then incorporated into a small subset of 
hepatocytes. The transgene would then be replicated and separated into daughter 
hepatocytes during mitosis; this identifies these cells as products of labelled  
parenchymal hepatocytes, and demonstrated patches of hepatocytes can be 






Further to this work multiple groups have used the fumarylacetoacetate hydrolase 
(FAH) knockout mouse, as well as the urokinase plasminogen activator (uPA) 
transgenic mouse to investigate the regenerative potential of hepatocytes. These 
studies demonstrated that hepatocytes from a donor animal are capable of cellular 
engraftment into the damaged liver akin to haematopoietic stem cells in the bone 
marrow, but moreover are capable of proliferation in a metabolically deficient liver, 
and as such have a selection advantage over the host hepatocytes. Furthermore  this 
work showed that the replenished wild-type hepatocytes can be isolated from this 
initial recipient, and will engraft into a second recipient for up to 69 serial 
transplantations, as such hepatocytes have an almost limitless replication potential 
36, 
37
. This work has been continued extensively by Grompe and colleges who have 
demonstrated that donor hepatocytes regenerate the recipient parenchyma in a 
clonally derived manner, but do however rely on the strong selection advantage of 
being in a metabolically deficient host environment
38
 as such hepatocytes may be 




Serial transplantation of hepatocytes does not define them as a stem cell. However in 
Dipeptidyl Peptidase IV (DPPIV) knockout mice wild-type donor hepatocytes have 
been shown to be bipotent, and reconstitute both hepatocytes during PHx and 
retrosine treatment and the biliary epithelium during bile-duct ligation (BDL)
39
. It 
should be noted with this study that the purity of the initial cell population may have 
been contaminated with biliary epithelial cells and as such highlights the need for 
means of clonal analysis during hepatocellular regeneration
40
, never the less the 




source of cells for liver disease. One great limitation of hepatocyte therapy for liver 
disease is their availability which often requires a cadaver as hepatocytes are 
notoriously difficult to expand in vitro
41
. One response to this has been to utilise ES 
and iPS cells directing these cells into hepatocyte-like cells
42-44
; which could in 
theory generate large numbers of patient specific hepatocytes for transplantation – 
these techniques are however still in their infancy
45
 and as such the current focus of 
much research is investigating how to manipulate the liver‘s normal regenerative 
function. It is well known that certain cytokines such as T3 and HGF are for example 
able to mobilise hepatocytes and in healthy liver result in hepatomegly
22
; these 





As previously discussed during biliary damage cholangiocytes are also activated and 
can proliferate to restore the biliary tree; however the mechanisms by which this is 
achieved is not as extensively studied as during hepatocyte regeneration. Recent 
work has shown that cholangiocyte serotonin can remodel the biliary tree in adult 
liver, further more EBP50 and the cholangiocytic exosome have been implicated in 
the activation and proliferation of cholangiocytes in response to damage
46, 47
. 
Furthermore the double-stranded RNA-activated protein kinase (PKR) is not 
typically expressed in quiescent bile ducts, however it is up-regulated during biliary 
proliferation in Primary Biliary Cirrhosis
48
. These proliferative stimuli are balanced 
by a novel, and atypical mechanism of apoptosis
49, 50
 – suggesting that the 





During chronic disease a second regenerative HPC compartment is classically 
described as becoming activated when hepatocyte and cholangiocyte regeneration is 
either impaired or indeed overwhelmed; however more recent work suggests that this 
progenitor cell compartment may contribute to the normal homeostasis of the adult 
liver and as such may be much more active than initially realised
51
.  Sox9 is 
expressed throughout the bile duct and within the HPC population. Using a 
conditional LacZ reporter combined with the Sox9-CreER
51
 Furuyama et al. 
demonstrated that even when the liver is not damaged the hepatocytes are 
regenerated from a Sox9 positive population – of course it is not known whether 
dividing hepatocytes go through a phase of Sox9 positivity; but this work does, for 
the first time investigate the possibility that hepatocellular and HPC regeneration are 
not as discrete as previously understood. 
 
HPC mediated liver regeneration 
Adult HPCs are well described as facultative progenitor cells which (until recently) 
have only been described as undergoing any significant expansion in response to 
liver damage. HPCs are scarce in the undamaged liver, however are apparent in high 
numbers during chronic damage or disease in both rodents and humans. Initially 
described in the early 20
th
 century HPCs have a basophilic cytoplasm and high 
nuclear to cytoplasmic ratio
52, 53
. HPCs are now understood to be crucial during the 





Classically HPCs have been induced using surgical resection and inhibition of 
hepatocyte regeneration using 2-N-acetylaminoflourene (AAF) or Retrosine; these 
works were initially successful in rats and later have been translated into mice. This 
results in the activation and proliferation of the HPC population and results in the 
rapid restoration of normal liver architecture within a matter of days
31, 54
. Carbon-
tetrachloride (CCl4) has also been used to induce fibrosis and a modest HPC 
response
30, 55, 56
. These models have been extensively used in the exploration of HPC 
origin and the proliferation capability of HPCs
55
, however both of these well 
described models are well suited to rats which have a greater propensity to develop 
end-stage liver disease, and are obviously large enough to operate on. There are 
though some disadvantages to the use of CCl4 and PHx with hepatocyte inhibition. 
During both CCl4 and surgical resection large components of the biliary tree and 
parenchyma are removed HPCs must contribute to the regeneration of both epithelial 
components. As such it is difficult to use this model to elucidate the differential 
regulation of HPC differentiation into hepatocytes and cholangiocytes. Dietary 
models have become increasingly popular as means of targeted hepatocellular or 
biliary damage and as such may allow investigation of this fate decision. 
 
The Choline Deficient Ethionine supplemented (CDE) diet has been used to great 
effect in the induction of hepatocellular damage and regeneration
57-60
. Initially 
described as a carcinogenic model in rats, the CDE diet has been adapted for use in 
mouse. Ethionine is an ethyl analogue of methionine and is responsible for the 
inhibition of SAM (S-adenosyl-L methionine) synthetase enzyme, as the effect of 




choline; a methionine precursor resulted in a more aggressive response to the 
ethionine treatment and as such resulted in the proliferation of HPCs throughout the 
liver. Furthermore chronic administration of the CDE regime results in progressively 





In opposition to the CDE diet, which can be observed as a model of hepatocellular 
damage and regeneration is the 3, 5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) 
model of biliary disease
63
. The DDC diet results in the accumulation of porphyrin 
aggregates within the biliary tree, this results in the blockade of the ducts and 
activates the HPCs, requiring them to regenerative the biliary tree – although the 
exact mechanism by which this damage and regeneration occurs in unknown. HPCs 
arising in this model evolve only close to the portal tract, and do not form columns 
into the parenchyma. Rather they evolve as distinct ductular vessels, which have 
poorly defined lumen. Chronic administration of DDC results not only in the 
establishment of biliary disease, but also in secondary necrosis of hepatocytes, and as 
such may, in the chronic situation provide a more appropriate model of human 




As multiple models of HPC activation are established in the field recent work has 
focused on the origin of HPCs. Work by Thorgeirsson and colleagues initially 
identified that HPCs arise from the terminal ducts or the biliary tree
54, 67
, which is 
now understood to be where the putative liver stem cell resides
68-70




and others, label retaining cells displaying a spectrum of differentiation were 
observed within the parenchyma and are also found within regenerative nodules 
suggesting that during parenchymal regeneration at least the liver ‗streams‘ from 
portal tract to central vein producing clonally derived patches of HPC-derived 
parenchyma 
71-73
. Experiments involving tracing cells with tritiated thymidine 
combined with mature cholangiocyte markers demonstrated that as well as deriving 
hepatocytes these HPCs could differentiate into biliary epithelium, suggesting that 
these cells are capable of differentiation into both mature hepatic epithelial cell 
types
31, 32
 (Figure 1.2).  
 
Despite the clear existence of bipotent HPC population the debate over their origin 
had been contested for several decades. One of the main limitations that the HPC 
field suffers is the lack of uniformity in what different groups call an HPC. The most 
accepted marker for HPCs in vivo is A6, which identifies HPCs though an as yet 
unknown epitope,  however pan-cytokeratin has been shown to almost exclusively 






 have been described 
as markers of the HPC population during regeneration. These are wide-spectrum 
molecules, and as such there has been an effort to identify novel and predicted 
markers of the HPC population which could give some insight into lineage hierarchy 
and differentiation capability of HPCs (similar to the situation in the haematopoietic 
system) however the search for these markers has resulted in a confusion of papers 





The HPC and Haematopoietic Stem Cell (HSC) share common markers, such as sca-
1 c-kit, CD34 and Thy-1 
7, 29, 30, 77
(although Thy-1 has recently been shown to be 
expressed in associated myofibroblasts, and not HPCs
78
). As many HPC markers are 
also found on haematopoietic stem cells opinion arose that HPCs may be bone 
marrow (BM) derived
79, 80
. These works are now generally discredited and the 
observations were likely to be a result of monocyte-hepatocyte cell fusion
81, 82
. There 
remains some recent work looking at BM differentiation into hepatocytes which, 
despite being convincing, is un-physiological and solely an in vitro phenomenon and 
has yet to be extensively tested in vivo models of disease
83, 84
. In recent years the 
consensus has shifted to a belief that the HPCs are prominently of hepatic lineage, 
however the identity of the hepatic stem cell remains elusive, and transgenic models 










Figure 1.2 – The liver demonstrates a two-tier mechanism of epithelial 
regeneration  
The liver has a two tier mechanism of regeneration. During acute parenchymal 
damage apoptotic hepatocytes and cholangiocytes are cleared though macrophage 
phagocytosis. Mature hepatocytes are then activated and are capable of multiple 
divisions to replenish the parenchyma. During chronic damage, where hepatocyte 
regeneration in overwhelmed or impaired a second population of hepatic progenitor 
cells is activated, where they proliferate and then migrate to the site of injury. Here 
they differentiate into mature epithelial cell types, depending on the type of epithelial 




The Hepatic Niche, and its Contribution to Liver Regeneration 
During regeneration of other adult organs from progenitor cells a niche consisting of 
both a cellular and matrix component has is necessary for the correct regulation and 
maintenance of progenitor cell phenotype
88, 89
. However exploration of how a 
multicellular hepatic niche affects HPC proliferation and differentiation remains 
under-studied, and as such on-going investigation into what cellular factors 




Importantly though there is an HPC niche which is formed during hepatic damage 
which is well conserved between species, and as such appears to be critical in 
appropriate activation, proliferation and differentiation of HPCs
91
 . During normal 
liver homeostasis this niche does not exist and as such may provide an insight into 
what cellular and a-cellular components are required for appropriate activation of 
HPCs in vivo. The HPC niche could also act as a putative therapeutic target through 
which the HPCs can be modulated in situ. 
 
The Hepatic niche consists primarily of two inflammatory cell types Hepatic Stellate 
Cells/Myofibroblasts and resident macrophages, or Kupffer cells
90, 92
. The stellate 
cell is strongly implicated in the deposition of new matrix, but can also mediate 
matrix degradation by expression of TIMPs, which regulate MMP activity, 
commonly expressed by macrophages throughout the damaged liver
93
. Increasingly 
we understand that the dynamic turnover of matrix is necessary for correct activation 




in the initial activation of HPCs. Interestingly using the Col1a1(r/r) mouse, which is 
unable to degrade collagen 1 has a severely abrogated HPC reaction during 
regeneration of parenchymal damage
94
. Interestingly HPCs are closely associated 
with a laminin rich sheath which surrounds HPCs during regeneration, suggesting 
that the de novo production of certain matrix may influence the maintenance and 
proliferation of HPCs in vivo. Curiously the laminin sheath which abuts the HPCs is 
perforated. These pores allow the Stellate Cells to extend fenestrations through these 
gaps and directly contact the HPCs suggesting that they are not simply present to 





More recent data that suggests that some of the cell types that were previously 
thought to be composites of the niche may actually be a sub-population of HPCs in 
their own right and are capable of contributing to epithelial regeneration through 
transdifferentiation
78, 95
. Stellate cells may be novel population of bipotent hepatic 
progenitors. As using a GFAP-GFP reporter there is notable expression of GFP cells 
in the parenchyma, which co-label with hepatocyte markers after damage has 
resolved and the GFAP
+
 myofibroblasts have regressed – the authors suggested  that 
these GFP
+
 cells which co-expressed GFAP can transit into the parenchyma and 
become mature hepatocytes, however the authors did not investigate whether there is 
a developmental window in which HPCs are GFAP positive and as such the GFP 
positive parenchyma could arise from a classical epithelial HPC source and not 




The hepatic macrophage (Kupffer cells) also appears critical during regeneration of 
damage. During fibrosis macrophages migrate to the site of injury where they 
phagocytose post apoptotic debris. Furthermore they generate numerous enzymes 
and cytokines which are responsible for the destruction of matrix but perhaps more 
importantly are implicated in the recruitment of other secondary cell types, which 
can have a pro-fibrotic or pro-resolution phenotype
92, 96
. During hepatocellular 
damage which results in HPC activation macrophages are known to migrate to these 
regenerative sites and as such may act to stimulate or influence the HPCs, certainly 
in models of other tissue injury macrophages are critical for the mobilisation of 
progenitor cells and are needed for the correct restoration of the epithelial 
architecture. In kidney for example regeneration of podocytes requires macrophage 
derived signals in order to regenerate appropriately – the loss of macrophages 
confers a reduction in renal repair
97, 98
.  Tissue macrophages must by definition be 
influenced by their local environment, where epithelial cells will be dying and 
fibrotic matrix will be both synthesised and destroyed. The specific mechanisms by 
which macrophages can sense their damaged environment and appropriately 
stimulate the macrophage to produce Wnt ligand is unknown, however there is likely 
to be a common pathway between the point of phagocytosis and activation of gene 
transcription. The damaged epithelium may liberate TGF-β, which induces 
phagocytosis of debris by macrophages
99
. The act of phagocytosis could stimulate 
gene change of these macrophages and allow them to adopt a pro-repair 
phenotype
100, 101
, however this has not been extensively explored, and has not been 




It is unsurprising then that during hepatocellular regeneration from HPCs, where a 
dynamic niche is involved that there are complex arrays of signals which allow 
proliferation of HPCs, and some which may control and influence the correct 
differentiation of HPCs. Regarding the latter very few of these pathways have been 
described in the adult, however there is an increasing body of evidence which 
examines those factors involved in the activation and proliferation of HPCs. 
 
The HPC Response is mediated by a many factors. 
During regeneration of the hepatocytes and cholangiocytes the HPC response should 
not be observed as a separate entity to inflammation, in fact many of the signalling 
molecules which are released during fibrosis have been shown to play an important 
role in the activation, proliferation and migration of these cells during liver 
regeneration. Anecdotal evidence suggests that the degree of regeneration from 
HPCs is proportional to the amount of injury, and as such the inflammatory milieu 





Transforming growth factor beta (TGF-β1) is a potent cytokine produced by both 
hepatic stellate cells and resident macrophages; furthermore it is sequestered in the 
ECM. During matrix remodelling TGF-β is liberated and as such can act upon HPCs 
and other cell types
13
. The TGF-β1 ligand is also processed into its activated state 
though interaction with inflammatory associated enzymes such as the Matrix 




inflammation and epithelial regeneration
93
. During regeneration there is a differential 
expression of TGF-β type I and type II receptors  on Hepatocytes and HPCs which 
correlates with the inhibitory affects of TGF-β on the hepatocyte population
102
. 
Activation of the TGF-β type I receptor results in the sequential phosphorylation of 
Smad2 and Smad3 which the authors suggest are the downstream mediators of 
proliferative inhibition in hepatocytes. As such HPCs are able to proliferate in the 
presence of this inhibitory cue due to heavy glycosylation of the TGFβII receptor on 
HPCs, and as such are not restricted in the same manner as hepatocytes, however the 
authors fail to investigate by which mechanism the TGFβII receptor is glycosylated.  
 
Another potent cytokine for the activation of HPCs is TNF-like weak inducer of 
apoptosis (TWEAK)
103
, which through its receptor Fn14 induces proliferation  of 
HPCs. In the absence of TWEAK either through ligand or Fn14 knockouts the HPC 
response is delayed or an attenuated HPC response is observed
103
. Further work 
demonstrated that activation of the Fn14 receptor results in the upregulation of NFκB 
and stimulated HPC proliferation in a dose dependent manner – interestingly this 




Other members of the TNF superfamily have been implicated in the activation of 
HPCs; however none to date are as potent as TWEAK, and cannot induce an HPC 
response independent of damage. TNFα for example is known to increase in the 
majority of chronic liver diseases and acts through the TNFR1 and TNFR2 receptors 




TNFR1 results in a partial abrogation of HPC activation – but does not prevent the 
activation of HPCs completely
105, 106
. As such there is suggestion that other TNF 
family members such as Lymphotoxin-α (LT-α), Lymphotoxin-β ( LT-β) and LIGHT 
(homologous to LT, inducible expression, competes with herpes simplex virus 
(HSV) glycoprotein D for HSV entry mediator (HVEM), a receptor expressed on T 





Many inflammatory cytokines are known to activate the gp130 pathway though 
dimerisation of the gp130 receptor and activation of the JAK/STAT and MAPK 
pathways. Classical inflammatory signals act upon HPCs through this pathway 
including Oncostatin-M (OSM), Interleukin-6 (IL6) and Leukaemia Inhibitory Factor 
(LIF); of these compounds IL6 is the most extensively studied and as known to be 
important in the activation, proliferation and migration of HPCs both in vitro and in 
vivo where IL6 knock out results in a decreased HPC response via the 
heterodimerisation of IL6Rα and gp130
108
. Conversely if the gp130 receptor is 
constitutively activated, such as in the gp130
Y757F





Finally the Interferon-γ (INFγ), cytokine has been shown to increase the mitotc index 
of HPCs when mice are fed a CDE diet in vivo. The same report does not suggest 
that this is a direct influence of INFγ on HPCs
105
, rather this is an upstream affect 
which exacerbates the number of α-SMA
+ 




recruitment of inflammatory cells and alters their cytokine expression in CDE livers 
altering the proliferation of residual hepatocytes
96
– all factors which contribute to 
HPC activation during disease. 
 
The ever increasing body of data which investigates the activation of proliferation of 
HPCs sits in stark contrast to those studies which have attempted to delineate the 
mechanisms by which HPC differentiation is mediated. Indeed there is almost no 
work in the literature looking at the pathways and components which allow lineage 
separation of cholangiocytes and hepatocytes from a bipotent HPC in the adult.  
 
Only very recently has one study arisen which looks at the differential presence of 
Notch and Wnt pathways during the regeneration from HPCs during biliary and 
hepatocellular regeneration during adult human disease
110
. This work was 
predominantly descriptive and as such offered no insight into the mechanism behind 
differentiation of HPCs into hepatocytes and cholangiocytes. Spee and colleagues 
found that during regeneration in human biliary diseases primary sclerosing 
cholangitis and primary biliary cirrhosis the Notch pathway is highly up-regulated in 
HPCs when compared to HPCs isolated from patients presenting with end-stage 
HCV infection. Furthermore this work demonstrated that the Wnt signalling pathway 
is upregulated in both chronic biliary and hepatocellular disease states – however 
these are end stage samples and say nothing of how the regenerative response is 




invariably a degree of biliary and hepatocellular regeneration which may confuse any 
mechanistic investigation of HPC specification. 
 
During hepatic ontogeny however the roles of the Notch and Wnt pathway have been 
well described
15, 111
. As regeneration appears, in some sense to recapitulate 
development, the mechanisms by which hepatoblasts and HPCs are specified may be 
similar and as such the role of Notch and Wnt signalling during hepatic ontogeny 
shall be discussed here, along with any work which alludes to a role for Notch and 
Wnt signalling during regeneration. 
 
Notch Signalling and its importance in development, disease and 
maintenance. 
Metazoan development is regulated by multiple pathways which are known to 
operate as networks in order to confer specific information and as such phenotype on 
a cell
112-114
. The Notch signalling pathway is classically described as a means by 
which a uniform group of cells can establish differences by signalling with one 
another and has been implicated in differentiation and proliferation in both the 




The Notch receptors and their ligands 
The vertebrate Notch signalling pathway consists of four Notch receptors (Notch 1-




membrane and receive signals from the DSL family of ligands
116
. All Notch 
receptors contain multiple EGFR-like repeats which are found on the extracellular 
domain of the cell surface receptor. These sequences are followed by cystine rich 
LNR domains and a transmembrane domain. On the inner surface of the cell 
membrane the Notch receptor has an interaction domain which is required for 
Notch‘s transcriptional function followed by ankyrin repeats and a PEST 
domain
117
(Figure 1.3).  
 
Notch receptor is cleaved to form its active isoform in the endoplasmic reticulum by 
a furin-like convertase (S1 cleavage), and is then trafficked to the cell surface as an 
inactive receptor
118
. Upon ligand binding the receptor is cleaved by an ADAM-
family metalloproteinase which is also membrane bound (S2 cleavage) 
119, 120
. This 
cleavage facilitates subsequent Notch activation. The product of S2 cleavage is 
rapidly processed by the γ-secretase containing complex presinillin, this cleavage 
(S3) liberates the cytoplasmic domain of Notch receptor from its membrane anchor 




The activation of Notch receptor requires an appropriate ligand. These can be 
classified into two families depending on their sequence homology to the Drosophila 
homologues Delta and Serrate, the latter is known as Jagged in vertebrates
123
. There 
are 3 Delta (Dll) homologues in vertebrates Dll1, 3 and 4. Also there are two 
homologues of Drosophila Serrate, known as Jagged 1 (Jag1) and Jagged 2 (Jag2). 




the Delta and Jagged ligands have large sequences of EGFR-like repeats on the 
extracellular surface; however contain a degenerate N-terminal EGFR, known as the 
DSL domain; and is required for ligand function in invertebrates
117
. Furthermore the 
Jagged family of ligands contains a cystine rich region which may act to modulate 
ligand receptor interactions, and explain why binding of these divergent ligands to a 









Figure 1.3 – The canonical Notch signalling pathway 
The Notch receptor is a multi-domain single-span receptor which is found associated 
with the cell membrane. Upon binding with a Jagged or Delta ligand which is found 
on an adjacent cell the Notch receptor undergoes a conformational change and 
sequential cleavage events. These cleavage events result in the translocation of the 
Notch intra-cellular domain to the nucleus, where it complexes with a transcriptional 
repressor complex. The association of the Notch intracellular domain with this 
complex results in its dissociation and the recruitment of a transcriptional activation 
complex. This complex results in the transcription of Hes/Hey gene family which act 





Notch Signalling is driven by mechanical changes at the cell 
membrane. 
As previously discussed the Notch receptor is sequentially cleaved by ADAM-10 




. Notch receptor 
however is not spontaneously cleaved and requires the interaction with Notch ligand, 
subsequent conformational change and processing of the Notch receptor. The 
mechanism of this processing has been intensely studied as there are multiple 
mutants which gives a striking phenotype similar to Notch receptor mutants 




The Drosophila Notch ligand Delta had a complex internal localisation pattern. 
Being detected as expected on the cell surface, but was also present in intracellular 
vesicles during certain stages of development. Further investigation elucidated that 
the Delta ligand undergoes endocytosis and it is this mechanism which is required to 
facilitate subsequent activation of the Notch receptor
125, 126
. Using the temperature 
sensitive Delta allele Dl
RF
 Parks and colleagues showed that this protein resides on 
the cell surface in a constitutive manner, and yet acts as a loss of function mutant. 
Similarly the same group also identified delta mutants which are described as 
‗trafficking-defective‘ – these too show a phenotype similar to Notch mutants 
leading to the hypothesis that removal of Delta from the cell surface membrane is 
critical for its role as a signalling ligand, and that loss of endocytic function results in 






Using the development of the Drosophila retina and primary wing vein it was shown 
that Delta binds to the Notch receptor. This ligand is trans-endocytosed along with 
the products of S2 cleavage. The remaining Notch receptor fraction is then available 
for subsequent activation via S3 cleavage. Flies that contain mutations in the third 
epidermal-like growth factor repeat (ELR) of Delta exhibit the ability to aggregate 
with S2 Notch expressing cells – that is to say there is appropriate binding of Notch 
Receptor and Delta ligand, however the integrity of the third ELR is compromised 





 as such a Notch mutant phenotype is observed. 
 
More recent studies implicate E3 ubiquitin ligases as playing a crucial role in Notch 
signalling. Neuralized (Neur) and Mindbomb (Mib) are two such ligases which are 
necessary for correct signalling by controlling the endocytotic activation of ligands. 
Mutants in these two proteins results in an increased level of ligand on the cell 
surface. In model systems such as Drosophila and Zebrafish, Neuralized and 
Mindbomb play a critical role
129, 130
, with knockouts of these proteins causing a 
neuralized phenotype similar to that observed with Notch inhibition
131
. Furthermore 
specific regions of the Neuralized protein are required for correct endocytosis, and as 
such appropriate Notch signalling
132, 133
. Naïve and inactive ligand is rapidly 
endocytosed and trafficked to the proteosome for degradation. Ubiquitination of the 
Notch ligands activates them, and allows the recruitment of Epsin, which facilitates 







The endocytosis of receptor bound ligand facilitates a conformational change in the 
Notch receptor making it receptive to S2 processing
126
. Other mechanisms of ligand 
regulation play an important role in regulation of Notch signalling. Kuzbanian-like 
which cleaves the Delta ligand in Drosophila acts to negatively regulate activation of 




In Drosophila, Kuzbanian (Kuz), a homologue of the mammalian ADAM10 
metalloprotease is required for correct processing of not only Notch receptor but also 
Notch ligand Delta
120
. This protein was originally identified in 1996 using 
Drosophila mosaics, as Kuz knockouts are embryonically lethal
135
. These flies 
exhibited clusters of sensory bristles – a typical phenotype of Notch mutants in 
Drosophila. This phenotype is characteristic of a lack of lateral inhibition. These 
sensory bristles are consistently Kuz
 
negative suggesting that there is a cell 
autonomous need for Kuz so lateral ectodermal cells to be inhibited by the emerging 
neural cell
136
. Delta cleavage has more recently been identified as an endocytosis 
independent mechanism for down regulation of Notch signalling by regulation of 




There is increasing evidence in the literature that mammalian Notch ligands can be 
sequentially processed in a similar way to both Drosophila delta and Notch
138-140
. 
Through a series of co-transfection studies Both mammalian Jagged and Delta were 
shown to undergo cleavage by the α-secretase ADAM-17 
139, 141
and these cleaved 




The cytoplasmic products of Jagged cleavage have NLS motifs which facilitate 
trafficking to the nucleus. Using a Jagged intracellular domain (J
icd
) construct this 
cleavage product was shown to be enriched in the nuclei of Jagged expressing cells. 
The production of this novel signalling fragment acts competitively with N
icd
 upon 
ligand and receptor interaction, potentially acting as a buffer mechanism against 




Notch signalling can also be regulated by a multitude of other mechanisms. Dll as 
mentioned is an activator of the Notch receptor. However there is increasing 
evidence that these typical ligands can also inhibit Notch receptor activation
142
. 
Recently atypical Notch ligands, which are structurally related to both Notch and 
Delta but are not involved in the facilitating the classical Notch cleavage events have 
been described
143
. These include Dlk1 and its homologue Dlk2
144
. Dlk1 can bind via 
the EGF repeats on both itself and Notch receptor can negatively regulate the normal 
action of Notch
143
. The Dlk1 family of atypical Notch ligands has been extensively 
characterised in adipogenesis. Known as pre-adipocyte factor 1 (Pref-1) in these 





Appropriate Notch receptor activation depends on glycosylation 
Ligand mediated activation of the Notch signalling pathway is not the only 
mechanism by which Notch signalling can be regulated. Notch receptor function is 






fucosyl-transferase is necessary for the addition of the first fucose molecule  the 
Notch receptor
128
, these can then be extended by other members of the Fringe family 
of glycosyl-transferases to give a unique pattern which may be associated with Notch 
activation in specific tissue types, but also may affect receptor-ligand affinity and 
subsequent receptor activation
147
. The glycosylation pattern of the Notch receptor is 





Notch signalling is mediated by CSL 
Liberation of the N
icd
 domain as a result of the S3 cleavage event is the start of Notch 
mediated repression of differentiation. N
icd
 interacts with a CSL, (Su (H) in 
Drosophila, lag-1 in C. elegans, and RBP-Jk in Mammals). Notch target genes are 
normally repressed by CSL and co-repressors
149, 150
. Upon interaction with N
icd
 this 
transcriptional repressor is converted to a transcriptional activator. This switch from 
repression to activation facilitates the expression of Enhancer or split genes (E (spl)) 
or the Hairy/Enhancer of split (Hes) genes in mammals. These genes code for bHLH 
transcriptional repressors which act upon class II bHLH transcription factors, for 
example the Achaete-Scute (A-Sc) genes (known as HLH-3 in C. elegans and the 
MASH genes is mammals). Typically high levels of A-Sc genes are markers of 
directed differentiation. In mice high levels of MASH1 are associated with neuronal 







The mechanism by which notch signalling can convert a complex of transcriptional 
repression into one of transcriptional activation if well described. In Drosophila the 
protein Hairless (H) 
155
enables global repression of target genes via its co-factors. 
When Su (H) forms a complex with DNA it can recruit Hairless. Hairless can in turn 
recruit co-repressors of transcription such as CtBP
156
. This H-CtBP complex acts to 
recruit Histone Deacetylases (HDACs) which function to make chromatin 
transcriptionally inactive. Hairless also has the ability to recruit Groucho proteins, 
which act as long range transcriptional repressors
157
. These proteins are able to 
recruit HDACs and co-factors, which as before suppress transcription on a chromatin 
level
158
. This high level of transcriptional suppression in response to Notch signalling 
also exists in vertebrate systems of Notch signalling (Figure 1.3). 
 
In mammals there is no known direct homologue of Hairless but global repression 
exists via co-repressors including SMRT and SHARP
159-161
 which recruit CtBP or 
other global repressors including SKIP
127
 and CBF-1 interacting co-repressor 
(CIR)
162
. Functionally Hes-1 can be observed as a homologue of Hairy (a binding 
partner to Su(H)) and as such Hes-1 can form a homodimer, which binds to the C or 
N box consensus DNA sites and can recruit the mammalian Groucho homologue 
TLE
163, 164
. As in Drosophila TLE recruits HDACs thus altering local chromatin 
structure preventing transcription from certain loci. The expression of Hes-1 can 
efficiently down-regulate its own expression through binding of the Orange domain 
to the Hes-1 promoter sequence
163
– thus preventing its own transcription and the 




After the recruitment of N
icd 
and associated co-factors the CSL-N
icd
 complex is 
converted into a transcriptional activator
167
. This conversion facilitates the 
expression of the HES and HERP genes in mammals and Enhancer Split E (spl) in 
Drosophila these proteins block the downstream events of Notch signalling in a 
similar way to Hairless acting on the HES promoter upstream. HES and HERP 
recognise motifs in classes of bHLH transcription factors, many of which are 
implicated in the early specification events during differentiation as previously 
discussed. 
 
Notch Signalling typically inhibits differentiation 
Notch signalling has typically been shown to act as a repressor of differentiation in 
multiple cells systems. Classically this fate control, known as lateral inhibition has 
been studied in the development of Drosophila, C. elegans and Xenopus due to the 
ease by which they are manipulated. 
 
At the level of patterning Notch signalling acts to amplify bias between adjacent cells 
where the levels of activator which drives differentiation is similar and only slight 
stochastic variations occur. The stochastic variation would cause an increase in 
Notch ligand in the signalling cell. This activates Notch receptor in the surrounding 
cells and resultantly suppresses the differentiation of these cells, or facilitates their 
transit along a default differentiation
168
 in turn receptor-ligand balance between these 




cell, and a decrease of ligand in the surrounding cells further driving these cells into 
divergent fates.  
 
The simplest role of this patterning mechanism is to drive asymmetry between two 
cells which have the same or a similar potential known as lateral inhibition. When 
cells express similar levels of activator, stochastic variations will occur. When the 
levels of this activator are at critical level cells will adopt a certain fate. A random 
increase of activator such as Notch ligand in one cell leads to a relative decrease in 
pathway activation in this cell. The result of this in a two cell system is the repression 
of activator i.e. ligand in the adjacent, non-signalling cell whilst also facilitating the 
down regulation of pathway and up regulation of activator in the signalling cells, 
driving the phenotypic separation of these two, otherwise equipotent cells. The initial 
bias in these cells may not be entirely stochastic, but a result of a separate input, such 
as a morphogen gradient, however Notch signalling increases this initial bias to 




Lateral inhibition occurs in complex cellular environments - patterning of sensory 
bristles (macrochaetes) in many invertebrates is observed as the classical example of 
lateral inhibition within a cluster of cells. Macrochaetes arise from a proneural 
cluster of approximately 20 cells
169
. These cells all express proneural genes such as 
Achaete-Scute (A-Sc) complex genes, which promote the expression of neurogenic 




mediated by these neurogenic genes restricts expression of proneural genes to a 
single cell within the cluster
170-172
.  
Non-classical contributions to Notch signalling 
Non-canonical notch signalling, that is to say Notch signalling which is not mediated 
by either CSL or DSL ligand can also dramatically influence cell behaviour, however 
has not been as extensively studied as the classical Notch signalling pathway.  
 
Deltex is a protein initially identified in Drosophila, but is also implicated in Notch 
signalling in both Mouse and Human
173-175
. It was the first component of the pathway 
which was shown to reside in the cytoplasm, and the first to be associated with the 
Notch receptor intracellular region. The Ankyrin repeats found on the intracellular 
region of Notch are necessary and sufficient for Deltex binding
176
. More recent 
studies have implicated Deltex in being a positive regulator of Notch signalling, and 





Deltex may also play a crucial role in non-CSL signalling through associating Notch 
receptor with the Grb2 protein, which is classically implicated in receptor tyrosine 
kinase signalling. Similarly there is also evidence that abl cytoplasmic tyrosine 








The importance of Deltex as a positive regulator of Notch signalling is further 
exemplified by its antagonistic counterpart the E3 Ubiquitin ligase, suppressor of 
Deltex (Su (dx)) in Drosophila, and Itch in mammals. Su(dx) acts to ubiquitinate N
icd
 
at a point where it is membrane tethered targeting it for degradation
179
. Similar 
protein modifications by the E3 ligases on Notch receptor targets offer a plethora of 
regulatory events. N
icd
 which is localized to the nucleus is hyperphosphorylated, with 
at least one phosphorylation occurring upon entry into the nucleus. This event is 
crucial for the recruitment of the Sel-10 containing SCF which targets N
icd 
to 




Further modifiers of the Notch signalling pathway have been described (summarised 
in Figure 1.4). Numb for example has been identified as a ubiquitin ligase which acts 
in Drosophila, mouse and human to prevent the ectopic activation of Notch 
receptor
181, 182
. The majority of functional work looking at Numb has been conducted 
in Drosophila where Numb acts to antagonize the Notch receptor in a dose 
dependent manner and results in a repression of a Hes1 reporter
183
. In mammalian 
cells Numb has been to shown to interact with the Itch (the mammalian suppressor of 
Deltex) and enhance ubiquitination of the Notch1 receptor
184
. Interestingly ablation 
of Numb does not prevent the endocytosis of Notch receptor, rather the receptor is 
recycled, however during Numb over expression the Notch1 receptor is endocytosed 
in clatherin containing vesicles and the receptor is targeted for destruction; and as 







The regulatory mechanism of Numb, as with many of the Notch signalling modifiers 
is complex, and involves the conversion of multiple pathways on Numb regulatory 
elements. Numb is regulated at the transcript level by Musashi-1 and this has been 
shown in liver cells to be modulated during differentiation
186, 187
; however the affect 
of this modulation on Numb was not demonstrated by the authors of this work, rather 
they focused on the role that a thermo reversible gelation polymer plays on HPC 
activation and Musashi-1 expression, there was no attempt to investigate the 
functional role for Musashi-1 and Numb interaction in these HPCs. Recently work 
looking into what are the key putative regulators of Numb demonstrated that there 
are conserved LEF/TCF binding domains upstream of the Numb gene, which are 
highly conserved in the Numb promoter region between species demonstrating that 
Numb is Wnt responsive
188
. Furthermore two recent papers have identified that in 
haematopoiesis and during zebrafish organiser restriction Wnt plays an important 














Figure 1.4 – The Notch pathway is heavily regulated through multiple 
interacting pathways. 
The Notch signalling pathway is heavily regulated though multiple mechanisms. The 
receptor is targeted by multiple extracellular and intracellular proteins which affect 
the affinity of the receptor and ligands. Furthermore the activated receptor can be 
targeted for degradation through multiple cytoplasmic pathways which either 
positively or negatively regulate Notch receptor activity. The Notch ligands Jagged 
and Delta are also regulated at the protein level, and can also be targeted for 





Notch Signalling, and its effect on cellular systems 
The Notch signalling pathway is implicated in multiple tissue types, and at multiple 
developmental and postnatal stages. The functional role of Notch signalling has been 
widely explored both in vitro, and more recently, in vivo using transgenic 
technologies to monitor activation of the pathway, but also to ―knock-out‖ or over 
express Notch receptor and pathway effectors as a means of demonstrating how 
Notch signalling regulates cellular and tissue homeostasis in multiple organ contexts. 
 
Notch Signalling in Embryonic Stem (ES) Cells 
Notch signalling has been implicated in the expansion and differentiation of multiple 
committed precursors and mature stem cells
191-193
. ES cells are derived from the 
inner-cell mass of the developing blastocyst. These cells are destined to become the 
embryo proper later in development and as such are capable of differentiating into all 
cell types if given the correct developmental cues. Human embryonic stem cells 
require close contact in order to grow efficiently
194
. In hES cells Notch2 is processed 
and sequentially cleaved to release the intracellular fragment. Using an siRNA 
against Notch2 cell growth was significantly inhibited and apoptosis in hES cultures 
was increased. This was confirmed using γ-secretase inhibitors where treated 
colonies were reduced in size as a result of cell cycle arrest and apoptosis, rather than 




Notch signalling has been implicated in the proliferation as well as the differentiation 
of ES cells in several independent investigations
196, 197




receptor and ligand in ES cells occurs when they are directed to differentiate into 
cardiomyocytes. Upon inhibition of the Notch signalling pathway contractile beating 
cells within the culture increased in frequency, this phenotype could be inhibited by 
the ectopic expression of N
icd
 in ES cells. These results indicate that entry into a 
mesodermal lineage can be inhibited by Notch signalling, a hypothesis which was 
corroborated by N
icd
 expressing cells showing a decrease in the mesoderm markers 
Brachyury and FGF-8
196
. Notch signalling and cardiac differentiation are mutually 
exclusive, in Embryoid Body (EB) experiments cells which have constitutive Notch 
signalling cannot form mesoderm, but express nestin, suggesting they are committed 
to a neurectodermal fate. 
 
Notch Signalling in the Nervous System 
Early in their characterisation Notch genes were identified as ‗neural‘ genes. That is 
to say if any component were mutated the resulting neurogenic phenotype was 
observed. In Drosophila this phenotype is typified by an increase in Neurons at the 
expense of the surrounding epidermis
198, 199
. As previously discussed Notch 
signalling is required for lateral inhibition, and in Drosophila neuroblasts, the neural 
precursor signals to, and subsequently inhibits the proneural cells around it, 
facilitating its own progression along a neuronal route
200, 201
. This mechanism is 
conserved in vertebrates where a prospective neuron signals to other, surrounding 
neural tube cells. Through RPB-Jκ, a central component of the Notch signalling 
pathway, this prospective neuron activates Hes-5 and subsequently represses the 








 both of which demonstrate an 




Notch signalling is crucial for the correct specification of neural progenitors; 
however the expansion of these neural progenitor cells is required to have correct 
numbers of cells in the developing brain before patterning can proceed. Notch 
signalling is important for the transition between proliferation of NPCs and their 
commitment to a developmental fate
202
. The presumptive chick spinal cord develops 
in a rostro-caudal manner, relying on the generation of NPCs from the caudal plate. 
In this region cells express both high levels of Delta ligand and Notch receptor, 
which maintains a highly proliferative pool undifferentiated cells. Subsequent events 
lead to the delamination of these neural progenitors, and an increase in Delta ligand, 
which commits the signalling cell to a neural fate and the surrounding cells to an 
epidermal fate similar to that observed in other models
203
. A switch between this 
mutual activation (in the caudal plate) and lateral inhibition (in rostral neural tube) is 
induced through Notch mediated lateral inhibition. Cell autonomous Delta activity is 
implicated in the up-regulation of Tis21, an anti-proliferative gene which facilitates 




Despite the clear role of Notch signalling in the separation of a precursor cell from a 
group of equipotent progenitors the archetypal model of neurogenesis has also 
demonstrated that Notch signalling can also promote certain developmental 




differentiation it also promotes an astroglial fate in those neural precursors which are 
not destined to become neurons
204, 205
. In the classical signalling network Notch 
signalling maintains receptive cells in a naïve state, allowing them to be receptive to 
secondary signals and as such adopt a secondary fate.  
 
Notch signalling induces neural stem cells to become neurons early and then 
switches to promote gliogenesis and a glial fate later through development of the 
central nervous system (CNS). Ge et al.
204
 demonstrated that Notch signalling 
actively signals to NPCs in order to promote their expansion and differentiation into 
GFAP
+ 
glia. This is achieved through RBP-Jκ, and when these primitive cells are 
treated with a synthetic clustered Dll ligand gliogenesis is promoted. This phenotype 
is countered by application of γ-secretase – again showing that this is a direct action 
of Notch signalling. These data suggests a temporal separation of neurogenesis and 
gliogenesis during development. The authors suggest that this could be intrinsically 
linked to the JAK-STAT signalling pathway activated by LIF, which is inactive in 





Neurospheres are aggregations of neural cells which are produced in suspension from 
a single neural stem cell. Using these spheres as models of neural differentiation it 
has been shown that in this in vitro situation Notch signalling controls the 
differentiation of neurons and glia in temporally progressive signalling events. Using 
Dll1
lacz/lacz




was possible to show that exposure to Jag
ED
 (a cleaved extra-cellular fragment of the 
Jag ligand) could significantly reduce neuronal differentiation after a short ligand 
exposure time, however glia require a longer exposure to the Jag
ED
 before they 
increase their representation within the neurospheres. These results combined 
implicate persistent Notch signalling in expansion and maturation of glial cells, but 
early and short exposure of neural progenitors to ligand is sufficient to restrict their 




Notch signalling in bone homeostasis 
Notch signalling has more recently been implicated in bone remodelling and 
regeneration. The process of bone homeostasis is dynamic, and relies on the correct 
equilibrium between osteogenesis and osteodegradation. The production of a mouse 
model, where N
icd
 was under the control of the Col1a1 promoter exhibited mice with 
an increase bone mass; consisting of immature woven bone in the marrow spaces
206
. 
Further analysis implicated an increase in early oesteoblasts, and a relative decrease 
in oesteoclasts. Excessive primitive bone was produced as a result of the oesteoblasts 





Transit into a late oesteoblast phenotype is restricted by excess Notch signalling as it 
directly binds to and suppresses the Runx2 gene. Similarly in C2C12 cells 
differentiated into oesteoblasts N
icd 
shows an enhancement in proliferation through 




showed that removal of Notch signalling through deletion of Notch1 and Notch2, or 
through γ-secretase reduces the number of bone marrow stem cells by committing 








 conditional double presinillin mutant mouse it 
was shown that a reduction in Notch signalling is implicated in the formation of 
Osteoporotic bones, which an increase in oesteoclastogenesis and increase in re-




Notch signalling in maintaining the intestinal epithelium 
Endoderm patterning is important for the formation of multiple organ systems, such 
as the lungs, liver digestive tract and pancreas all of which arise from a primordial 
endodermal tube present soon after gastrulation
208
. The developing gut can be 
separated into three regions, the foregut, midgut and hindgut. The architecture of the 
gut is defined by signals from the overlying mesenchymal cells. The endodermal 
epithelium evaginates giving rise to villi and intervillus regions. The latter of which 




In the adult intestinal crypts are the locations of intestinal stem cells. These cells can 
give rise to all cell types in the adult intestine, whilst at the same time are capable of 
self renewal. This is important in the intestine as epithelial turnover is constant and 




these ISCs are located approximately 4 cells up from the base of the intestinal crypts. 
Recently Lgr5/GPR49 has been described as specifically labelling intestinal stem 
cells and through use of the Lgr5-GFP-IRES-Cre ERT reporter mouse  it has been 
demonstrated that these Lgr5 positive intestinal stem cells can mature into all 
intestinal epithelial cell lineages as well as undergoing self renewal
210
. The two stem 
cell populations Lgr5 and +4 are not mutually exclusive and may represent two 




Notch1 is the predominant Notch receptor found at the intestinal crypts. Along with 
it Jagged-1, Dll1 and Dll3 are also present. The importance of Notch signalling in 
proliferation and differentiation has been demonstrated in the gut. Using RBP-Jκ 
conditional knockout mice, or by treating mice with γ-secretase inhibitor secretory 
cells numbers are significantly expanded at the expense of enterocytes
211, 212
. These 
observations are corroborated in developing gut using the Hes-1
-/- 
mouse, which 
shows aberrant regulation of endodermal endocrine cells in liver, gut and pancreas
213
. 
In a separate study the converse was also shown to be true, that in mutants where 
constitutive activation of Notch occurs there is depletion in secretory lineage cells 




In the intestine Notch signalling acts in a typical manner, that is to say it functions to 
laterally inhibit cells from adopting a secretory cell fate. Atoh1 (also known as 
Math1 in mouse and Hath1 in humans) marks progenitors which are destined to 




genes such as Neurogenin3 and Gfi-1. Atoh1 expression is negatively regulated by 
Hes-1 and RBP-Jκ knockout mice show an increase in Atoh1, and subsequent up-




Notch Signalling: A role for liver development 
Notch signalling has been heavily implicated in both the development of the foetal 
liver and where inappropriate Notch signalling results in a retardation of hepatic 
phenotype. During development the ductal plate is located between the portal 
mesenchyme and the hepatic parenchyma as a continuous layer which undergoes 
focal dilations and gives rise to epithelial bile ducts some of which are incorporated 
into the portal mesenchyme
215
. Recent work has demonstrated that during hepatic 
ontogeny Jagged-1 supplied by the portal mesenchyme is necessary for correct 
patterning of the biliary tree. Ablation of the ligand Jagged-1 specifically in the 
portal mesenchyme results in a phenotype similar to that when Notch receptor is 
ablated transgenically (discussed extensively in the next section)
216
. Intriguingly 
recent data indicates that Notch-1 acts in a dose dependent manner to specify the 
branching and 3D structure of the portal tract
217
. Loss of the Notch1 receptor results 
in a retardation of the developing biliary tree however ectopic activation of Notch1 
results in hyper-arborisation of the biliary structure, although it does not appear to 
affect the proliferation rate of the developing cholangiocytes, and as such acts 







Furthermore reiterative work in Zebrafish demonstrates that the Notch signalling 
pathway has a biphasic role during hepatic development. Initially to specify 
cholangiocytes from the bipotent hepatoblasts; but then latterly to select for the 
correct patterning of the biliary tree
218, 219
; this work has been corroborated in mouse 





Delta-like1 (Dlk1) is a known marker of hepatoblasts in the developing liver
221
. 
However Dlk1 positive cells are also present in the CDE and DDC rat diet model of 
liver injury
222
. Dlk1, as discussed previously is a negative regulator of Notch 
signalling
143
. Hepatoblasts are foetal liver cell precursors and are known to become 
both hepatocytes, when located in the liver parenchyma, but can also become 
cholangiocytes when located in the portal Zone-1 regions. Over expression of N
icd
 in 
these cells this was shown to down regulate terminal markers of hepatocyte 
differentiation including G6Pase, tyrosine amino transferase, and 
carbanoylphosphate synthetase; this over expression also reduced levels of Albumin, 
a functional marker of Hepatocyte development
223
. When cultured in contact with 
laminin N
icd
 expressing hepatoblasts up regulate known cholangiocyte markers such 
as CK7, CK19 and HNF1β – suggesting a synergy between activated Notch and the 
Integrin signalling pathway in defining cholangiocyte and hepatocyte 
differentiation
224
. The link between Notch signalling and hepatic development in the 
developing liver is mediated by a plethora or liver-enriched transcription factors such 




responsible for the correct specification of hepatocytes (involving Hnf1α and Hnf4α) 




Notch Signalling in the diseased liver 
Alagilles syndrome results in the aberrant development of multiple organs including 
the heart, eye and is associated with severe cranio-facial malformations
219, 227
. Bile 
duct retardation is also characteristic of this condition, with sufferers often requiring 
a liver transplant as a result. In this situation the biliary tree is not correctly specified 
and as such the branches terminate prematurely, and fail to function correctly. 
Interestingly Alagilles patents are incapable of mounting an HPC response to 
damage, and as a result these individuals suffer from a lack of regeneration during 




Alagilles syndrome is classically associated with a mutation in the jag1 gene, which 
encodes the Notch ligand Jagged1
229
. Multiple mutations in this gene are implicated 
in an altered transcript which cannot function in a manner similar to the native 
protein. It is this haploinsufficiency which results in attenuated Jagged1 activation of 
Notch receptor. There are however, multiple cases of Alagilles patients who have 
normal jag1 but who phenotypically appear to suffer from Alagilles. Current lines of 
study are also focusing on the presence of mutations in the Notch receptor
230
. In a 
mouse model of Alagilles mutations or heterozygous knock outs of jag1 do not result 
in the typical hepatic and cardiac deficiencies commonly associated with Alagilles. It 




typical Alagilles phenotype is observed, suggesting that Alagilles is a heterogeneous 




The specific action of certain Notch homologues reveals that Notch2 and not Notch1 
is required for correct hepato-biliary specification
233
. Conditional liver specific 
knockouts of both Notch1 and Notch2 with Cre expressed under the Albumin (Alb) 
promoter have been reported. Conditional deletion of Notch1 and Notch2 resulted in 
retardation of the biliary network with cells rarely forming any tubular structures; 
these structures did appear later, however they were disorganised and the vessels do 
not appear to be incorporated into the portal mesenchyme. Notch2, but not Notch1 
was indispensable for correct biliary development as demonstrated in single 
conditional knockouts. Notch1 displays none of the hyperplasia observed in the 
Notch2 single knockout, which were indistinguishable from the Notch1/Notch2 
double mutant
233
. Intriguingly the AlbCreER transgenic mouse is widely used in 
these studies, giving widespread Cre expression in the liver, and may recombine any 
targets in the parenchyma as well as in the biliary tree; suggesting that in 
development these phenotypes could be induced though perturbed specification of 
the parenchyma rather than specific alteration of the developing bile ducts. 
 
 
Notch signalling is clearly implicated in the development of normal liver and is a key 
mediator in congenital disorders of multiple organ systems. Is Notch then implicated 
in HPC mediated resolution of liver injury? In a partial hepatectomy model of liver 




for the initial 6 days. Jagged levels however increase significantly in the following 
hours before returning to normal by 12h. During this phase there is a considerable 
increase in N
icd
 into the nucleus of the remaining liver. There was enhanced 
expression of Jagged in both the biliary epithelium and periportal hepatocytes, where 
as Notch2 was up regulated strictly in the periportal hepatocytes
234, 235
. Furthermore 
recent work in human chronic and acute diseases has highlighted a difference in the 
expression of Notch pathway components when regenerating the biliary tree in 
primary sclerosing cholangitis, and primary biliary cirrhosis when compared to 
regeneration of the hepatocytes following infection with hepatitis c virus; where the 




 HPCs are located in a multi-cellular niche as discussed above. The close physical 
relationship between the stellate cells, which protrude through the laminin sheath and 
the HPCs, implicates a potentially direct rather than a diffusible signal may be 
involved in the regulation of HPC differentiation in vivo. Notch signalling seems to 
be a likely candidate as in other systems where there is this close relationship 
between supportive stromal cells which constitute the niche and the progenitor cells. 
 
The Wnt signalling pathway and its importance in development, disease 
and maintenance 
The Wnt signalling pathway plays numerous and complex roles during foetal 
development, tissue homeostasis and disease progression
236, 237
. The pathway was 
originally identified by the Drosophila wingless (Wg) mutation
238, 239




a multifaceted protein pathway which is conserved between vertebrates and 
invertebrates has been described
240
. The Wnt signalling pathway is responsible in 
part for cellular proliferation, differentiation, apoptosis, survival and migration, and 
as such is regulated at multiple levels
241
. Furthermore the Wnt signalling pathway 
has been implicated in appropriate hepatic development and regeneration and as such 





The Wnt signalling pathway and its ligands 
Both Drosophila Wg and vertebrate Wnt can operate through the dimerisation of two 
highly conserved receptor families known as Frizzled (Fzd)
244
 and the LDL-receptor 
related proteins 5 and 6 (LRP5/6) – known as Arrow in the fly
245
. The mammalian 
genome contains 10 frizzled receptors, which contain striking sequence similarities, 
and as such probably act in a highly redundant manner to maintain the Wnt 
signalling cascade. LRP5/6 appears to have a partially redundant function, LRP6 is 
required for embryonic specification, and is sufficient for this role in the absence of 
LRP5
245
 .  
 
The Wnt receptors are known to activate two families of downstream pathways 
known as the canonical and non-canonical signalling pathways. The canonical 
signalling pathway, which is certainly the most extensively studied involves the 
dimerisation of the Fzd and LRP5/6 receptors and the modulation of gene 
transcription in a Ctnnb1 (β-catenin) dependent manner
241, 246, 247




pathways will not be extensively explored during this chapter, as they are by far less 
well described, and have not been implicated significantly in the specification and 
patterning of the vertebrate liver or its regeneration. Briefly, the Fzd receptor can 
bind a sub-family of non-transforming Wnt ligands, which induces either a 
heterotrimeric G-protein coupled receptor-type response, which involves the 
liberation of Ca
2+
 and activation of calcium dependent signalling processes, or can 





The canonical Wnt signalling pathway requires the close association of Fzd and LRP 
proteins and formation of a hetero-dimer at the cell surface membrane in order to 
activate downstream events, this is achieved though the binding of anyone of a 
family of canonical Wnt ligands. Wnt ligands (of which there are 19 in vertebrates) 
are cystine rich proteins peptides with a secretory motif at the N-terminus
250
. The 
archetypal canonical Wnt ligand is Wnt3a, which has earned this position though it‘s 
efficient secretion, meaning that it has the most compete biological and chemical 
characterisation of all of the mammalian Wnt ligands, and correlates generally with 
what is known about the synthesis and secretion of Wg in Drosophila (Figure 1.5). 
 
Wg and Wnt ligand is synthesised in the endoplasmic reticulum (ER), where it 
rapidly undergoes parmitoylation by the ER protein Porcupine
250, 251
. From here the 
Wnt ligand is transported through the Golgi to the cell surface in secretory vesicles, 




Retromer complex to allow loss of Wg/Wnt secretory vesicles. Studies in which WI 
has been ablated demonstrate that the Wg/Wnt containing secretory vesicles are 





Secreted Wnt ligand binds to the Fzd and LRP5/6 extracellular domain, and as a 
result brings these two membrane proteins with functional proximity to one another. 
This change in location is sufficient for the activation of the Wnt signalling pathway, 
even in the absence of ligand, and results in the stabilisation of Ctnnb1, a critical 




Activation of the canonical Wnt pathway stabilised Ctnnb1 and results 
in gene transcription. 
Ctnnb1 is central to the transduction of the Wnt signalling pathway, and its 
persistence or degradation can be observed as the mechanism by which the canonical 
Wnt pathway functions. When the Wnt signalling pathway is in an off state, that is to 
say there is no dimerisation of the membrane receptors Fzd and LRP5/6, Ctnnb1 is 
degraded (Figure 1.5) . 
 
The degradation of Ctnnb1 is by no means simple. In the absence of signal Axin, a 
major scaffold protein binds to GSK3, CK1α and Ctnnb1 which results in a 
phosphorylation complex with Ctnnb1 acting as the substrate
241




sequentially phosphorylated initially by CK1α
256, 257
 and then by GSK3 at multiple 
residues
258, 259
. Secondary phosphorylation by the GSK3 protein results in Ctnnb1 
presenting a binding domain for the E3 ubiquitin ligase β-Trcp, and as a result these 
Ctnnb1 is ubiquitinated and targeted for destruction
260, 261
. This complex alone is 
sufficient for Ctnnb1 phosphorylation; however Axin acts in tandem with the APC 
scaffold protein, which can independently bind Ctnnb1 and facilitate its degradation. 
Interestingly CK1α and GSK3 also phosphorlyate both Axin and APC resulting in 
their increased affinity for one and other and resultantly causes an increased 




The formation of the Axin-APC destruction complex is highly robust. Seminal work 
in Drosophila demonstrated that in Axin null flies expressing truncated Axin 
proteins, lacking their APC-, GSK3- or Ctnnb1- binding domains were capable of a 
significant restoration of normal phenotype, again highlighting the requirement for a 
multivalent system which can continue function to a greater or lesser degree despite 
being mutated
264-267
. The net result of the destruction complex is that cytoplasmic 
and as such nuclear Ctnnb1 is not present and transcription of target genes cannot be 
achieved. 
 
The result of the ―Wnt-On‖ state, during which the Fzd and LRP5/6 receptors 
dimerise is that Ctnnb1 is the cytoplasm is protected from degradation. Wnt-induced 
phosphorylation of the LRP6 receptor is a critical event in the maintenance of 
Ctnnb1
268




PPPSPxS motifs which undergo a sequential dual phosphorylation, by GSK3 and as 
such bind Axin to the cytoplasmic surface of the plasma membrane. These PPPSPxS 
domains are necessary for the activation of Wnt signalling, and when expressed 
heterologously causes constitutive stabilisation of the Ctnnb1 protein
268-270
. The 
LRP5/6 receptor cannot be phosphorylated independent of binding or indeed close 
localisation of the Fzd co-receptor. Fzd binds a cytoplasmic scaffold protein known 
as Dishevelled (Dsh) which binds the Axin-GSK3 complex and sequesters it to the 
cell surface membrane, before LRP5/6 is phosphorylated and prior to the attachment 
of Axin to these phosphorylation motifs
269
. As such Fzd and LRP5/6 are 
synergistically required for the recruitment and long-term sequestration of the Axin-
GSK3 complex, and also may establish a positive feedback loop which results in 
complete phosphorylation of the LRP5/6 receptor and then further recruitment and 
removal of Axin from the cytoplasm. 
 
Translocation of Ctnnb1 to the nucleus results in TCF/LEF mediated 
transcription 
During canonical Wnt signalling the levels of stabilised Ctnnb1 in the cytoplasm is 
reflected as an accumulation of un-phosphorylated Ctnnb1 in the cell nucleus. The 
mechanism by which Ctnnb1 translocates to the nucleus, and the means by which it 
is retained there is unknown, however Ctnnb1 does associate with the nuclear pore 
proteins through a nuclear localisation signal motif, and that this coupled with the 
association of Ctnnb1, transcription factors transcriptional co-activators may 
maintain Ctnnb1 in the nucleus
271
. Ctnnb1 may though be actively transported from 









Once in the nucleus Ctnnb1 complexes with the TCF/LEF family of transcription 
factors, which function as the most downstream components of the Wnt signalling 
cascade
273
. The TCF/LEF transcription factor family contain a High Mobility Group 
domain through which these proteins can bind to DNA in the minor groove to a 
highly conserved consensus site. The binding of TCF/LEF transcription factors is not 
sufficient to initiate transcription (with the exception of LEF which contains a 
context-dependent activation domain and as such is transcriptionally competent when 
associated with the co-activator Aly), however the bend they induce in DNA means 
that co-transcription factors are able to access this site and initiate target gene 
transcription
274
. The TCF proteins frequently associate with Ctnnb1 in order to drive 
transcription, where TCF provides the DNA binding moiety and Ctnnb1 supplies the 
transcriptional ability, through the trans-activation domain at the C terminus of the 
Ctnnb1 protein, and may act though complexing with the TATA binding protein 
(TBP) in order to contact the transcriptional machinery
275
. Furthermore TCF-Ctnnb1 
is known to bind with CREB binding protein, which is known to recruit histone 
acetyl transferases, and as such may make the region to which it is bond more 




The TCF transcription factors are also mediators of transcriptional repression when 




respectively) is a TCF associated co-repressor, which in the absence of Wnt 
signalling recruits histone deacetylases (HDAC) and prevents target gene 











Figure 1.5 – On-Off activation of the Wnt signalling pathway. 
The Wnt signalling pathway involves binding of the Fzd and Lrp protein families at 
the cell surface membrane in the presence of the Wnt ligand. In the ―off-state‖ 
Ctnnb1 is phosphorylated, ubiquitinated and targeted for degradation by the 
destruction complex consisting of Axin, APC, GSK3 and CK1α. This results in 
repression of the canonical Wnt signalling pathway. Upon receptor dimerisation the 
LRP receptor is heavily phosphorylated and as a result the destruction complex is 
sequestered to the cell membrane, via Dishevelled. This results in the activation the 
Wnt pathway by allowing Ctnnb1 to translocate to the nucleus and convert the 
TCF/LEF mediated repressor complex containing Groucho and HDAC into a 
transcriptional activator, which induces multiple downstream genes. The Wnt 
signalling is classically repressed at the level of ligand and receptor through soluble 
receptor antagonists such as the sFRP and WIF1 or though interaction and 
modification with the receptor components, where sFRP binds to the Fzd receptor 





The Wnt pathway is regulated though the expression of two families of 
receptor antagonists. 
The Wnt-Ctnnb1 signalling pathway importantly regulated though signal binding, 
Ctnnb1 stability and through chromatin regulation; atop this pathway is a further 
level of fine-tuning and regulation which acts to restrict the effect of canonical Wnt 
signalling in certain cells, whilst allowing geographically close cells to be permissive 
to the signals. 
 
The Dickkopf family of Wnt inhibitors bind specifically to the LRP5/6 receptor and 
as such are specific inhibitors of the canonical Wnt signalling cascade. They contain 
two cystine rich domains, Cys-1 and Cys-2 with the latter being highly conserved 
between family members. The classical Wnt antagonists can be divided into two 
functional classes the secreted Frizzled-related protein (sFRP) family which contains 
the sFRPs, WIF1 and Cerberus which generally though binding and sequestration of 
the secreted Wnt ligand. These sFRP proteins contain a cystine-rich domain, and as 
such can act as a decoy receptor. Furthermore the sFRP proteins can bind directly 
with Fzd, and as such become competitive inhibitors of Wnt ligand, as such 
preventing the assembly of the Fzd-LRP5/6 receptor complex. WIF1 on the other 
hand can only regulate a subset of the secreted ligands though its WIF domain (WD) 






The importance of Wnt signalling in development and disease 
The Wnt signalling pathway is of critical importance in these cellular fate 
designations, and as such plays a critical role in the development and regeneration of 
multiple cellular systems. Here the role of Wnt-Ctnnb1 signalling during 
Neurogenesis and Neuronal repair as well as intestinal turnover will be discussed as 
the role for Wnt in these organ systems is well described and extensively studied. 
Less well defined is the role of Wnt signalling during hepatic ontogeny and repair; 
however there is emerging evidence which indicates that the Wnt signalling pathway 
is important for correct differentiation in both hepatic contexts. 
 
The Role of Wnt Signalling during Neurogenesis  
During Neurogenesis both the canonical and non-canonical Wnt signalling pathways 
have been implicated in correct specification of neurons, appropriate release of 





The adult brain active Neurogenesis occurs within the subgranular zone (SGZ) of the 
dentate gyrus and the subventricular zone (SVZ) of the lateral ventricles of the 
forebrain. The putative neural stem cell resides within these two areas, and Wnt 
signalling has been implicated as an extracellular factor involved in their 
proliferation and specification
279, 280
. During development Wnt signalling is 
necessary for the expansion of progenitor cells which will ultimately contribute to 
the neural tube
281
. Moreover inhibition of GSK3, and as such activation of the 




into neurons, as did ectopic administration of Wnt7a
282
. More recent studies have 
found that the canonical Wnt signalling cascade is required for maintenance and 
selection of newborn neurons in the adult hippocampus, in a cell autonomous 





The role of Wnt signalling during adult neurogenic diseases has also been 
highlighted. The induction of a dominant negative Wnt in the dentate gyrus for 
example reduces memory retention
284
. Furthermore suppression of the Disrupted in 
Schizophrenia-1 (DISC-1) gene which directly interacts with GSK3 resulted in a 
decreased proliferation of neuronal progenitor cells in vitro and in vivo again 
implicating the canonical Wnt cascade in the maintenance of neural phenotype in the 
adult
285
. NEUROD1, a key regulator in the specification of neuronal tissue during 
both embryogenesis and adult neural stem cell specification has been clearly 
demonstrated to be a direct target of the Wnt-Ctnnb1 signalling pathway and as such 
reiterates the need for an intact canonical Wnt cascade in the development and 




As the neural stem cell compartment is relatively slow cycling, the requirement for 
canonical Wnt signalling within this cell population, and the phenotypes associated 
with aberrations in the Wnt signalling pathway may take time to manifest and may 




has been used extensively to investigate the roles of Wnt signalling in tissue 
homeostasis and disease. 
 
Wnt signalling is critical for Intestinal homeostasis 
The importance of Wnt signalling in the murine intestine was initially described 
using the APC
Min/+
 mouse which was generated as part of an ethylnitrosurea mutagen 
programme
287
. This mouse spontaneously develops frequent, small intestinal 
adenomas, and colonic polyps; indicating that the haplosuffiency of APC and ectopic 
activation of the Wnt signalling results in a phenotype similar to the human familial 
adenomatous polyposis. The use of transgenic tools during investigation of Wnt 
signalling in the intestine has, unsurprisingly, been powerful. Conditional deletion of 
functional APC regions using either the Villin-CreER or indeed the Cyp1A-Cre 
transgenic early on revealed that loss of Ctnnb1 degradation resulted in altered 
proliferation, differentiation and morphogenesis of the intestinal epithelium
288, 289
. 
Further to these observations stabilisation of Ctnnb1 in the intestine using a targeted 
exon3 mutation results in a recapitulation of the APC phenotype, and once again 
points to the critical role of the canonical Wnt signalling pathway in the maintenance 




The recent description of the Lgr5
+
 intestinal stem cell has brought about a new 
impetus, and generation of transgenic technologies to the intestinal field
210
. The Lgr5 
stem cell population in the liver is capable of, from a single cell forming crypt like 
structures in vitro
292, 293




demonstrates that all components of the intestinal epithelium are derived from this 
source, and that over time the collection of stem cells within the base of the intestine 
are progressively replaced by one stem cell, and as such the epithelium within a crypt 
is genetically identical
294, 295
. Using the Lgr5-Cre mouse Clevers and colleagues have 
demonstrated once again the importance of Wnt signalling in the maintenance and 
correct specification of intestinal stem cells. Loss of Wnt effector Achaete Scute-
Like 2 (Ascl2) controls intestinal stem cell fate, and its ablation results in the loss of 
Lgr5 intestinal stem cells, as Ascl2 is a well described target of the Wnt pathway it is 
likely that modification of the Wnt signalling pathway in these progenitor cells is 
likely to affect their fate, and their proliferative potential
296-298
; Indeed in the fly Wg 
signalling is required to maintain Drosophila intestinal stem cells, highlighting the 




The Lgr5-Cre mouse also allows tracing of crypt cells in intestinal cancers. When 
APC is conditionally deleted in the Lgr5 population, small polyps occur within the 
crypts, which develop over time and become large adenomas which protrude out into 
the intestinal lumen. Lgr5 positive intestinal stem cells do not migrate during this 
process, rather they remain at the crypt base, and contribute to the growing polyp as 
they would typically restore the intestinal epithelium
300
. Furthermore when the same 
APC transgenic was crossed with the tamoxifen inducible Ah-Cre, which recombines 
the transit amplifying population only small short lived polyps were observed, 
reflecting the finite potential of these transit amplifying cells and their contribution to 






The importance of Wnt signalling within the intestinal niche is of critical importance, 
and again this is reflected in the role of Paneth cells in the maintenance of the 
intestinal stem cells, and crypt. Paneth cells migrate towards the regions of high Wnt 
expression within the intestine, and require Wnt signalling to ensure their maturation 




As the intestine and liver are derived from a similar endodermal origin, the hepatic 
stem cell, although not yet defined, may respond in a similar fashion to the Lgr5 
intestinal stem cell and have similar signalling requirements for its proliferation and 
differentiation. By investigating the HPC population, and the developing liver, it may 
be possible to garner information about what signalling pathways are required for 
hepatic regeneration, in a similar way to how Villin-CreER and Cyp1A-Cre studies 




Wnt signalling during hepatic ontogeny 
The mammalian liver develops from a region of the definitive foregut endoderm 
epithelium. During ontogeny the liver derives from the lateral domains of the 
endoderm, and the endothelial components of the liver such as the sinusoids, and 
vasculature derive from the ventral midline
303
. These endodermal movements occur 
early on in development, and in human the liver is specified by three weeks and in 
mouse within 8.5 days. During this period FGF and BMP signalling are necessary for 
initiation of the liver bud, and its migration
304
. Once the liver bud is specified there is 
a second phase of hepatic development and growth which is characterised though 
expansion and proliferation. There is conflicting evidence regarding the role of 




Repression of Wnt signalling, and Ctnnb1 stability is suppressed by sFRP5 and 
results in the specification of the liver from foregut endoderm, if Wnt repression is 
inhibited in the hind-gut endoderm, this region which classically contributes to the 
lower GI tract and intestine becomes an ectopic liver
306, 307
. There is emerging 
evidence however that the Wnt-Ctnnb1 axis is also activated during foregut 
specification, and required for promotion of hepatic specification by expression of 




Once the liver is specified from the for gut endoderm the Wnt-Ctnnb1 signalling 
pathway is required for expansion of the foetal hepatoblasts. Ablation of Ctnnb1 




genetic ablation of Ctnnb1 in the developing mouse demonstrated a failure of liver 
growth and retardation of hepatoblast proliferation
309-311
. This phase of proliferation 
may be mediated though the activation of Cyclin D1, a known target of the Wnt 
signalling pathway
312
. Furthermore in embryos from APC knockout mice which 
demonstrated a high degree of biliary differentiation, however there is little to 
suggest a mechanism by this but may involve a temporal difference in Wnt 
signalling, priming hepatoblasts for subsequent specification through the Notch 
signalling pathway
313
.   
 
Ctnnb1 and the Wnt signalling pathway appears to directly drive hepatocyte 
differentiation and maturation too as when Ctnnb1 was conditionally knocked out 
using the Foxa3-Cre in hepatoblasts cells remained in a rudimentary phenotype with 
low expression of the hepatocellular enriched transcription factors Hnf4α and 
CEBP/α, did not express liver enzymes, and could not store glycogen
312
. Further to 
this postnatal liver growth requires intact Ctnnb1 in order to reach an appropriate 
volume. Adult murine livers where Ctnnb1 had been ablated using the αFP-enhancer-
Albumin-promotor-Cre demonstrated that out to 12 weeks livers appeared immature 
on a cellular level and small compared to litter mates which had intact Ctnnb1
314, 315
. 
Further work has demonstrated that in Zebrafish there is a biphasic requirement for 
Wnt signalling, and that in APC
+/-
 fish hepatomegly is commonplace and 
proliferation occurs are a greater rate
316
. In vitro hepatoblasts can be induced into 
mature hepatocytes using Dexamethasone, however treatment with sFRP3 results in 
the attenuation of hepatocyte differentiation, indicating once more that murine 






. In extension to this, recent work has also demonstrated that not only 
is hepatocyte differentiation controlled by Wnt signalling, but hepatic zonation is 
also Wnt, but not c-Myc dependant, with aberrant metabolic zonation (or indeed 




As such increasing evidence suggests that during ontogeny and shortly after birth the 
canonical Wnt signalling pathway is required for the initial establishment of the liver 
primordium, expansion of naive bipotent hepatoblasts, differentiation into mature 
epithelium, terminal differentiation into hepatocytes, but also metabolic patterning of 
the parenchyma. However during disease does the Wnt signalling pathway have a 
role in the expansion and differentiation of HPCs? 
 
Wnt signalling during regeneration in the adult liver 
During surgical resection levels of stabilised Ctnnb1 increase rapidly in the 
remaining liver; this occurs rapidly within minutes, and persists during 
regeneration
318
. Zebrafish and Mice with the APC
+/-
 mutation, have an upregulation 
Ctnnb1 protein and increased proliferation in order to restore the hepatic parenchyma 
after partial hepatectomy
316
. Furthermore mice with Ctnnb1 loss in hepatocytes 
demonstrated a smaller liver after birth, but also showed that immediately after a 
partial hepatectomy, the rate of proliferation in hepatocytes was stunted for the first 
2-3 days compared to WT and that only after this period was there an increase in the 
rate of hepatocyte proliferation, presumably due to residual Ctnnb1 accumulation 






in acute liver failure induced by overdose of acetaminophen in mice and a 
retrospective analysis of patents who had taken an overdose demonstrated a rapid 
inactivation of GSK3, and induction of Ctnnb1 stabilisation in those mice and 
patients which spontaneously regenerated following acute phase injury
319
. In both of 
these hepatocyte dependant regenerative contexts the requirement for Ctnnb1 is 
clear, and sufficient for rapid regeneration of the liver architecture, but may not be 
absolutely necessary for hepatocellular regeneration as the liver can regenerate in the 
absence of Ctnnb1.  
 
Only a few studies have convincingly investigated the role of canonical Wnt 
signalling during chronic regeneration, however evidence is emerging in the 
literature that the Wnt-Ctnnb1 signalling cascade is important in the HPC mediated 
regeneration of liver in both human disease and animal models of such
110
. Monga 
and colleagues have demonstrated in a model of partial hepatectomy with hepatocyte 
injury that the nuclear localisation of Ctnnb1 is increased in HPCs, and that along 
with this GSK3 and WIF1 levels decrease in order to facilitate high levels of Wnt 
signal transduction
320
. Furthermore this group demonstrated that in the DDC dietary 
model of regeneration that Ctnnb1 deletion resulted in an attenuated proliferation of 
progenitor cells, however this study utilised a whole liver knockout of Ctnnb1, and as 
such the failure of regeneration may have been the result of altered hepatic 





Further data has shown that during the DDC model HPCs are responsive to Wnt3a, 
and that this is capable of inducing cellular proliferation and de-phosphorylation of 




These two works are interesting as both use the DDC model which, is one of biliary 
fibrosis and sclerosing cholangitis, where Wnt signalling may be important for the 
initial propagation of these cells, however later on, when in DDC mice get secondary 
confluent necrosis of the hepatocytes there is no mention of how HPCs are able to 
reconstitute both the biliary epithelium and hepatocytes.  
 
As such the field is limited. We do understand that during development both the 
Notch and Wnt signalling pathways act in unison, but also in opposition to correctly 
pattern the different cellular aspects of the liver, and that during tissue turnover in 
other organs Notch and Wnt signalling act to maintain tissue homeostasis in an 
appropriate fashion. However we have no functional evidence that the HPC in the 
liver is maintained by these two factors, or that they play any role in the maintenance 
and specification of HPCs. 
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Hypotheses and Aims 
 
The Hypothesis for this work: 
The Notch and Wnt signalling pathways play an important role in the specification of 
adult hepatic progenitor cells into hepatocytes and cholangiocytes. 
 
I aim to test this hypothesis though: 
1. Establishing two divergent models of liver regeneration, one which is 
hepatocyte specific, and the other which is cholangiocyte specific 
 
2. Defining the activation status of both the Notch and Wnt pathways in both 
models of regeneration 
 
3. Interrogate the Notch and Wnt Signalling pathways both in vitro and in vivo 























Chapter 2 - Materials and 
Methods 
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Choline Deficient Ethionine Supplemented (CDE) and the (DDC) 
progenitor induction regime. 
All mice were housed and cared for in accordance with UK Home Office 
Regulations with food supplied ad libitum in 12h light/dark cycles. 
 
C57Bl6 strain animals were fed on a Choline Deficient diet (MP Biomedicals) for 
18d. Animals were given sweetened water containing 0.15% DL-Ethionine (Sigma 




S129S2 stain mice were fed Purina mouse food containing 0.1% w/w 3, 5-
diethoxycarbonyl-1, 4-dihydrocollidine (DDC) for 18d with unaltered drinking 
water. 
 
Fixation and Preservation of Liver Tissue 
Mice were euthanized using CO2 for 5mins. 
 
Isolated liver tissue was excised and fixed in either buffered Formalin (10mls 37% 
formalin in 100mls PBS) or in Methacarn (70mls Methanol, 20mls Chloroform and 
10mls Acetic Acid) over night. Fixed Tissues were then dehydrated and stored in 
70% Ethanol and mounted in paraffin. Sections 4um thick were used for all 
immunohistochemistry 
 
For frozen sections liver tissue was excised and mounted in OCT fixative. These 
samples were snap frozen in dry ice and 100% ethanol until the OCT had set. 
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Samples were stored at -80ºC. Frozen sections were cut at 10um thickness. 
 
Immunohistochemistry of paraffin embedded liver tissue 
For enzymatic detection: 
Liver sections were dewaxed in xylene for 10m at room temperature and sequentially 
rehydrated through 100%, 75%, 60% ethanol for 5m each and then finally rehydrated 
in water for 10m. When antigen retrieval was required samples were antigen 
retrieved using Sodium Citrate pH6 or Tris-EDTA pH9 in a microwave indicated in 
Table 2.1. Proteinase K was used for 2m at 37ºC. Tissues were washed in PBS 
containing 0.05% Tween 20 for 5m. All further washes were performed using PBS 
alone. 
 
Sections were incubated in 1% H2O2 for 20m to block native Peroxidase activity in 
the tissue. Sections were washed and mounted in Sequenza racks using PBS. 
Endogenous avadin and biotin were blocked using an avadin and biotin blocking kit 
(DAKO) for 15m each; sections were thoroughly washed between blocks. Non-
specific binding of the secondary antibody was prevented using 10% species specific 
serum to block sections for 30m at room temperature. Sections were then incubated 
with primary antibody diluted in 10% species specific serum overnight at 4ºC. 
Primary antibodies are washed off using PBS and sections are incubated with 
biotinylated secondary antibody for 30m at room temperature. Secondary antibodies 
were washed off using PBS and sections are incubated for 30m with Vector RTU. 
Binding of the primary antibody is detected using DAB chromagen substrate for 3m 
followed by washing in water. 




Sections were counterstained for 30s in Haematoxylin and dehydrated through 
graduated ethanol and into Xylene to dehydrate completely. Sections were mounted 
using Pertex hard set mounting medium and stored. 
 
 
For Fluorescent Detection: 
Liver sections were dewaxed in xylene for 10m at room temperature and sequentially 
rehydrated through 100%, 75%, 60% ethanol for 5m each and then finally rehydrated 
in water for 10m. When antigen retrieval was required samples were antigen 
retrieved using Sodium Citrate pH6 or Tris-EDTA pH9 in a microwave indicated in 
Table 2.1. Proteinase K was used for 2m at 37ºC. Tissues were washed in PBS 
containing 0.05% Tween 20 for 5m. All further washes were performed using PBS 
alone. 
 
Sections were blocked using 10% species specific serum in PBS for 30m. Primary 
antibodies were diluted in 10% species specific serum over night at 4ºC. Sections 
were thoroughly washed and incubated with secondary antibody diluted in 10% 
species specific serum for 30m at room temperature in the dark. Sections were 
thoroughly washed and mounted in Vectashield containing DAPI. 
 
Isolation and Culture of primary HPCs in vitro 
Mice were euthanized using CO2 for 5m. The livers were excised and minced in 
Leibovitz-15 medium containing Collagenase B and DNase I for 45m at 37ºC. 
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Digested liver was passed through a 40um cell strainer and spun at 50xg for 5m. 
Supernatant was removed to a clean tube and the 50xg spin was repeated twice more. 
The final supernatant was spun for 10m at 120xg. This cell pellet was re-suspended 
in Ammonium Chloride red cell lysis buffer on ice for 5m. Erythrocyte depleted cells 
were then pelleted and re-suspended in HPC medium: 
 
HPC Medium: 
 50% Dulbecco's Modified Eagles Medium 
 50% Hams-F12 Nutrient Mix 
 10% FCS 
 50ug/ml Insulin 
 30ug/ml Hydrocortisone 
 5ml Sodium Pyruvate 
 500ul Gentamicin 
 
Re-suspended cells were underlayed with a discontinuous gradient of 20%/50% 
Percoll diluted with PBS and centrifuged at 1400xg for 20m at 4ºC. Cells were 
collected from the 20%/50% Percoll interface and washed twice using culture 
medium. The resulting cells were pelleted by centrifuging at 120xg for 5m and 
resuspended with CD45R iMag magnetic beads (BD Biosciences), which were 
incubated for 20m at 4ºC. Bead labelled cells were removed using an iMag magnet 
for 15m at room temperature. CD45 depleted cells were re-suspended in culture 




 on tissue culture 
plastic which had been incubated with laminin for 2h at 37ºC. 




Non-adherent cells were washed off 12h after initial plating with PBS. Adherent cells 
were plated with medium containing 10% FCS for 48h after which the amount of 




Culture of the BMOL Progenitor Line 
Cryopreserved BMOL cells were resuscitated into media described below. These 
cells were grown until 70% confluence and were then trypsinised and either passaged 
or re-plated for use. 
 
BMOL growth Medium: 
 William's E Medium 
 5% Foetal Bovine Serum 
 2mM L-Glutamine 
 2.5ug/ml Fungizone 
 10U/ml Penicillin; 100ug/ml Streptomycin 
 30ng/ml IGF2 
 20ng/ml EGF 
 10ug/ml insulin 
 
Growth of plasmids 
All plasmids were propagated in DH5α strain E. coli (Invitrogen). 10ng of plasmid 
 Materials and Methods 
82 
 
was introduced to 50ul of DH5α and kept on ice for 30m followed by 1m heat shock 
in a 42ºC water bath followed by 2m incubation on ice. 0.5mls of S.O.C. medium 
was added to the cells and samples were shaken at 37ºC at 225rpm for 1h. Reactions 
were spread 1:50, 1:100 and 1:200 on LB agar plates containing 100ug/ml Ampicillin 
and were incubated overnight at 37ºC. 
 
Distinct, single colonies were selected and transferred into 5mls of LB broth 
containing 100ug/ml Ampicillin and were shaken at 300rm for 8h at 37ºC. 50ul of 
starter culture was transferred to 25mls of LB broth containing 100ug/ml Ampicillin 
for 16h at 37ºC. 
 
Cells were harvested by centrifugation at 6000 x g for 15m at 4ºC. Plasmid DNA 
(pDNA) was harvested using a MiniPrep kit (Qiagen). Briefly, bacterial cells were 
lysed using the buffer supplied. pDNA is sequentially precipitated using a range of 
buffers. The lysate is centrifuged at >20000 x g at 4ºC for 30m and the plasmid 
containing supernatant is removed. The supernatant is spun again for 15m and the 
plasmid containing supernatant is removed. The plasmid preparation is placed over a 
resin and washed to remove any contaminating proteins and carbohydrates. pDNA is 
eluted from the column and precipitated using isopropanol and pelleted at >15000 x 
g for 15m at 4ºC. Pellets are subsequently washed using ethanol, spun again and re-
suspended in 200ul TE buffer pH8. The concentration of pDNA was determined 
using a Nanodrop (ThermoScientific). 
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Transfection of Notch constructs in the BMOL line and derivation of 
stably transfected lines  
For both transient and stable transfections Qiagen Effectene reagent was used. 10
5
 
BMOL cells were plated and allowed to recover overnight. The following day 1ug of 
vector containing Nicd, GFP or Empty pDNA (kindly donated by Dr. Sally Lowell; 
MRC CRM Edinburgh) was combined with enhancer and Effectene as described in 
the manufacturer‘s instructions. Transfected cells were left in normal growth medium 
for 3 days and assayed for transgene expression. For stable transfectants cells were 
moved into medium containing 2ug/ml puromycin for 14d and colonies were picked 
and grown to give clonally derived lines which have stably incorporated Nicd, GFP 
or empty vectors. 
 
Transfection of RNAi in the BMOL line 




 cells on tissue culture plastic and 
allowed to adhere overnight. The following day cells were transfected with 10nM 
siRNA against specific targets using 4ul of HiPerfect transfection reagents (Qiagen). 
A GFP tagged siRNA which has no homology to any murine gene was used as a 
positive control for transfection and served as a negative control for RNAi efficiency 
(Qiagen). Cells transfected with siRNA were assayed 6h – 96h after transfection to 
monitor loss of gene expression. A complete list of the siRNA used in this study can 
be found in table 3. 
 
GSI inhibition of BMOL line and primary HPCs 
Notch inhibitor N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycin e-1,1-
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dimethylethyl ester (DAPT, also known as compound IX) was re-suspended in 
DMSO at a concentration of 25mM. This was diluted to a working concentration of 
5uM in the appropriate culture medium. 
 
Activation of the Wnt pathway using LiCl and Wnt3a 
BMOL and primary cells were moved into medium containing 1% FCS and either 
3uM LiCl (Gibco) or supplemented with 50ng/ml Wnt3a (Peprotech) for up to 5 
days. 
 
Isolation of RNA from liver tissue and cultured cells 
Liver tissue was frozen in RNA protect (Qiagen) and stored at -80ºC. 200mg of 
tissue was homogenised in 500ul of TriReagent (Amersham). The homogenate was 
centrifuged at 12,000xg and removed to another clean tube. 100ul of chloroform was 
added to the homogenate and this was vortexed for 15s. Homogenate was centrifuged 
for 15m at 4ºC. The aqueous phase of the homogenate was removed to a clean tube 
to which 100ul of 70% RNase free ethanol was added. Samples were allowed to 
precipitate for 15m at room temperature and then were transferred to MiniPrep tubes 
(QIAGEN). Tubes were centrifuged at <8000g for 30s to bind RNA to the 
membrane. Samples were washed using 500ul RW1 wash buffer by centrifugation 
for <8000g. Samples were washed twice with RPE buffer by spinning for 1m at 
<8000g. RNA was dried by spinning for 2m at 13,000g. RNA was eluted in 30ul 
RNase free water. RNA concentration was determined using a Nanodrop from 
Thermofisher. 
 





Reverse Transcription and qPCR 
RNA from 10ng to 1ug was reverse transcribed using Quantitect reverse transcription 
kit from Qiagen. Genomic DNA was eliminated by incubating RNA samples with 
gDNase at 42ºC for 10m. Reverse Transcription of mRNA was achieved by 
incubation of template with reverse transcriptase and random hexamers at 42ºC for 
30m. The reaction was quenched by heating the sample to 90ºC for 3m. 
 
Generation of standard curves for qPCR: 
cDNA from each sample was combined and this was diluted 1:10 with RNAse free 
water to give a starting concentration of 5ng/ul. Serial 1:1 dilutions were produced 
giving a final range of concentrations. Samples of cDNA were diluted 1:100 for 
analysis of gene expression (5.0, 2.5, 1.25, 0.625, 0.312, 0.156, 0.078, 0.039 ng/ul) 
 
SYBR Green- qPCR was performed using Qiagen SYBRfast master mix and Qiagen 
Quantitect primers. 2.5ul of diluted cDNA was mixed with 2.5ul of Qiagen 
Quantitect primers summarised in table 2 as well as 7.5ul of SYBR fast master mix. 
qPCR was conducted on an ABI 7500 fast. Primers are summarised in Table 2.2. 
 
FACS isolation and characterisation of HPCs 
Single cell suspensions were achieved as previously described in this chapter, and 
Hepatocytes were removed through centrifugation. The NPC population (1x10
6
 for 
analysis 1 x 10
7
 for sorting) was re-suspended in PBS containing 0.1%BSA and 
 Materials and Methods 
86 
 
1mg/ml Fc block for 30m. Cells were pelleted and re-suspended in blocking buffer 
containing Dlk1-FITC, EpCAM-648 or F4/80-APC at the appropriate concentration 
in the dark for 30m (summarised in table 2.1). Cells were washed and analysed on a 
FACS Calibur (Beaton Dickson) or sorted using either the FACS Diva or FACS Aria 
(both Beaton Dickson).  
 
GSI blockage of Notch activation and BrdU lineage tracking in vivo 
S129S2 mice were given 300ul of BrdU (Amersham) intraperitoneally (I.P.). For 
three days following mice were given 50mg/Kg DAPT dissolved in 1:9 ethanol: corn 
oil I.P. Finally mice were given EdU I.P. at a concentration of 50ug/g w/w.  
 
Isolation of BM and culture of BMDMs 
Male 8 week old mice were euthanized using CO2 and the Tibia, Femur and Fibula 
were removed to PBS. After tissue has been removed from the bones the bone 
marrow was flushed out of the bone cavity using Glutamax DMEM/F12. Whole bone 
marrow was dissociated using a 21G needle to ensure a single cell suspension. Bone 
marrow was plated in low adhesion flasks with DMEM/F-12 with 10% FCS and 20% 
L929 conditioned medium (prepared in house) 
 
In vivo macrophage depletion 
Macrophages were depleted in vivo using repeat administration of clodronate 
liposomes (clodronateliposomes.org) that were kindly supplied by Dr. Nico van 
Rooijen. Briefly, liposomes were brought to room temperature and were injected into 
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the tail-vein at 200ul per 25g. During the study mice were given liposomal 
clodronate 3h before the start of damage, and then every three days throughout the 
time course of damage to ensure complete and persistent depletion of macrophages. 
 
Isolation of primary hepatocytes and production of debris 
Hepatocytes were isolated under terminal anaesthesia. Once sedated mice had their 
portal vein canulated and liver was perfused through the inferior vena cava for 
100mls at 12.5mls/m with a EDTA containing perfusion medium (Gibco). After 
perfusion was complete, the liver was digested in situ using liver digestion medium 
(Gibco) for 10m at 12.5mls/m. The digested liver was dissected and dissociated in 
Williams E medium with 10% FCS, and kept on ice. Dissociated livers were passed 
through 100um cell strainers and spun at 50g for 5m. Hepatocytes were washed and 





 on Collagen I coated dishes (Gibco). Isolated Hepatocytes were trypsinised 
and subject to 20 repeat freeze thaw cycles; hepatocytes were then sonicated to 
ensure disruption of any intact cells. 
 
In vitro phagocytosis assay 




 in DMEM/F12 and were allowed to attach 
overnight. The equivalent of 5 hepatocytes worth of debris was fed to macrophages 
for 18h, after which cells were extensively washed before analysis, this number was 
informed by previous studies in the lab of Prof. John Iredale which has used 
thymocytes to generate apoptotic material. 





Data was analysed for normal distribution using a D‘Agostino and Pearson omnibus 
normality test. Parametric data was analysed using a two-tailed unpaired Students t-
test. In instances where the n was too low to determine normal distribution or the 
data was non-parametric then a two-tailed Mann-Whitney test was used. In case 
where more than two groups were being considered, or where multiple variables 
were being considered then a one-way ANOVA or two-way ANOVA were used 
respectively. 
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Table 2.1: A complete list of primary Antibodies used during this work. 






Notch1 Santa-Cruz  sc-6014 Frozen, 1/50 Anti-goat Alexa555 
Jagged1 Santa-Cruz  sc-8303 Methacarn, 1/50 
Anti-rabbit 
Alexa555 
NUMB Abcam Ab14140 
Formalin, Tris-
EDTA pH9, 1/150 
Anti-rabbit 
Biotnylated 
αSMA Sigma Aldrich A5228 
Formalin NaCt 
pH 6 1/3000 
Anti-mouse 
Biotnylated 









and PK 1/300 
Anti-rabbit 
Biotnylated 




































EDTA pH9 1/50 
HRP polymer 
Ctnnb1 Abcam Ab2365 Frozen 1/100 
Anti-rabbit 
Biotnylated 
Ki67 Novocastra Ki67p 
Formalin Tris-
EDTA pH9 1/500 
Anti-rabbit 
Biotnylated 
Flow Cytometry and Fluorescence Activated Cell Sorting (FACS) 
Dlk-1 Caltag D187-4 NA NA 
F4/80 Caltag MF48004 NA  NA  
EpCam Biolegend 118212 NA NA 
CD45 ebiosciences 12-0454 NA NA 
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Table 2.2: Table of Primers used during this work. 
Recognises Company Primer Code 
Notch Pathway Components 
Notch1 Qiagen QT00156982 
Notch2 Qiagen QT00153496 
Notch3 Qiagen QT01051729 
Notch4 Qiagen QT00135653 
Jagged1 Qiagen QT00115703 
Jagged2 Qiagen QT01043819 
Dll1 Qiagen QT00113239 
Dll3 Qiagen QT00113477 
Dll4 Qiagen QT01053598 
Hes1 Qiagen QT00313537 
Hes5 Qiagen QT00268044 
HeyL Qiagen QT00128954 
NUMB Qiagen QT00097328 
Wnt Pathway 
Axin Qiagen QT00126539 
Sox9 Qiagen QT00163765 
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Myc Qiagen QT00096194 
Twist1 Qiagen QT00097223 
Wnt3a Qiagen QT00250439 
Wnt7a Qiagen QT00168812 
Liver Specific Transcription Factors 
Hnf1α Qiagen QT00170975 
Hnf1β Qiagen QT00103320 
Hnf4α Qiagen QT00144739 
Hnf6 Qiagen QT00297815 



















Chapter 3 - Establishing Models 
of Liver Regeneration  




The ability of the hepatic parenchyma to regenerate from HPCs has been well 
described however the mechanisms by which HPCs assume a hepatocyte or biliary 
fate have not been addressed. Recent work has looked at the mechanism of 
proliferation and expansion of these progenitor cells and has highlighted the role of 
the HPC niche in this process
6, 90
. As a transient niche has been implicated in both 
the proliferation and differentiation of multiple progenitor types in other adult organ 
system I aimed to establish two models of regeneration in order to address 
fundamental questions in the biology of HPCs. 
 
Two dietary models of liver damage and regeneration were established and 
characterised. The Choline Deficient Ethionine (CDE) supplemented model causes 
primary damage to hepatocytes whilst preventing the proliferation of any residual 
hepatocytes. The second model I established is the 3, 5-diethoxycarbonyl-1, 4-
dihydrocollidine (DDC) model which acts principally through blockade of the bile 
ducts. This blockage results in periportal inflammation and rapid fibrosis throughout 
the portal tract and subsequent activation of HPCs. 
 
The aim of this chapter is to describe how I established and characterised both the 
CDE and DDC models and demonstrate that they are appropriate for tools to study 
the mechanisms by which hepatocytes and cholangiocytes are specified from HPCs. I 
describe the effects of both the CDE and DDC models on mouse and undertake 
extensive characterisation of the niche surrounding the HPCs during regeneration. I 
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have also characterised the HPC population through immunohistochemistry and 
established in vitro culture system to investigate adult HPC regulation I also 
demonstrate a means by which to sort these HPC populations and analyse them for 
accepted HPC markers. 
 
Characterisation of the CDE diet as a model of hepatocellular 
regeneration 
The Choline-Deficient Ethionine supplemented diet (CDE) is well described as 
means of inducing primary hepatocyte damage though choline deficiency and 
prevention of hepatocyte division though Ethionine administration. The CDE regime 
was administered to adult animals from 0 days to 12 days (Figure 3.1a). During CDE 
administration animals lost weight for up to 5 days; this was followed by a period of 
normalisation and weight gain; however CDE treated animals did not reach 
equivalent weights of animals maintained on a normal diet with standard drinking 
water (Figure 3.1b).  
 
Healthy adult liver has a small degree of apoptosis as healthy biliary ducts and 
hepatocytes die and are replaced by activation and division of mature cell types. This 
normal parenchymal turnover results in a low basal level of TUNEL staining 
throughout the adult liver (Figure 3.1c). The CDE diet induces hepatocyte apoptosis 
as demonstrated though a progressive increase in the levels of TUNEL positive 
hepatocytes throughout the adult parenchyma (Figures 3.1c).  
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Figure 3.1 — The Choline-Deficient Ethionine (CDE) supplemented diet results 
in hepatocyte damage and HPC activation. 
a. Adult mice were fed a choline-deficient diet supplemented with Ethionine 
drinking water for 12 days. Tissue was harvested at day 0, day 8 and day 12 for 
analysis. 12 days was chosen as a suitable time point based on previous investigation. 
b. During CDE administration mice rapidly lost weight out to day 5 followed by a 
period of stabilisation and minor weight gain compared to controls which as 
expected increased in weight as they aged. c. During the CDE regime I observe 
infrequent necrosis, but increasing levels of hepatocyte apoptosis as demonstrated by 
a marked increase in TUNEL positivity in the hepatic parenchyma (green nuclei, 
white arrows). This appears to be an early phase response as the level of apoptosis 
increases by day 8, but may have equalised by day 12 (n=3, p<0.05: Mann-Whitney 
U test). Scale bar = 50µm. 
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In healthy adult liver clearly defined portal tracts are found throughout the organ. 
These consist of venous and arterial vessels surrounded by well ordered hepatocytes 
and typically low numbers of biliary vessels (Figure 3.2a). During hepatocellular 
damage and regeneration induced by the CDE regime the hepatocyte parenchyma 
appears disordered with poorly arranged hepatocytes and an increased degree of 
inflammation around the portal tracts. After 12 days of CDE treatment hepatocytes 
appear both apoptotic and with observable secondary necrosis; in response to this 
there is an emergence of small cells from the terminal branches of the biliary tree 
(Figure 3.2 a-c, black arrows) which have a clear epithelial morphology and high 
nuclear to cytoplasmic ratio. Throughout the injury these cells emerge and infiltrate 
the hepatic parenchyma in small chord like structures, which can appear to 
differentiate into mature hepatocytes and as such reconstitute the damaged hepatic 
parenchyma. 
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Figure 3.2 — The Choline-Deficient Ethionine (CDE) supplemented diet results 
in hepatocyte damage and HPC activation. 
a. In animals which had not been exposed to CDE a normal hepatic architecture was 
observed (day 0). b. By day 8 hepatocytes appear disorganised alongside a modest 
inflammatory infiltrate. c. At d12 there is considerable hepatocyte damage, 
considerable inflammation and also the emergence of a small population of cells with 
scant cytoplasm. (a-c arrows identify the portal tract in each image, scale bar = 
200µm) d. Black arrows highlight a healthy bile duct with a clearly defined lumen 
and polarised epithelium in close proximity to the portal vein. e. At day 8 the 
emergence of small epithelial cells (red arrows) outwith the portal tract (black arrow) 
are detectable on histology, however they are infrequent f. By day 12 the portal tract 
appears disarranged, and chords of small epithelial cells are frequently found 
irradiating from the portal tracts (black arrow denotes a bile duct, red arrows denote 
HPCs).d-f Scale Bar = 50µm. 
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Hepatic Progenitor Cells arise in the CDE dietary model 
As previously described chords of small progenitor-like cells emerge during the CDE 
model of hepatocyte regeneration. These small cells are positive for panCK, which 
detects the basic cytokeratins Krt7 and Krt19 – markers of the biliary epithelium and 
hepatic progenitor cells. In healthy liver panCK is localised to the cytoplasm of 
cholangiocytes which are the constituent cells of the biliary tree (Figure 3.3 a). After 
8 days of CDE damage a population of panCK positive cells emerge in a similar 
pattern to progenitor cells observed in the H and E stains. These HPCs lack a 
ductular lumen, and as such are not proliferating bile ducts (Figure 3.3b). After 12 
days of CDE administration panCK positive progenitor cells produce extensive 
cellular chords which extend to the sites of parenchymal damage. Here they 
terminate, and differentiate into hepatocytes (Figure 3.3c) at which point HPCs 
expand their cytoplasm and lose positivity for panCK. Quantification of panCK 
positivity in the liver shows a modest increase in HPC numbers by 8 days, however 
by 12 days there is a significant increase in the number of HPCs found thought out 
the hepatic parenchyma (Figure 3.3d; panCK day 8 vs. panCK day 12 p<0.05). The 
number of HPCs does not increase between 12 days and 28 days and decreases when 
CDE is removed (personal communication with Thomas Bird, Edinburgh) 
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Figure 3.3 — Hepatocellular damage in the CDE results in the emergence of a 
HPC population within the liver 
a, d. In healthy adult liver panCK predominantly identifies the biliary tree. This 
extends alongside the vasculature throughout the adult liver. b, e. 8 days into the 
CDE diet small panCK positive cells emerge from the portal tract and form thin 
migratory structures which stretch through the hepatic parenchyma. c, f. By day 12 
these HPCs form long chords of cells which extend from the portal tract into the 
regions of damage. f. PanCK positive cells increase in frequency throughout the time 
course of CDE. By day 8 HPCs are becoming much more frequent around portal 
tracts g. however by day 12 there are a significantly higher number of HPCs in 
damaged livers (Day 0 0.31 ± 0.04 vs. Day 12 1.139 ± 0.3. (day 0 and 12 n=5, day 8 
n=4, p<0.05 Mann-Whitney U test). a-c scale bar  = 200µm, d-f scale bar  = 50µm. 
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The HPC population can be identified using multiple markers 
The phenotype of hepatic progenitor cells in the adult liver is not extensively 
categorised, and as such I qualified my initial observation of panCK positive HPCs 
by staining for two widely accepted foetal and HPC markers, Dlk1 and EpCam. 
During CDE treatment panCK positive HPCs express EpCam and Dlk1 (Figure 
3.4a). Interestingly these markers are not universally expressed throughout the HPC 
population; panCK appears to be the most widely expressed of these markers, with 
extensive localisation to both the biliary tree and HPCs. EpCam and Dlk1 appear 
within subsets of these panCK positive cells, and demonstrate localisation with one 
and other as well as independent staining suggesting that the HPC population may 
not be as homogenous during the CDE diet as initially thought (Figure 3.4b). 
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Figure 3.4 – HPCs can be marked with numerous markers which identify both 
discrete and overlapping populations. 
a. HPCs can be identified with panCK, Dlk1 and EpCam. All three markers localise 
to the bile ducts of healthy animals and the HPC population of animals on the CDE 
diet b. When these expression domains of these three markers are artificially colours 
and digitally overlaid the three markers of HPCs co-localise in regions, and are found 
typically around the portal tract in HPC/ductular structures. Intriguingly there does 
appear to be a degree of heterogeneity, as panCK is much more widely expressed 
compared to EpCam and Dlk1.  
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Regeneration occurs on the back of inflammation during hepatocellular 
regeneration 
During chronic human liver disease, the liver is exposed to chronic inflammation, 
with infiltration of multiple inflammatory cell types and the remodelling of matrix 
throughout the site of damage. It is increasingly accepted that these inflammatory 
processes are involved in the activation of HPCs in the adult liver, and as such may 
be involved in the specification of HPCs into mature hepatic epithelium; either 
hepatocytes or cholangiocytes. 
 
Within the normal adult liver macrophages are found to lie in close proximity to 
hepatocytes (Figure 3.3a), and extend processes though the space of Disse. During 
the CDE regime macrophage migrate towards the site of regeneration and the portal 
tracts (Figure 3.3b, c). By day 12 there is a close association of macrophages and 
HPCs. The number of macrophages in the liver changes modestly after 12 days, 
however this increase is not as marked as one would expect in a chronic disease 
model; As such resident hepatic macrophages may migrate to the regions of 
regeneration (F4/80 day 0 vs. F4/80 day 12 p<0.05), and are observed clustering in 
Zone-1. 
 
During chronic inflammation, fibrosis and cirrhosis it is well described that 
activation of resident hepatic stellate cells into myofibroblasts is an important factor 
in the deposition of new matrix and the formation of hepatic scaring
13
. Previously it 
has been shown that myofibroblasts form close associations with HPCs. During CDE 
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treatment I found that there is a progressive increase in the number of myofibroblasts 
(Figure 3.3h) throughout the hepatic parenchyma and that are frequently associated 
with HPCs. These cells are positive for αSMA at day 8 and day 12; whereas in the 
healthy liver, only the vessel walls are positive for αSMA. Myofibroblasts extend 
fine processes between mature hepatocytes to access the HPCs emerging from the 
portal tract (Figure 3.3d – f). The close association of both macrophages and 
myofibroblasts may play an important role in the maintenance of HPCs during 
progenitor mediated regeneration. 
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Figure 3.5 — CDE induces a HPC niche within the liver consisting 
predominantly of myofibroblasts and macrophages 
a. In healthy liver F4/80 macrophages are distributed throughout the parenchyma. b, 
c. During hepatocyte regeneration from HPCs macrophages appear close to the portal 
tract, and in close proximity to the emerging HPCs. d. In healthy adult liver there is 
little presence of αSMA outwith the venous endothelia. e, f. During hepatocellular 
regeneration in the CDE diet there is a progressive increase in the presence of thin 
spindle like myofibroblasts which extend adjacent to proliferating HPCs. g. During 
regeneration of hepatocytes the number of macrophages changes significantly at 12 
days (F4/80 D0 2.25 ± 0.47 vs. D12 3.42 ± 0.18) h. Similarly the numbers of 
myofibroblasts increases, but does not reach significance. (For all images scale bar = 
200µm g, h day 0 and 12 n=5, day 8 n=4) 
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The 3, 5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) model induces 
biliary inflammation and ductular regeneration 
HPCs are able to regenerate both the hepatocellular parenchyma and the biliary 
epithelium. As I mean to investigate the mechanism by which these two divergent 
states are assumed from a bipotent cell population I established a model of ductular 
damage and regeneration. 
 
3, 5-diethoxycarbonyl-1, 4-dihydrocollidine (DDC) results in the accumulation of 
porphyrin within the biliary tree which ultimately causes biliary apoptosis and 
necrosis; the HPC population is therefore activated in order to regenerate the ductular 
epithelium. 0.1% DDC diet was administered to adult mice instead of normal food. 
Animals were sacrificed at day 0 - as a healthy control, and then at day 8, day 12 and 
day 18 to assess hepatic damage, progenitor response, and inflammatory response 
(Figure 3.6a). 
 
Throughout the DDC regime animals were subject to aggressive weight loss, losing 
20-30% of total body mass over 18 days (Figure 3.6b). After 18 days weights 
normalised, however animals became jaundiced. Within 8 days of DDC exposure 
hepatocytes appear relatively normal, although disorganised. More noticeably after 8 
days of DDC small regions of inflammation are found surrounding the portal tracts 
(Figure 3.6c-j). This inflammatory infiltrate increases throughout the duration of 
injury and by 18 days large regions of inflammation are found surrounding the portal 
tracts. By 18 days there frequent biliary aggregates which can be observed 
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throughout the majority of ducts, extending throughout the biliary tree (Figure 3.6 f, 
h).  
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Figure 3.6 — Biliary damage is induced using the 3, 5-diethoxycarbonyl-1,4-
dihydrocollidine (DDC) dietary model 
a. The DDC diet was administered for 18 days with normal drinking water; Animals 
were harvested at days 8, 12 and 18. b. Throughout the time course of DDC animals 
suffer from progressive weight loss which does not recover by 18 days (daily 
weights, n = 30-50, means plotted) . c, g. Throughout the course of damage animals 
move from having a normal hepatic architecture (d0) to acute portal inflammation by 
day 8 of DDC treatment (d, h) which gets progressively more aggressive throughout 
the regime out to day 12 (e, i) with large regions of infiltrating inflammatory cells 
and matrix deposition around the portal tracts by day 18 of DDC treatment (f, j).  
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The DDC model induces cell turnover through apoptosis and 
proliferation 
The DDC model of biliary injury and regeneration unsurprisingly induces a large 
degree of apoptosis within the ductular epithelium which can be clearly visualised 
using TUNEL staining for DNA double strand breaks. (Figure 3.7 a, b) Throughout 
the duration of DDC TUNEL staining gradually increases; interestingly I found that 
hepatocytes are also apoptotic, indicating that during long term DDC there is a 
degree of secondary parenchymal damage in response to primary biliary death, and 
as such is representative of human cholestatic disease where secondary necrosis of 
the parenchyma is common. 
 
H & E stains of the DDC model demonstrate the emergence of small HPC-like cells 
after 8 days, which form pseudo ducts surrounded by an inflammatory infiltrate. 
These new structures have a small, ill defined lumen, but do not migrate out into the 
parenchyma; rather they remain close to the portal tract and assume a more biliary 
phenotype. These structures are highly proliferative by 8 days as demonstrated by 
staining with Ki67 (Figure 3.7 c, d-f).  
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Figure 3.7 — The DDC model causes ductular apoptosis and proliferation 
a. During DDC there is an increase in hepatic injury, with progressively increasing 
levels of apoptosis as through increased TUNEL positivity when evaluated over 18 
days. b. Demonstrates a representative cluster of apoptotic biliary cells induced by 
the DDC (TUNEL in green) c. In response to increased apoptosis HPCs are activated 
and proliferate. In the DDC model of liver damage there is a significant increase in 
the number of proliferating HPCs (Non-Treated 1.556 ± 0.24 vs. d8 12.13 ± 4.19, 
d12 20.38 ± 7.596 and d18 15.44 ± 5.52. For non-treated and day 18 n=9 for day 8 
and day 12 n=8. *** p <0.001, a D'Agostino & Pearson omnibus normality test 
demonstrated that the data was normally distributed, as such a Student‘s t test was 
used to analyse these data.) d-f Increased proliferation can be visualised using Ki67 
detection. Over 18 days the number of HPCs which are close to the portal tract, and 
positive for Ki67 increases (black arrows), of note however it is worth highlighting 
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The DDC model of biliary regeneration results in activation of HPCs 
The resting liver has clearly defined panCK positive ducts with a wide lumen (Figure 
3.8a). During treatment with DDC however, activation and proliferation of HPCs 
results in the rapid emergence of atypical ductular structures which remain close to 
the portal tracts as previously discussed. Similarly to the CDE ductular HPCs are 
positive for panCK. Throughout the time course of the DDC damage the network of 
panCK positive cells becomes increasing extensive and begins to develop an atypical 
lumen (Figure 3.8b-d).  
 
The DDC model of regeneration is highly reproducible with similar injury responses 
between animals. Analysis of a small number of animals from each time point 
showed a remarkable homogeneity between animals on the DDC diet; at days 8, 12 
and 18 animals have a similar mean number of luminal ducts per portal tract (Figure 
3.8e). To confirm that there was indeed a ductular HPC response within DDC treated 
animals, I quantified panCK positive structures with a clearly defined lumen. These 
structures increase significantly by day 8 and continue to increase out to day 18 of 
damage (Figure 3.8f). The number of ducts per portal tract was compared to that of 
CDE. Following CDE diet HPCs have a much more ―infiltrating phenotype with a 
ductular network similar to that of a non-treated animal. 
 
As in the CDE model of hepatocyte regeneration DDC induced HPCs widely express 
panCK; however they also express EpCam and Dlk1 which co-localise within the 
ductular structures. This may indicate differences in the maturity of these cells in 
vivo (Figure 3.9 a, b). 
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Figure 3.8 — The DDC regime induces a biliary progenitor response in adult 
mice. 
a. The healthy portal tract demonstrating a clear well defined portal tract (black 
arrow). b. During early DDC damage and regeneration small ductular structures 
appear from the portal tract and are associated with a modest inflammatory niche 
(black arrows denote the emergence of HPCs). c, d Throughout damage the number 
of atypical ductular structures increases associated with a sizable inflammatory 
infiltrate (black arrows). e. The DDC model is highly reproducible between animals 
with increasing numbers of ducts surrounding each portal tract the majority of which 
have poorly defined lumen (n=20 portal tracts counted in three independent animals 
per experiment). f. The numbers of ducts per portal tract increases throughout the 
damage time course (d0 0.40 ± 0.1 vs. d8 3.63 ± 0.25 vs. d12 5.58 ± 0.26 vs. d18 
8.67 ± 0.7) n=4-6, ***p<0.001 using a Mann-Whitney U test 
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Figure 3.9 — The DDC diet activates a heterogeneous population of HPCs 
a. During the DDC regime HPCs can be identified through their positivity for numerous 
antigens including EpCam, Dlk1 and panCK. These markers are expressed throughout the 
regenerative process. b. Using digital false colouring to represent EpCam in green, panCK in 
red, and Dlk1 in blue we stacked these images to look at co-localisation of the three 
markers, which despite having some regions of co-localisation also have exclusive 
expression domains, with panCK being most broadly expressed. 
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Localised peri-portal inflammation is associated with biliary 
regeneration 
As with the CDE model of hepatocyte regeneration I find an impressive infiltration 
of inflammatory cells. Early in the DDC model there is a peri-portal association of 
HPCs with a thick band of small inflammatory cells. In healthy adult liver 
macrophages are typically localised throughout the parenchyma, however within 8 
days these cells have migrated from the parenchyma and surround the emerging 
biliary ducts (Figure 3.10 a, b). This migration and association appears to increase 
over time with increased damage and regeneration. By 18 days of injury 
macrophages form dense cell layers around portal tracts (Figure 3.10 c, d). As in the 
CDE dietary model there is a very modest increase in the number of macrophages 
within the liver as a whole; however their distribution during damage and 
regeneration appears to be important in the restoration of normal biliary architecture 
and function (Figure 3.10 e). 
 
The DDC model of biliary restoration has a much more aggressive activation of 
myofibroblasts which form direct associations with the emerging HPCs. Even at 8 
days of DDC treatment there is a sizable sheath of myofibroblasts encircling each 
new duct. (Figure 6.10 g). The ensheathment of these ducts increases over time and 
by 18 days are many cell layers thick (Figure 3.6 f- i). During regeneration of the bile 
ducts αSMA positive myofibroblast numbers increase dramatically (Figure 3.10 j), 
but are infrequently found within the parenchyma – suggesting they may play an 
important role in the maintenance of ductular HPCs during chronic biliary disease 
and could play an important role in the regulation of HPC fate choice. 





Establishing Models of Liver Regeneration 
125 
 
Figure 3.10 — The DDC diet is associated with an aggressive inflammatory 
response throughout the liver. 
a. Macrophages are scattered throughout the parenchyma in healthy liver tissue, 
however very rapidly these cells migrate to the portal tracts. b-d. Over the DDC time 
course the association of Macrophages with HPCs increases by d18. e. The overall 
number of macrophages in the liver does not increase significantly. f-i During the 
DDC diet there is a progressive increase in the number of myofibroblasts which are 
closely associated with HPCs close to the portal tract. j. The overall number of 
myofibroblasts increases throughout the liver during regeneration. (n=3 for each time 
point. No significant difference with a Mann-Whitney U test. Scale Bars 400µm) 
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Hepatic Progenitor Cells can be isolated and cultured in vitro 
To investigate the mechanisms of lineage specification I established a protocol by 
which HPCs could be isolated and cultured in vitro. Animals were treated with 12 
days of either CDE or DDC. Whole livers were digested using an in situ perfusion 
protocol. Briefly, livers were perfused with an EDTA solution to remove blood, and 
chelate free metal ions. This was followed by a Collagenase and DNase digestion. 
The liver was removed and dissociated, and then further digested to ensure liberation 
of large cell numbers. Hepatocytes were removed from the cell suspension by slow 
centrifugation. The resulting non-parenchymal cells were separated though a density 
gradient, depleted for CD45 positive cells using MACS and plated on laminin 
(Figure 3.11 a). I assessed depletion of the CD45 positive cells from these cultures 
and found that there is an almost complete CD45 depletion following MACS (Figure 
3.11 b). After 12 days of culture, HPCs proliferate and appear to have a cobble stone 
morphology with a high nuclear to cytoplasmic ratio, as described in the literature 
(Figure 3.11 c)  
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Figure 3.11 — Hepatic Progenitor Cells can be isolated and cultured in vitro 
a. Adult liver was digested into a single cell suspension and separated based on cell 
size using a density gradient. Small Cells were placed on Laminin and allowed to 
grow for 12 days before being used. b. To remove any circulating haematopoietic 
cells from the liver cell culture cells were purified by depletion of CD45 positive 
cells using MACS selection. c. HPC cultures regularly formed large densely packed 
colonies of morphological epithelial-like cells  
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Primary HPCs are positive for panCK after culture, which localises to fibres in the 
HPC cytoplasm (Figure 3.11 a). Primary HPC cultures express early hepatic 
transcription factors from the Hnf family. I observed expression of Hnf1α, Hnf4α, 
Hnf1β and Hnf6 at the level of transcript (Figure 3.11 b) within the epithelial 
population suggesting that this population has the ability to become both 
cholangiocytes and hepatocytes. 
 
Further to this isolation and culture FACS for Dlk1 was established in the laboratory 
in order to isolate HPCs from animals undergoing liver damage without the need for 
in vitro cell culture which may alter the phenotype of the HPCs, and may result in 
spurious data. FACS isolation with Dlk1-FITC also offers a specific and ‗clean‘ 
population of HPCs for gene expression analysis. Figure 3.11 c demonstrates a 
typical plot from CDE liver Dlk1 antibody; staining with which gave a clear 
population which could be sorted from other cell types, It should be noted that a 
FITC-Isotype control antibody gives a negligible shift in the FITC channel and as 
such a population which emerges with Dlk1-FITC could be sorted and correlated 
with the Dlk1 positive populations I observe in vivo. 
 
  









Establishing Models of Liver Regeneration 
131 
 
Figure 3.12 — Hepatic Progenitor Cells express hepatocyte enriched 
transcription factors and can be isolated ex-vivo for direct transcript analysis 
a. Primary HPCs cultures express cytokeratins, which when detected with panCK 
demonstrates dense fibrils throughout the cytoplasm (green) scale bar = 20µm. b. 
Primary HPCs which have been cultured express liver enriched  transcription factors 
Hnf1α, Hnf4α, Hnf6 and Hnf1β. c. HPCs can be isolated using FACS for Dlk1 from 
damaged liver. Isotype treated samples demonstrate very little shift in the FITC 
channel, however using a Dlk1-FITC a population of HPCs can be identified and 
sorted form the remaining cells within the population. 
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Discussion - CDE and DDC dietary models provide two diverse patterns 
of hepatic regeneration in adult liver 
During chronic patterns of human liver disease both parenchymal, hepatocellular 
damage and biliary, cholangiocytic damage must be replaced by an endogenous 
population of HPCs. The mechanisms by which these diverse fates are regulated are 
currently understudied, and as a result it is impossible to manipulate these pathways 
in order to promote ―healthy‖ regeneration and a positive clinical outcome. 
 
Both the CDE and DDC models of hepatic damage and repair have been used 
previously to great success in induction of HPCs within the adult liver
60, 63
; however 
the difference in these disease models has not been addressed, and as such they have 
not been used to model diverse liver pathologies. This chapter examines how in both 
CDE and DDC there is localised damage to the hepatocytes and cholangiocytes 
respectively. In both these regenerative contexts I have found that there is an increase 
in HPCs alongside a concurrent increase in the macrophage and myofibroblast cell 
populations and that these classical inflammatory cells appear closely associated with 
HPCs and may be involved in the maintenance and specification of progenitor cells 
(Figure 3.13)
6
. This description may offer some insight into how adult HPCs are 
regulated. 
 
Interestingly I found that HPCs express multiple markers, panCK, Dlk1 and EpCam; 
all of which have been classically associated with varying stages of hepatoblast 
development during ontogeny. During adult regeneration these markers associate 
with one another, however not all HPCs express these markers and as such may 
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indicate an inherent heterogeneity of HPCs during adult hepatic regeneration or may 
define degrees of naivety within the adult HPC population. 
 
By utilising both the CDE and DDC models of hepatic regeneration, coupled with 
cell isolation and culture I can modulate components of varying signalling pathways 
to elucidate the fundamental mechanisms behind specification of adult HPCs. 
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Figure 3.13— the adult HPC is associated with an inflammatory niche, but how 
its lineage is controlled remains unclear. 
HPCs are found in two models of chronic liver disease—which have different 
regenerative patterns. In both of these systems HPCs are found closely associated 
with a niche which consists predominantly of macrophages and myofibroblasts. 
HPCs express early transcription factors which are associated with either a biliary or 
hepatocyte fate, however how these genes are controlled is yet to be ascertained, and 
















Chapter 4 - Characterisation and 
Interrogation of the Notch 
pathway during hepatic 
regeneration  





During hepatic ontogeny the Notch signalling pathway is required for correct 
patterning and specification of the developing biliary tree from embryonic 
hepatoblasts
220
. In vivo ablation of the Notch-2 receptor, or indeed ablation of RBPj 
in foetal hepatoblasts results in the retardation of biliary tree formation. Further to 
this over-expression of the Notch intra-cellular domain, which acts to constitutively 
activate the Notch signalling in these isolated hepatoblasts results in up regulation of 
early biliary lineage genes such as Hnf1β and Hnf6 and reduces expression of late 
hepatocyte makers such as Hnf4α and CEBP/α
222, 223
. During human development 
abrogation of the Notch signalling pathway, caused by mutation in Jagged-1 and/or 
Notch-2 results in the heterogeneous Notch pathway disorder Alagilles syndrome. 
Alagilles syndrome is typified by bile duct paucity as well as other congenital 
malformations. Interestingly sufferers of Alagilles syndrome fail to induce an HPC 
response in later life indicating that an intact Notch signalling pathway is needed for 




The initial aim of this chapter is to characterise the Notch signalling pathway during 
both biliary and hepatocellular regeneration in the mouse and to understand whether 
there is likely to be an intact Notch signalling pathway during hepatic regeneration 
during chronic damage. This work led to the second aim discussed in this chapter 
which deals with interrogation and blockade of the Notch signalling pathway both in 
vitro and in vivo. Further to this I identify the endogenous mechanisms which may 
prevent inappropriate Notch activation during regeneration. 




The Notch pathway is differentially activated during Biliary and 
Hepatocellular regeneration. 
During regeneration of the adult liver HPCs differentially express components of the 
Notch signalling pathway depending on whether they are assuming a hepatocellular 
of biliary fate
322
. I have also investigated mouse models of hepatocellular and biliary 
regeneration (the CDE and DDC regimes respectively) to ascertain whether the 
Notch signalling pathway is differentially regulated in these contexts as this would 
offer an important tool in understanding the mechanism of HPC specification in two 
divergent hepatic disease phenotypes. 
 
I have found that during liver regeneration in the mouse, Dlk1
+
 isolated HPCs 
express Notch1 and Notch2 mRNA transcripts at high levels during regeneration of 
the bile ducts after DDC injury. In contrast to this I have also found that Dlk1
+
 HPCs 
isolated during hepatocellular regeneration induced by the CDE regime express low 
levels of Notch1 and Notch2 (Figure 4.1a). These data suggest that my models may 
recapitulate high Notch state found during biliary regeneration in human PSC/PBC. 
 
To further these initial observations I investigated the downstream targets of the 
Notch signalling pathway. Here I demonstrate that Hes1 expression differs only 
moderately between these two injury states, this is perhaps unsurprising as I know 
that Hes1 expression is downstream of other pathways which are potentially 
activated in murine Dlk1
+
 HPCs. Instead I analysed expression of Hes5 and HeyL, 
both of which are more highly expressed at the mRNA level during DDC than during 




CDE, once again indicating that during biliary regeneration the Notch signalling 
pathway is highly upregulated and highly activated (Figure 4.1a). 
 
During biliary regeneration in the mouse I detected high transcript levels of both 
Notch1 and Notch2. To ascertain whether I observe both of these receptors expressed 
on the HPCs during biliary regeneration I used immunohistochemistry for these 
receptors, in tandem with EpCam (an alternative marker which co-localises with 
Dlk-1 during hepatic regeneration, observe results, chapter 3) to demonstrate their 
presence at the level of protein during biliary regeneration. I have found that during 
biliary regeneration Notch1 demonstrates consistent nuclear localisation within the 
EpCam
+
 HPC population (Figure 1b), again indicating that this receptor may be 
cleaved and is translocating to the nucleus. However during hepatocellular 
regeneration I only observe infrequent Notch1 positive cells which co-stain with 
EpCam (Figure 4.1c). During both hepatocellular and biliary regeneration Notch-2 
protein is undetectable within the HPC population, however can be faintly observed 
within the associated mesenchyme during biliary regeneration (data not shown). Of 
particular interest is that during human patterns of biliary and hepatocellular 
regeneration in PBC/PSC and HCV respectively in collaboration with Olivier 
Govaere and Tania Roskams, Leuven Belgium we find that there is a recapitulation 
of this paradigm where the Notch pathway is highly activated during biliary 
regeneration. 
 








Figure: 4.1: The Notch signalling pathway is highly expressed and activated 
during biliary regeneration 
a. The CDE and DDC mouse models show differential expression of the receptors 
Notch1 (DDC: 64659 ± 36087 vs. CDE 12.78 ± 1,784) and Notch2 (DDC 29525 ± 
10687 vs. CDE 2.015 ± 0.87) with high expression in HPCs isolated from DDC. 
Associated with these high levels of Notch receptor expression I find higher levels of 
Notch targets Hes1 (DDC 5595 ± 1391 vs. CDE 4491 ± 92.88), Hes5 (DDC 8785 ± 
4266 vs. CDE 688.8 ± 211.4) and HeyL (DDC 7030 ± 2182 vs. 475.4 ± 166.3) 
expressed in DDC. For each group, DDC and CDE n=4, *p<0.05 according to a 
Mann-Whitney U test b, c. During biliary regeneration in the DDC I observe 
accumulation of Notch1 in the nucleus of EpCam positive HPCs, however during 
hepatocellular regeneration in the CDE I observe an absence of Notch1 within the 
HPC nucleus, this correlates with my data indicating a high Notch state during 
biliary repair, but not during hepatocellular regeneration. Scale bar = 100µm    




During Biliary Regeneration Jagged1 is found in close association with 
Notch positive HPCs. 
Activation of the Notch pathway is mediated through binding of a membrane 
tethered ligand from the Delta or Jagged families to the Notch receptor. During 
murine regeneration I find high transcript expression of Jagged1 during biliary 
regeneration after administration of DDC; with lower expression of this Jagged1 
mRNA during CDE induced hepatocellular repair (Figure 4.2a). I further 
characterised the protein expression of Jagged1 in the mouse using 
immunohistochemistry for Jagged1, however rather than finding expression of the 
protein in the HPC population as described during human disease by Tania Roskams, 
and Olivier Govaere, Leuven Belgium, unpublished, personal communication, I 
found strong staining in the associated inflammatory infiltrate. To investigate this 
further I looked at two major consentient components of the inflammatory infiltrate 
myofibroblasts and macrophages (as described in the previous chapter) to ascertain 
whether these cells are the ligand expressing cells during regeneration. 
 
Macrophages associated with murine biliary damage and restoration do not express 
the Notch ligand Jagged-1. F4/80
+
 cells surround the site of regeneration, however 
are infrequently found associated directly with the emerging HPC population (Figure 
4.2b). There is rather, a population of cells directly adjacent to the HPCs which 
expresses Jagged1. I have found that αSMA
 
positive myofibroblasts are often, but 
not always positive for Jagged1 suggesting some heterogeneity within the HPC 
associated myofibroblast population (Figure 4.1c). During murine biliary 




regeneration these myofibroblasts form direct contact with HPCs and form sheaths 
around the emerging bile duct ranging from one cell layer to multiple cell layers 
which give an ―onion-skin‖ phenotype around the duct. 
 
During hepatocellular regeneration myofibroblasts can also form intimate 
associations with HPCs, however in this context I never found a αSMA positive 
myofibroblast which is positive for Jagged1 (Figure 4.1d) and as such conclude that 
as well as the Notch receptors being lowly expressed during hepatocellular repair 
that the cellular stereotypical niche is rather dynamic in the pathway components it 
expresses. It should be noted that again in human disease in collaboration with 
Olivier Govaere and Tania Roskams, Leuven, Belgium we find a higher levels of the 
Notch ligand JAGGED1; however this does not appear to localise to the 
inflammatory infiltrate, it is rather expressed by HPCs perhaps indication of a species 
difference during hepatic regeneration or could be reflective of disease progression. 
  










Figure: 4.2: The Notch signalling pathway is highly expressed and activated 
during biliary regeneration 
a. In mouse models CDE and DDC I find a differential expression of Jagged1 in 
isolated mHPCs, with negligible expression levels during hepatocellular repair (DDC 
1211 ± 436.7 vs. CDE 6.153 ± 2.798.) n=4, *p<0.05 according to a Mann-Whitney U 
test b. In mouse Jagged1 (Red) shows a localisation which does not localise to the 
biliary epithelium similarly it is discrete from F4/80 positive macrophages (Green). 
c. During DDC Jagged1 co-localises with αSMA positive myofibroblasts, and form a 
sheath around the emerging HPCs which are regenerating bile ducts. d. During 
hepatocellular regeneration in the CDE regime αSMA positive cells can still form 
close associations with HPCs, however these myofibroblasts are Jagged1 negative 








Inhibition of the Notch pathway in vitro attenuates expression of biliary 
genes. 
To investigate the role of Notch signalling during specification of HPCs I isolated 
these cells and cultured them in vitro. These cells formed compacted epithelial 
colonies as previously described within the literature. These HPCs where co-cultured 
in contact with myofibroblasts under differentiation conditions for three days in the 
presence or absence of DAPT which prevents Notch signalling through inhibition of 
γ-secretase.  
 
In vitro co-culture inhibition results in a reduction in biliary phenotype. 
HPCs express the Notch1 receptor at the level of protein in HPCs when they have 
been isolated and cultured in vitro for up to 12 days (Figure 4.3a). In vitro cultured 
myofibroblasts express Jagged1 as protein on the cell surface (Figure4.3b). Having 
described that HPCs and myofibroblasts express receptor and ligand respectively I 
combined these cells in vitro in order to activate the Notch signalling pathway I 
analysed the effect of inhibiting this co-culture system using 10mM DAPT or DMSO 
vehicle alone (Figure 4.3c). 
 
I found that during co-culture the Notch signalling pathway is activated as 
demonstrated through expression of Hes1, Hes5, Hey1 and HeyL. In HPCs alone I 
find only low expression of these pathway effector genes compared to when the 
HPCs are combined in co-culture with myofibroblasts (Figure 4.3 d and Figure 4.3 
e). During DAPT treatment of these HPC/Myofibroblast co-cultures I demonstrate a 




significant reduction in the expression of these Notch pathway effector genes, 
demonstrating efficient inhibition of γ-secretase and by extension the Notch 
signalling pathway (Figure 4.3e).  
 
During treatment with DAPT I found a modest decrease of Hnf1β expression; a 
transcription factor classically associated with a biliary phenotype during hepatic 
ontogeny, and which has an adult expression pattern which is restricted to the bile 
duct. Along with this I also observe a significant reduction in the mRNA expression 
of a second biliary transcription factor Hnf6, and also in the expression of Gamma-
glytamyl transpeptidase (Ggt), a clinical marker of biliary damage. During inhibition 
of γ-secretase in vitro I found no increase in the expression levels of HNF4α a 
transcription factor associated with terminal hepatocyte differentiation (Figure 4.3f); 
suggesting that inhibition of the Notch signalling pathway restricts a biliary 
phenotype; however blockade does not induce a hepatocyte phenotype within this co-
culture system. Inhibition of the Notch signalling pathway importantly does not 
affect the expression of my housekeeping gene PPIA, or the proliferation of 
myofibroblasts in vitro assessed by monitoring cell density during the experiment. I 
can therefore extrapolate that the affect of DAPT on biliary fate is due to inhibition 
of the Notch pathway rather than through differences in gene normalisation or 
number of myofibroblasts. 
  









Figure 4.3: Inhibition of myofibroblasts/HPC co-cultures results in abrogated 
biliary gene expression:  
a. During culture of HPCs small colonies with epithelial ‗cobble stone‘ morphology 
emerge in culture. These cells are small, have a high nuclear : cytoplasmic ratio and 
are positive for Notch1 receptor. b. Myofibroblasts isolated from healthy murine 
livers were activated by culture in vitro. Myofibroblasts are positive for αSMA (Red) 
which is typically fibrous. Cultured myofibroblasts are also positive for Jagged1 
protein (Green) which is detected throughout the membrane and cytoplasm. c. 
Schematic representation of the co-culture experiment. HPCs and Myofibroblasts 
were cultured separately, and subsequently recombined in vitro in the presence of 
DAPT or vehicle (DMSO) alone. These cells were co-cultured for 3 days with repeat 
administration of DAPT on day 2. d. During co-culture of HSCs and HPCs Notch 
pathway effectors Hes-1 (HPC 0.2345 ± 0.017 vs. HSC 0.277 ± 0.025 vs. co-culture 
2.749 ± 0.266), Hes-5 (HPC 0.604 ± 0.207 vs. HSC 0.174 ± 0.1078 vs. co-culture 
1.354 ± 0.41), Hey1 (HPC 0.1236 ± 0.014 vs. HSC 0.1746 ± 0.128 vs. co-culture 
1.871 ± 0.324) and HeyL (HPC 0.338 ± 0.131 vs. HSC 0.4592 ± 0.16 vs. co-culture 
3.411 ± 0.187). e. Inhibition of HPC/Myofibroblast co-cultures with DAPT results in 
a reduction in Notch signalling pathway effectors Hes1 (DMSO 2.532 ± 0.32 vs. 
DAPT 1.377 ± 0.23), HeyL (DMSO 3.133 ± 0.3230 vs. DAPT 0.9829 ± 0.0906), 
Hey1 (DMSO 1.647 ± 0.3475 vs. DAPT 0.08625 ± 0.01981) and Hes5 (DMSO 
1.254 ± 0.4185 vs. DAPT 0.983 ± 0.01693). f. In concordance with a reduction in 
Notch effector expression I find an abrogated expression of genes associated with the 
biliary lineage. I observe a modest reduction in the transcription factor Hnf1β 
(DMSO 369.8 ± 64.14 vs. DAPT 322.7 ± 31.28) however I observe a significant 




reduction in the expression of Hnf6 (DMSO 77.94 ± 12.52 vs. DAPT 14.97 ± 4.57) 
and Ggt (DMSO 6082 ± 757.7 vs. DAPT 3169 ± 449.0). Interestingly during 
inhibition I observe promotion of the hepatocyte gene Hnf4α (DAPT 10.38 ± 1.338 
vs. 8.039 ± 1.898). In all experiments n=4 repeated 3 times. *p<0.05, **p<0.01, 
***p<0.001. Data analysed using a Mann Whitney U test Scale bar = 10µm 
  
  




Inhibition of gamma-secretase in vivo results in attenuated biliary 
regeneration without affecting fibrosis 
During inhibition of the Notch signalling pathway in my co-culture system I 
demonstrate a reduction in biliary specification; to demonstrate that the Notch 
signalling pathway is required for biliary specification in vivo I inhibited γ-secretase 
in vivo using DAPT. Using the DDC diet to model biliary damage and regeneration 
for twelve days I administered a repeat dose of DAPT at 50mg/Kg daily for 3 days 
(Figure 4.4a). The physiological efficacy of DAPT administration was confirmed by 
the conversation of the small intestine into a secretory phenotype typified though 
high numbers of goblet cells as previously described in the literature (Figure 4.4b). 
  















Figure 4.4: Gamma-Secretase inhibition in vivo results in a reduction of biliary 
phenotype 
a. During biliary regeneration, where I have described HPCs as being in a Notch 
high state I have used DAPT given repeatedly between day 12 and day 15 in order to 
inhibit the cleavage of Notch receptor in the liver. b. As a positive control for γ-
secretase inhibition I used small intestine and demonstrated that when treated with 
DAPT the intestinal epithelium assumes a more secretory phenotype when compared 
with control mice as described in the literature (white arrows in the DAPT treated 
animal highlight the large number of goblet cells). Scale bar = 100µm 
 
  




Does Gamma-secretase inhibition affect proliferation and apoptosis in 
the regenerating adult liver? 
DAPT acts as a general inhibitor of γ-secretase, and as such has off-targets affects on 
pathways other than those mediated through the Notch receptor. For example both 
Epidermal Growth Factor Receptor (EGFR) and amyloidal-beta are processed by γ-
secretase, as well as numerous other membrane tethered proteins – and as such 
gamma-secretase inhibition may alter the survival of HPCs through deregulation of 
proliferation and/or apoptosis. As such I have investigated whether there is any 
change in the rate of proliferation or degree of apoptosis during DAPT treatment 
compared to Vehicle alone. I analysed the number of KI67 positive cells as a means 
of demonstrating changes in proliferation. As previously described I saw 
proliferation of HPCs, inflammatory cells and hepatocytes during DDC treatment. 
During γ-secretase inhibition I found that there was no detectable difference in the 
degree of proliferation when compared to vehicle treated alone (Figure 4.5a). 
Conversely I investigated whether administration of DAPT during biliary 
regeneration resulted in HPCs becoming apoptotic. I found no significant difference 
in the rate of biliary apoptosis between DAPT and control groups when TUNEL, 
suggesting that inhibition of the Notch signalling pathway does not result in 
increased apoptosis during biliary regeneration (Figure 4.5b). 
  
  










Figure 4.5: Gamma-Secretase inhibition in vivo does not alter proliferation or 
apoptosis 
a. During DAPT administration the amount of proliferation is not significantly 
changed in vivo as assessed through quantification of KI67 positive cells. (DAPT 
126.0 ±3.536 vs. Vehicle 114.3 ± 11.92). Black arrows denote positive, nuclear 
staining in HPCs b. DAPT administration does not significantly affect the rate of 
apoptosis during biliary regeneration (DAPT 13.36 ± 0.49 vs. DMSO 11.89 ± 1.075) 
as assessed through quantification of TUNEL positive cells in DAPT vs. Vehicle 
treated animals. For both groups n=5, data was analysed using a Mann-Whitney U 
test. Scale bar = 100µm. 
  




Gamma-secretase inhibition results in a reduction of HPCs and reduced 
biliary gene expression 
As I found no difference in the proliferation and apoptosis during DAPT 
administration I quantified the number of HPCs in animals treated with gamma-
secretase inhibitor versus control animals. Inhibition of γ-secretase resulted in the 
significant reduction in the number of HPCs during biliary regeneration as 
demonstrated through quantification of panCK
+
 cells in both DAPT and control 
livers (Figure 4.6a). To demonstrate that this reduction is due to a loss of biliary 
phenotype I isolated HPCs through a discontinuous Percoll gradient as inhibition of 
γ-secretase may have some off target affects on processing of other surface 
molecules such as Dlk1 and EpCam. 
 
Inhibition of γ-secretase is associated with a reduction in the expression of Hes1 and 
Hes5, effectors of Notch signalling pathway; this loss of Hes expression indicates 
that in isolated cells the Notch pathway has been appropriately inhibited, although as 
the expression of these genes is not completely attenuated then I cannot assume 
complete inhibition of this pathway. The reduction in activation of the Notch 
signalling pathway is associated with a loss of biliary gene expression in DAPT 
treated animals vs. controls. I demonstrate a significant reduction in the mRNA 
expression of two transcription factors Hnf1β and Hnf6 which are both associated 
with commitment to an early biliary lineage during hepatic ontogeny (Figure 4.6b). 
  










Figure 4.6: Inhibition of the Notch pathway in vivo reduces HPC number and 
biliary specification 
a. During DAPT administration I found that panCK HPC positivity throughout the 
liver was significantly decreased when compared to mice injected with vehicle alone 
(DAPT 8.437 ± 1.325 vs. Vehicle 16.00 ± 2.883).b. The decrease in panCK positive 
HPC number during biliary regeneration is associated with a decrease in Hes5 
expression (DAPT 0.08 ± 0.008 vs. Vehicle 0.21 ± 0.09) as well as early biliary 
lineage genes Hnf1β (DAPT 0.749 ± 0.05 vs. Vehicle 1.918 ± 0.45) and Hnf6 
(DAPT 0.41 ± 0.008 vs. Vehicle 1.47 ± 0.44). However I observe no change in the 
expression of the hepatocyte associated gene HNF4α (DAPT 0.42 ± 0.02 vs. Vehicle 
0.386 ± 0.03). For both groups n=5, data was analysed using a Mann-Whitney U test. 









Inflammation and fibrosis are not affected by DAPT administration  
Inhibition of γ-secretase and the Notch signalling pathway with DAPT may have 
some off target affects on other cell types within the liver, despite not observing 
expression of the Notch receptors throughout other cells, separate pathways may be 
affected. For example that CX3CL1/Fractalkine shedding by myofibroblasts in the 
liver affects chronic inflammation and fibrosis, as this shedding is mediated in part 
by γ-secretase
323
, inhibition with DAPT could result in a reduction in fibrosis which 
results in a loss of biliary proliferation. To assess whether the change I observe in 
fate of HPCs is due to a change in the surrounding stroma I analysed the numbers of 
myofibroblasts and macrophages during biliary regeneration and during DAPT 
inhibition.  
 
During the DDC regime I observe the emergence of portal fibrosis found, (as 
previously described in chapter 3). Repeated DAPT administration during DDC 
treatment and biliary regeneration does not significantly reduce the levels of portal 
fibrosis as demonstrated through image analysis of picrosirius red (PSR). Peri-portal 
PSR staining is still present surrounding the ductules and the distribution of this 
staining does not change with DAPT treatment (Figure 4.7 a).  
 
PSR acts as a measure of total fibrillar collagen, and as such does not give any 
indication of whether during DAPT administration there is a change in the cellular 
components of the HPC niche. As I have previously described, macrophages and 
myofibroblasts are closely associated with the HPC reaction during biliary 




regeneration and that in mouse Jagged1 is expressed by myofibroblasts; to this end I 
quantified αSMA and F4/80 to investigate whether γ-secretase inhibition resulted in 
a modulation of myofibroblasts and macrophages in vivo. 
 
During biliary regeneration in either in the presence or absence of DAPT I found that 
the number of αSMA
 
positive myofibroblasts remained constant during regeneration 
and that the spatial relationship of these cells to HPCs did not change compared to 
control vehicle only treated animals where myofibroblasts form close sheath-like 
associations with HPCs (Figure 4.7b). I made comparable observations when 
quantifying macrophages. As previously demonstrated these cells are found 
throughout the hepatic parenchyma, and also in close association with the 
regenerating bile ducts (Figure 4.7c). Administration of DAPT does not have any 
effect on the number or localisation of macrophages during biliary regeneration in 
the adult mouse.  









Figure 4.7: Inhibition of gamma-secretase does not affect inflammation and 
fibrosis in vivo. 
a. During the course of DDC administration I observe a progressive increase in 
fibrillar collagen as detected by PSR. Treatment with DAPT does not cause a change 
in collagen deposition and fibrosis when compared to Vehicle alone (DAPT 0.76 ± 
0.24 vs. Vehicle 0.529 ± 0.05). b. To demonstrate that γ-secretase inhibition does not 
alter the presence of myofibroblasts, which are closely associated with HPCs I 
stained for αSMA protein and quantified this, I found no significant difference in the 
numbers of myofibroblasts between those treated with γ-secretase inhibitor and 
vehicle alone (DAPT 46.94 ± 8.229 vs. Vehicle 46.30 ± 8.817).c. Similarly I observe 
no significant change in the amount of staining for F4/80 within these groups (DAPT 
0.8721 ± 0.32 vs. Vehicle 0.655 ± 0.09). For each group n=4-5, data generated using 









During Hepatocellular Notch signalling is endogenously inhibited 
through expression of Numb 
I have shown that during hepatocellular regeneration in my murine model CDE that 
components of the Notch signalling pathway are differentially expressed when 
compared with biliary regeneration in PBC/PSC and DDC We have confirmed this 
paradigm also exists within the context of human diseases such as PBC/PSC and 
HCV, in collaboration with Olivier Govaere and Tania Roskams, Leuven Belgium. I 
have also demonstrated that activation of the Notch signalling pathway is 
significantly abrogated during hepatocellular regeneration as effectors of the Notch 
signalling pathway, namely members of the Hes/Hey gene family are down 
regulated. Ectopic expression of the Nicd in hepatocytes, and as such constitutive 
activation of the Notch pathway results in the transdifferentiation of hepatocytes into 
CK19 expressing ―biliary-like‖ cells
220
 - This observations led me to ask whether 
there are any associated repressors of the Notch signalling pathway which may also 
act to suppress Notch signalling during hepatocellular regeneration, accounting for a 
second tier of Notch repression and as such a more complete prevention of aberrant 
Notch signalling. 
 
Using my murine models of damage and regeneration I investigated whether I can 
find instances of Notch suppression during hepatocellular regeneration. Initial 
analysis of whole liver transcripts suggested that during hepatocellular regeneration 
induced with CDE, and biliary regeneration induced with DDC that there is a 




difference in the levels of Numb during these divergent regenerative contexts (data 
not shown).  
 
 During normal hepatic homeostasis Numb is expressed within the bile ducts, 
however during biliary damage and regeneration isolated Dlk1
+
 HPCs demonstrate a 
loss of Numb transcript (Figure 4.8 a). I confirmed the loss of Numb protein by 
staining a time course of DDC damaged livers. Numb protein is lost within the first 8 
days of damage and this loss persists out to 18 days (Figure 4.5 b). During the DDC 
regime designed to give biliary damage I at times also observe some associated zone-
one hepatocellular death; as such I also find very infrequent Numb positive HPCs 
during biliary regeneration – which I speculate remain in order to regenerate the 
hepatic parenchyma.  
 
During CDE induced hepatocellular regeneration I find the converse to be true. As 
described previously the number of HPCs increases over time during CDE 
administration all of these HPCs are Numb positive throughout the time course I 
studied, suggesting that Notch signalling is inhibited during this process. Isolated 
HPCs demonstrated a clear persistence of Numb expression with a non-significant 
trend to up-regulation of Numb transcript expression (Figure 4.8 c) I also 
demonstrate that these cells stained strongly for Numb protein with definite 
cytoplasmic and membranous localisation; supporting the notion that during 
hepatocellular regeneration the Notch signalling pathway must be suppressed (Figure 
4.8 d). 




In collaboration with Olivier Govaere and Tania Roskams I investigated whether 
NUMB was important in HPCs during two patterns of human disease. In these two 
regenerative contexts I found that NUMB was indeed highly expressed in HCV, but 
expression of NUMB was repressed in the human diseases PSC and PBC – a context 
in which Notch signalling is activated. 









Figure 4.8: During Hepatocellular regeneration Numb is highly expressed, but 
is lost during biliary regeneration 
a. At 18 days this positivity was confirmed through analysis of Numb transcript 
which is present at high levels following 18 days of CDE injury (Control 1.00 ± 
0.025 vs. CDE 1.866 ± 1.369) . b. During CDE induced hepatocellular regeneration I 
found that over 18 days Numb protein persists in the HPC population. c. The loss of 
Numb from HPCs was confirmed by analysing the expression of Numb transcript. In 
contrast to what I observe during hepatocellular regeneration, I find that during 
biliary repair there is a significant reduction in Numb gene expression. (Control 
1.194 ± 0.070 vs. DDC 0.108 ± 0.022). d. During biliary regeneration the presence of 
Numb protein throughout the biliary regeneration is below levels of 
immunohistological detection, with only occasional Numb positive cells persisting 
(DDC, day 12). In each experimental group n=4, significant differences were 











Discussion – Notch signalling is important for biliary regeneration but 
dispensable during hepatocyte repair  
During hepatic regeneration I observe a cellular niche which is stereotypical as 
previously described by our group and others. However during divergent patterns of 
disease, damage and as such repair we observe a diverse signalling phenotype 
emerge in order that HPCs would correctly regenerate either biliary epithelium or 
hepatocytes. 
 
This is certainly the case for both human and mouse where effectors of the Notch 
pathway, namely the Hes and Hey gene families are expressed to a greater degree 
during biliary regeneration. Interestingly our collaborator Tania Roskams finds that 
in human NOTCH2 appears to be the predominant receptor expressed on HPCs. This 
may not be surprising given the crucial role the role of NOTCH2 during hepatic 
ontogeny and the crucial role it plays during establishment of the biliary network. 
 
Murine regeneration in typified by expression of the Notch1 receptor in HPCs. The 
presence of this Notch homologue may point to species variability in how the bile 
duct regenerates after damage; however the difference in Notch receptor may be 
down to the chronic nature of disease, where in human many of these pathologies 
have built up over decades in mouse these aetiologies take weeks, this too could 
explain why in chronic human disease I observe expression of the JAGGED1 ligand 
on the biliary epithelium, however during regeneration of the biliary tree in mouse I 
observe Jagged1 is expressed by the myofibroblasts surrounding the hepatic 




progenitor cells; chronic diseases in human may eventually result in ―niche 
independence‖, and as such allow the epithelium to operate independent of its 
surrounding microenvironment.  
 
Inhibition of the Notch signalling pathway both in vitro and in vivo has severe 
consequences for biliary phenotype. In both these systems I have demonstrated that 
small molecule inhibitors targeted at Notch receptor processing restricts the 
expression of biliary genes in HPCs, and also abrogates the number of HPCs present 
during biliary regeneration. Reassuringly I have also shown that this reduction is not 
due to an off target affect which alters cell number, and that fibrosis is not reduced 
between in those mice given DAPT. 
 
Critically I have identified that the Notch pathway is down regulated during 
regeneration of hepatocytes in a mouse model of hepatocellular regeneration CDE 
and during human hepatocellular disease (in collaboration with Olivier Govaere and 
Tania Roskams, Leuven Belgium). As well as there being a lack of Notch ligand 
(and indeed receptor expression in the mouse) and potential endogenous repression 
of the Notch signalling pathway through the ubiquitin ligase Numb it is possible to 
conclude that that there is a two tier repression of Notch signalling during 
hepatocellular repair (Figure 4.9). 
  












Figure 4.9— A schematic representation of Notch mediated regeneration in the 
adult liver 
During biliary regeneration hepatic progenitor cells express high levels of Notch 
receptor, and the pathway is activated during biliary regeneration which acts through 
the Hes and Hey transcription factor family. This pathway is activated through 
stimulation by Jagged1 derived from the HPC population or a surrounding 
myofibroblast niche. Blockade of this pathway results in reduced cholangiocyte 
numbers in vivo and abrogated expression of early biliary transcription factors. 
During hepatocellular regeneration the Notch signalling pathway is expressed at low 


















Chapter 5 - Wnt Signalling 
facilitates hepatocyte 
differentiation during liver 
regeneration  




During foetal development the Wnt pathway is important in specification of multiple 
different cells types. During hepatic ontogeny Wnt signalling is required for correct 
temporal regulation of hepatic differentiation. Early on in hepatic specification Wnt 
is required for correct budding and morphogenesis of what will become hepatic 
endoderm
304, 324
. During early hepatogenesis the role of Wnt signalling is disputed, 
with some contradictory data in the literature. During hepatocyte specification there 
are several reports of Wnt pathway inhibitor expression, such as Sfrp5 and calcinurin 
which interfere with Ctnnb1 signal and subsequently allow hepatic differentiation
307
. 
In contrast to this it has been demonstrated in Zebrafish that a homologue of Wnt2b, 
Prometheus is expressed in mesenchyme adjacent to the developing liver, and that 
abrogation of this signal results in a retardation of liver development; similarly when 
Prometheus is inhibited Prox1 and Hex, Ctnnb1 target genes, are down regulated. 
Initiation of hepatic development is not the only role played by the Wnt pathway. 
Later in hepatic development the liver must undergo zonation, where different 
regions of the parenchyma assume different functional traits
305
. This zonation is 
established through Wnt signalling, where loss of APC prevented peri-venous zonal 
restriction of Ctnnb1 activation and glutamine synthetase, but was rather found 




Postnatal Wnt/Ctnnb1 signalling is also important in the growth and regeneration of 
the liver. Where over expression or stabilization of Ctnnb1 results in liver growth 
and hepatomegly. During hepatic regeneration Ctnnb1 levels rapidly increase after a 
partial hepatectomy (PHx) – mice lacking Ctnnb1 demonstrated an attenuated ability 
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This chapter aims to define the role of Wnt signalling in the hepatic progenitor 
response, and investigate whether interrogation of this pathway can induce a 
hepatocyte phenotype in HPCs. Interestingly I found that there is again a difference 
in Wnt/Ctnnb1 signalling between biliary and hepatocellular regeneration in the 
mouse, and that this may also correlate to what is observed in the human disease 
PSC/PBC and HCV. Macrophages are a rich source of canonical Wnt ligands and 
when they form close associations with HPCs then they can drive a hepatocellular 
phenotype. Ablation of Macrophages results in a reduction in Wnt/Ctnnb1 and as 
such suggests that this pathway, driven by macrophage derived Wnt is required for 
HPC specification into hepatocytes. 
 
The Wnt signalling pathway is highly activated during hepatocellular 
regeneration but not during biliary regeneration 
During both hepatocellular and biliary regeneration the Wnt pathway activation 
status of HPCs varies, ultimately depending on the fate of the HPC, and the context 
in which it is found. 
 
 During biliary regeneration in the mouse liver initiated by chronic DDC 
administration I found the emergence of HPCs as previously discussed. These HPCs 
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were found typically after 18 days of treatment to have low levels of Ctnnb1 in the 
nucleus of HPCs (Figure 5.1a). This observation correlates with HPCs found in 
human biliary diseases PBC/PSC where CTNNB1 protein is found to consistently 
localise to the HPC membrane and only infrequently is found localised to the 
cytoplasm and nucleus, personal communication Tania Roskams and Olivier 
Govaere. 
 
I do however observe a different paradigm during hepatocellular regeneration in the 
mouse CDE model of hepatocyte regeneration. HPCs emerging from the portal tracts 
and have similar levels of staining for nuclear Ctnnb1 (Figure 5.1b). However using 
Dlk1
+
 cells isolated from both CDE and DDC murine models I can demonstrate that 
there is a phenotypic difference in Wnt pathway target genes. During hepatocellular 
regeneration the Wnt pathway target genes Axin2, Myc, Sox9 and Twist are all more 
highly expressed during hepatocyte regeneration compared with biliary regeneration 
(Figure 5.1c) – suggesting that Ctnnb1 nuclear translocation activates the Wnt 
cascade. 
 
Sox9 immunohistochemistry demonstrates that this variation in transcript level could 
be relayed to the amount of protein found in HPCs. During hepatocellular 
regeneration the Sox9 protein is nuclear and stains strongly, however the intensity of 
Sox9 staining during biliary regeneration is less, and appears more diffuse within the 
HPC nucleus (Figure 5.1d and Figure 5.1e), however further work would be required 
to validate the effects of this modulation.   
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Figure 5.1 The Wnt/β-catenin pathway is activated during hepatocellular 
regeneration: 
a During regeneration of the biliary tree I observe presence of β-catenin localised to 
the cell membrane of HPCs and hepatocytes. When looking for activated, 
phosphorylated I found none in the nucleus of HPCs regenerating the biliary tree. b. 
In contrast to this during CDE induced hepatocellular regeneration β-catenin is 
localised to the cell membrane and also is found within the cytoplasm and nucleus. c. 
Associated with varying localisation of β-catenin I found differential activation of the 
Wnt pathway as demonstrated through target gene expression Axin2 (CDE 3.270 ± 
0.80 vs. DDC 0.1587 ± 0.36) and Myc (CDE 13.29 ± 4.59 vs. 1.209 ± 0.11) Sox9 
(CDE 4.529 ± 2.50 vs. DDC 0.970 ± 0.33) and Twist1 (CDE 6.320 ± 1.684 vs. DDC 
2.522 ± 0.735) were also more highly expressed during hepatocellular regeneration 
than during biliary restoration. d. During Biliary regeneration Sox9 is found within 
the nucleus of the HPCS, demonstrating that a well described Wnt target is found in 
these cells, e. Of interest is that during hepatocellular regeneration in the CDE the 
staining of HPCs appeared much more concentrated in HPC nucleus, again 
reiterating that Sox9 protein may be more highly expressed during hepatocellular 
regeneration;. In both CDE and DDC gene expression n=4, statistical significance 
was determined using a Mann Whitney U test *p<0.05. a, b Scale Bar =  100µm. D, 
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In vivo Wnt ligand is supplied by HPC associated macrophages, and is 
upregulated in response to phagocytosis of hepatocyte debris 
I have demonstrated that during hepatocellular and biliary regeneration there is a 
divergent Wnt activation phenotype in HPCs undergoing biliary or hepatocellular 
regeneration. To examine this further I sought to identify and characterise the source 
of the Wnt ligand and describe how this Wnt ligand may be regulated.  
 
Initial work (described in chapter 3) demonstrates that HPCs are found in a 
stereotypical cellular niche composed primarily of macrophages and myofibroblasts; 
however here I describe how the geographical distribution of these cellular 
components is variable depending on regenerative context. During murine biliary 
regeneration in the DDC model I found that HPCs are surrounded by F4/80 positive 
macrophages, however these inflammatory cells infrequently form contacts with the 
emerging HPCs as there is a cellular sheath of αSMA positive myofibroblasts 
surrounding the HPCs and preventing penetration of the macrophage to the site of 
regeneration (Figure 5.2a). As previously discussed this myofibroblast sheath is 
expressing high levels of the Notch ligand Jagged-1 and as such is involved in both 
positive signalling to the HPCs to assume a biliary fate, but also in preventing 
differentiation down a hepatocellular lineage by preventing the association of other 
cell types, namely the macrophages. 
 
In contrast to this, during CDE, murine hepatocellular injury I describe a much more 
infiltrative niche where both myofibroblasts and macrophages are found in close 
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proximity to the HPCs, and as such can both influence the phenotype of the HPCs 
(Figure 5.2a). 
 
As I found this geographical variation in the niche, and also know that there is 
phenotypic differences in myofibroblasts during regeneration I sought to identify 
whether macrophages themselves have a plastic phenotype between regenerative 
patterns. I isolated macrophages from the livers of mice undergoing both CDE 
induced hepatocellular regeneration, DDC biliary regeneration or age and stain 
matched healthy mice based on positivity for F4/80-PE. During hepatocellular 
regeneration in the CDE I found that compared to control animals, macrophages 
expressed high levels of Wnt3a, whilst during the DDC pattern of regeneration the 
expression of Wnt3a decreases relative to expression in macrophages isolated from 
control animals (Figure 5.2b). 
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Figure 5.2— Macrophage distribution and Wnt expression is dynamic in 
different contexts of regeneration 
a. During regeneration Myofibroblasts and Macrophages are associated with HPCs, 
during DDC myofibroblasts closely associate with HPCs, however during CDE there 
is a more heterogeneous niche with both macrophages and myofibroblasts contacting 
HPCs. b. Macrophages isolated from both CDE and DDC demonstrate a divergent 
expression of the canonical Wnt3a ligand (CDE. 1.578 ± 0.67 vs. DDC 0.509 ± 
0.23). For each image scale bar = 50µm. For gene expression F4/80 macrophages 
were isolated from CDE and Control and DDC and Control, n=4 for each. Students T 
test was performed, no significance were seen with a 95% confidence interval. 
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To investigate a potential mechanism for this Wnt status I isolated bone marrow 
(BM) from mice and differentiated it into bone marrow derived macrophages 
(BMDMs). I achieved approximately 80 – 85% F4/80 positivity during 
differentiation of BM into BMDMs (Figure 5.3a, FACS panels 1-4) – demonstrating 
a representative differentiation at 84%).  F4/80 positive macrophages are grown in 
suspension. Once differentiated macrophages were removed from their 
differentiation conditions and plated on plastic where they rapidly attached. After 8 
hours of attachment non-adherent cells were removed through washing 
 
These macrophages were then fed with sonicated hepatocyte debris (Figure 5.4a). 
During the process of feeding macrophages ingested debris, as demonstrated through 
their large size and granulated cytoplasm (5.4 b-d). I found that those BMDMs plated 
in the absence of debris express levels of canonical ligands Wnt3a and Wnt7a, which 
have been implicated during hepatic ontogeny and also in the differentiation of ES 
cells into hepatocytes at levels barely detectable through qPCR, however after debris 
ingestion I found there to be a marked increase in the levels of Wnt3a and Wnt7a 
transcript within these macrophages (Figure 5.4e), whilst debris alone gave no signal.   
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Figure 5.3— Bone Marrow can be differentiated into F4/80 positive 
macrophages in vitro. 
a. Isolated bone marrow was differentiated into F4/80 positive cells using L929 
supplemented medium for 1 week. At day 0 unstained samples were negative for 
F4/80-PE as expected (top left panel), bone marrow stained for anti-F4/80-PE 
demonstrated approximately 1% of the bone marrow cells are F4/80 positive (upper 
right panel). After 7 days of culture the FSC/SSC profile of the differentiated bone 
marrow changes, unstained differentiated bone marrow remains excluded from the 
PE gate however differentiated bone marrow, stained for F4/80-PE demonstrates > 
80% positivity for the epitope. The positivity of these cells was confirmed through 
cytospins and immunohistochemistry for F4/80. Scale Bar = 10µm 
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Figure 5.4— Debris fed macrophages up-regulate Wnt in vitro 
Hepatocyte debris was fed to macrophages to ascertain whether ingestion induces the 
expression of Wnt ligand, briefly hepatocytes were isolated using a two step 
perfusion and digestion protocol followed by density centrifugation of the cells 
which pellet early due to their size. These cells were then sonicated and freeze 
thawed to ensure that they were sufficiently broken down. b-d. Isolated and 
sonicated hepatocytes were to macrophages. e. Macrophages fed hepatocytes 
expressed significantly higher levels of Wnt3a and Wnt7a when compared to unfed 
macrophages (Wnt3a; fed 21.79 ± 8.076 vs. unfed 0.0004 ± 0.0001, Wnt7a; fed 
340.3 ± 187.4 vs. unfed 0.012 ± 0.006) on images scale bar = 50um, and all 
photomicrographs lacking a scale bar are at the same magnification. n=6 for fed vs. 
unfed macrophages. Analysis of data using a Mann Whitney U test, p<0.05. 
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Post-phagocytic macrophages can induce a Wnt mediated hepatocyte 
phenotype in HPCs in vitro. 
Hepatic progenitor cells in vivo express high levels of Wnt target genes during 
hepatocellular regeneration, and this is associated with translocation of Ctnnb1 to the 
cytoplasm and nucleus of this HPCs.  
 
To demonstrate that the canonical Wnt pathway can be stimulated in primary HPCs 
in vitro I treated cultures with recombinant Wnt3a (rWnt3a) or DMSO (Vehicle) 
alone. In control treated cells Ctnnb1 is found constantly associated with the cell 
surface membrane (Figure 5.3a); with only very faint cytoplasmic localisation. 
However during treatment with Wnt3a I found multiple clusters of cells which stain 
positive for both membranous and cytoplasmic Ctnnb1 indicating stabilisation of 
Ctnnb1 and translocation to the HPC nucleus activating the Wnt pathway (Figure 
5.5a, Wnt3a, green cytoplasmic staining) 
 
Interestingly I found that when I treated HPCs with rWnt3a I could detect modest but 
significant changes in the levels of Numb transcript and also the levels of Hnf4α 
transcript, both associated with the establishment of a hepatocellular phenotype 
(Figure 5.5b). 
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Figure 5.5 — Hepatocyte phenotype is induced through canonical Wnt 
signalling 
a. HPCs express Ctnnb1 which is predominantly localised to the cell membrane 
(green) however when treated with recombinant Wnt3a there is a shift in localization 
of Ctnnb1 from the membrane to the cytoplasm. b. Treatment with rWnt3a results in 
an increase in the expression of Hnf4α (35 fold induction) and Numb (2 fold 
induction). n=3, p<0.05 derived using a Mann Whitney U test  
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As I have shown primary HPCs in vitro are Wnt3a responsive I established a co-
culture system between post-phagocytic macrophages expressing Wnt3a, and 
primary HPCs (Figure 5.6a). After the duration of co-culture I can demonstrate that 
the expression level of Wnt target genes increases compared with either macrophages 
or HPCs cultured alone (Figure 5.6b) – These data suggest that macrophage and HPC 
co-culture is capable of stimulating Wnt target genes, and hepatocyte phenotype in 
vitro, however this does not address the role of canonical Wnt signalling in this 
system or whether this co-culture can induce a hepatocyte phenotype. 
 
I used my co-culture system in combination with Wnt Inhibitory Factor 1 (WIF-1) to 
investigate what role macrophage derived Wnt had on HPC specification in vitro. 
When I cultured HPC and Macrophage co-cultures in the presence of WIF-1 I found 
a significant abrogation of Wnt target genes Axin2, Myc, Twist1 and Sox9 (Figure 
5.6c) . In tandem with this I found a decrease in expression of the early hepatocyte 
genes Hnf1α and Hnf4α, suggesting that early hepatocyte phenotype may be linked 
with Wnt signalling (Figure 5.6d). Unexpectedly during inhibition of the Wnt 
pathway with WIF1 I found a significant increase in expression of the early 
cholangiocyte genes Hnf1β and Hnf6 (Figure 5.6d), suggesting that in this context 
biliary differentiation is occurring at the expense of hepatocyte specification. I 
speculate that as these are primary co-cultures there may be contaminating cells such 
as myofibroblasts which in the presence of Wnt inhibition are alternatively 
specifying the HPCs into a biliary phenotype. 
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Figure 5.6 — In vitro perturbation of the Wnt pathway results in reduced 
hepatocyte specification and activation of the biliary differentiation pathway 
a. Macrophage and HPCs were co-cultured in the presence and absence of Wnt 
inhibition using WIF1. b. During macrophage co-culture Wnt target genes are more 
highly expressed when cells are combined than compared to HPCs and Macrophages 
alone (Axin2 HPC 0.008 ± 0.004, Mø 0.10 ± 0.01, HPC/Mø 44.52 ± 12.26; Myc 
HPC 0.242 ± 0.11, Mø 0.78 ± 0.10, HPC/Mø 42.45 ± 11.54); Twist1 HPC 0.01 ± 
0.003, Mø 0.37 ± 0.05, HPC/Mø 59.80 ± 15.14; Sox9 HPC 0.03 ± 0.008, Mø 0.37 ± 
0.13, HPC/Mø 65.84 ± 16.26) c. During inhibition with WIF1 Wnt pathway genes 
are down regulated (Axin2 vehicle 59.84 ± 6.8 vs. WIF1 20.75 ± 6.44; Myc vehicle 
82.70 ± 8.05 vs. WIF1 56.21 ± 2.169; Twist1 vehicle 52.78 ± 7.63 vs. WIF1 38.96 ± 
2.29; Sox9 vehicle 17.29 ± 7.63 vs. WIF1 38.96 ± 2.29) d. Inhibition of Wnt 
signalling results in abrogation of hepatocyte phenotype and induction of biliary 
genes (Hnf6, vehicle 12.04 ± 1.38 vs. WIF1 17.87 ± 1.9 0; Hnf1β vehicle 6.05 ± 0.50 
vs. 14.70 ± 1.29; Hnf1α, vehicle 12.76 ± 1.02 vs. WIF1 2.639 ± 0.43; Hnf4α vehicle 
3.28 ± 0.96 vs. 1.153 ± 0.15). n = 6 replicates, experiment repetition three times. 
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In vivo ablation of macrophages worsens hepatic function but has no 
affect on the cellular niche 
As I have demonstrated Wnt signalling is an important factor in the specification of 
hepatic progenitor cells into a hepatocyte phenotype, and that inhibition of the Wnt 
signalling pathway in vitro results in attenuation of both Wnt target gene expression 
and early hepatocyte genes in vitro. To investigate the importance of Macrophages 
and by extension the role of Wnt signalling during hepatocellular regeneration I 
ablated macrophages using repeat administration of liposomal clodronate throughout 
the hepatocellular regenerative process (Figure 5.7a). Liposomal Clodronate is well 
described tool to ablate macrophages in vivo
326
. Briefly, clodronate containing 
liposomes are phagocytosed by macrophages where the toxic clodronate accumulates 
in the macrophage cytoplasm and ultimately induced apoptosis when it reaches a 
toxic threshold. Free clodronate is rapidly cleared from the circulation and cannot 
penetrate cell membranes without being loaded into a liposomal vector, and as such 
is inert to non-phagocytic cells. 
 
During liposomal clodronate administration I found that there was a failure to 
degrade and clear dead and dying hepatocytes from the liver parenchyma, and that 
this resulted in regions of confluent necrosis within the liver parenchyma. Ablation 
of macrophages resulted in progressive weight loss and animals which received 
liposomal clodronate appeared less healthy than control counterparts. The ablation of 
hepatic macrophages was also associated with a worsening of liver function as 
demonstrated though elevated serum albumin (Figure 5.7c), AST (Figure 5.7d), ALT 
(Figure 5.7e) and Alkaline Phosphatase (Figure 5.7f) (data in collaboration with 
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Thomas Bird). As I found a change in liver function during macrophage ablation I 
investigated whether this was having an adverse effect on the formation multicellular 
HPC niches, and resulting in the failure to support HPCs.  
 
Unsurprisingly I found that there was an almost complete ablation of F4/80 positive 
macrophages throughout the hepatic parenchyma compared with those animals 
which received vehicle alone (Figure 5.8a). However this did not result in a loss of 
myofibroblasts (Figure 5.8b) , and did not result in the increased apoptosis of HPCs 
(Figure 5.8c) demonstrating that macrophages are not required for the survival of 
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Figure 5.7 — Administration of Liposomal Clodronate results in increased liver 
pathology 
a. Liposomal Clodronate was administered IV every three days into animals 
receiving the hepatocellular damage from the CDE diet. b. Treatment with 
Liposomal Clodronate resulted in a greater weight loss than when treated with PBS 
alone. c. Albumin means 44.3 vs. 38.0 at day 6 and 39.32 vs. 32.41 at day 12. d. Alt 
384 vs. 137 at day 6 and 736 vs. 228 at day 12. e. AST means 719 vs. 191 at day 6 
and 1317 vs. 536 at day 12. f. Alk Phos mean 87 vs. 191 at day 6 and 414 vs. 132 at 
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In vivo ablation of macrophages results in conversion of hepatocyte 
progenitors into a biliary phenotype. 
During macrophage ablation during hepatocellular regeneration I was surprised to 
observe that there is change in the cellular phenotype of the liver. Indeed when I 
quantified HPCs in animals given liposomal clodronate versus those animals which 
had received vehicle alone there was no change in the number of HPCs. (Figure 
5.8d), these experiments were conducted in collaboration with Thomas Bird, 
Edinburgh. 
 
Further analysis of the HPCs during macrophage ablation demonstrated that rather 
than failing to proliferate, these HPCs fail to migrate in long extended chords as 
typically observed during hepatocellular regeneration (Figure 5.8e). During treatment 
with liposomal clodronate these cells form atypical ductular structures, with a poorly 
defined lumen and remain close to the portal tract – reminiscent of HPCs during 
ductular regeneration (Figure 5.8f cf DDC model of liver damage, Figure 3.5). 
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Figure 5.8— Liposomal Clodronate does not affect myofibroblasts and does not 
change HPC number. 
a. During Liposomal Clodronate treatment macrophages are ablated and are barely 
detectable within hepatic tissue compared to animals treated with PBS alone (Lip 
Clod 0.01 ± 0.002 vs. PBS 0.41 ± 0.04). b. Myofibroblast numbers do not change 
during ablation of macrophages. c. In Liposomal Clodronate treated animals I 
observed apoptosis of macrophages throughout the parenchyma; however this is not 
associated with an increase in apoptosis of the biliary tree. d. Macrophage ablation 
during the CDE diet does not affect the number of HPCs detectable in the tissue. e. 
HPCs normally form thin, infiltrating cords which move into the parenchyma. 
However during macrophage ablation HPCs do not form these typical structures, but 
rather pseudo-ductule structures (f). N=8-9 for each group in each analysis. >30 
adjacent, non-overlapping images were captured for each data point. Data points 
represent the mean numerical value of these images generated through pixel analysis. 
A D‘Agostino and Pearson omnibus normality test was used to assess the distribution 
of the data. The data is normally distributed and as such analysed using a Student‘s t-
test. Scale bar a-c  = 400µm, d = 100µm. 
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Macrophage ablation results in the differentiation of HPCs into bile 
ducts 
To investigate whether the failure of HPC migration and formation of ductular 
structures was due to a failure of Wnt signalling during macrophage ablation I looked 
at the localisation of Ctnnb1. In HPCs forming ductular structures I clearly observe 
the majority of Ctnnb1 is localised to the cell surface membrane (Figure 5.6a) and is 
not found in the cytoplasm and nucleus of the HPCs as normally observed during 
hepatocellular regeneration (Figure 5.6a), as such the Wnt pathway is abrogated. To 
confirm this finding I isolated HPCs from both liposomal clodronate and vehicle 
treated animals. In this situation I find a significant reduction in the Wnt pathway 
target genes Axin2, Myc, Twist1 and Sox9 (Figure 5.6b).  
 
I have shown that reception of Wnt ligand in HPCs during macrophage ablation 
affects the morphological phenotype of HPCs and may cause a failure of HPC 
migration during regeneration. However to examine whether the ablation of 
macrophages had an effect on the specification of HPCs in vivo I assessed early 
hepatocellular gene expression. Here I found that ablation of macrophages during 
hepatocellular regeneration resulted in a reduced expression of hepatocyte specific 
transcription factors Hnf4α and Hnf1α. Interestingly I also observe a reduction in the 
expression of Numb transcript which may liberate Notch signalling in these HPCs 
and induce a biliary phenotype which I can defect here through increase expression 
of both Hnf1β and Hnf6. (Figure 5.6d). 
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To confirm that the ablation of macrophages during hepatocellular regeneration 
resulted in a conversation of hepatocyte progenitor cells into biliary progenitor cells I 
quantified the number of Hnf1β or Hnf4α positive HPCs. Here I demonstrate a 
significant increase in the number of Hnf1β positive cells which throughout 
hepatocellular regeneration form biliary structures. Furthermore the number of 
Hnf4α positive HPCs is decreased throughout regeneration during macrophage 
ablation. 
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Figure 5.9 — Ablation of Macrophages results in a loss of Wnt signal and 
conversion of progenitors to a biliary phenotype. 
a. Typically Ctnnb1 is found in the cytoplasm and nucleus of HPCs undergoing 
hepatocyte specification, however during macrophage ablation the majority of 
Ctnnb1 is localised to the cell surface membrane. b. Loss of cytoplasmic Ctnnb1 
results in a reduction in Wnt target gene expression Axin2 (PBS 0.06 ± 0.01 vs. Lip 
Clod 0.02 ± 0.004) Myc (PBS 0.04 ± 0.01 vs. Lip Clod 0.02 ± 0.001) Sox9 (PBS 
0.06 ± 0.01 vs. Lip Clod 0.02 ± 0.003) Twist1 (PBS 0.03 ± 0.002 vs. Lip Clod 0.02 ± 
0.002) The reduction in HPC. c. During macrophage ablation HPCs lose early 
hepatocyte markers Hnf1α (PBS 0.08 ± 0.02 vs. Lip Clod 0.02 ± 0.004); Hnf4α (PBS 
0.07 ± 0.01 vs. Lip Clod 0.03 ± 0.005) and Numb (PBS 0.04 ± 0.004 vs. 0.004) and 
increase the expression of early biliary genes (PBS 0.02 ± 0.005 vs. Lip Clod 0.08 ± 
0.01) and Hnf6 (PBS 0.02 ± 0.004 and Lip Clod 0.07 ± 0.01) d. After macrophage 
ablation during hepatocellular regeneration there is a significant increase in the 
number of Hnf1β positive HPCs (black arrows). e. During hepatocellular 
regeneration ablation of macrophages results in a significant decrease in the number 
of Hnf4α, this is associated with clear loss of protein in the HPCs (black arrows). 
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Discussion - Macrophage derived Wnt acts upon HPCs to induce a 
hepatocyte phenotype. 
Hepatic ontogeny requires Wnt signalling at numerous junctures to achieve correct 
specification, maturation and biochemical zonation
15, 312, 314, 327
; similarly the initial 
proliferative stimulus for HPCs appears to include Wnt signalling. However the 
mechanism by which Wnt affects the fate of adult HPCs is as yet unknown. 
 
During diverse patterns of injury such I found that there was diversity in Ctnnb1 
staining, and that only during hepatocellular regeneration could I find consistent 
Ctnnb1 staining in the cytoplasm and nucleus of HPCs. During biliary regeneration I 
typically found localisation of Ctnnb1 at the cell surface membrane – suggesting that 
the canonical Wnt signalling pathway was not highly activated during this process. 
These data correlate with what is known in the field of hepatocyte differentiation 
from ES cells where correct terminal differentiation requires stimulation of the 
canonical Wnt pathway in a Wnt3a dependent mechanism. The diverse localisation 
of Ctnnb1 observed in two murine models of hepatocyte and biliary regeneration 
correlates this to a diverse expression of Wnt target genes, all of which show an 
increased expression during hepatocellular regeneration than compared to 
regeneration of the bile ducts. Interestingly it has been described in the literature that 
Wnt signalling is required for activation of the HPC population in the DDC biliary 
model
328
. This does not however lie in complete contrast to my observations, as Wnt 
is a potent mitogen for HPCs so is Tweak, as such the removal of the early Wnt 
signal may be compensated for over time by other mitogenic cues only once HPCs 
have expanded and later on in the life of the HPC population do I observe the 
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ultimate result of Wnt removal which is one of phenotype, rather than of 
proliferation.  
 
It has been previously described in the Kidney that macrophage derived Wnt7a is an 
important mediator of renal epithelial repair, and that loss of this ligand results in 
abrogated re-epithelialisation of the glomerulus. During this work I have described 
how hepatic macrophages express Wnt3a in a modulated way – suggesting that the 
Wnt phenotype of the macrophage is important in eliciting the correct regenerative 
response. I have also discussed how the previously described stereotypical niche is 
highly dynamic, and is distributed differently between regenerative contexts in the 
mouse. During hepatocellular regeneration I found the cellular components of the 
niche to be much more heterogeneous, where both macrophages and myofibroblasts 
can form close associations with the HPCs. Conversely I describe how during biliary 
regeneration penetration of the macrophage to the site of regeneration is prevented 
by a sheath of myofibroblasts, preventing the delivery of paracrine signals from the 
macrophage. 
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Figure 5.10 — A schematic representation of Notch and Wnt mediated 
regeneration in the adult liver 
During biliary regeneration hepatic progenitor cells express high levels of Notch 
receptor, and the pathway is activated during biliary regeneration which acts through 
the Hes and Hey transcription factor family. This pathway is activated through 
stimulation by Jagged1 derived from the HPC population or a surrounding 
myofibroblast niche. Blockade of this pathway results in reduced cholangiocyte 
numbers in vivo and abrogated expression of early biliary transcription factors. 
During hepatocellular regeneration the Notch signalling pathway is expressed at low 
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The adult liver has a remarkable regenerative capability; however the health burden 
faced by the UK and Europe suggests that the normal regenerative capability of the 
adult human liver is being overwhelmed and as a result chronic liver disease is 
increasing throughout the western world
1
. In order to stem the progression of liver 
disease and its associated pathologies it is important to consider not only the gross 
pattern of disease, but also the molecular pathology of these diseases and how these 
factors are ultimately the driving force of both disease establishment, but also disease 
propagation.  The adult liver offers a unique model of tissue regeneration in a solid 
organ, and could ultimately shed light on the regenerative mechanisms in other solid 
epithelial tissues which are subject to fibrosis and regeneration. Importantly the 
healthy liver does not demonstrate cellular turnover from progenitor cells
7
; rather it 





Only during chronic disease does the liver rely on a population of progenitor cells to 
regenerate its epithelial components, and as such this organ offers a unique 
opportunity to evaluate the signals which are present in disease pathology, but not in 
healthy liver. Interrogation of these pathways to investigate what mechanisms are 
present to stimulate and control progenitor cell proliferation and differentiation, the 
latter of which is grossly under described within the current literature and as such 
may provide a novel insight into what pathways could be targeted to a therapeutic 
end. 
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During chronic regeneration of the adult liver diverse epithelial compartments must 
be regenerated in order for the liver mass to function correctly
18, 63, 90, 329
.  
 
The vast body of work in the literature which looks mechanisms of proliferation in 
HPCs
61, 102-104, 330
, and to a much lesser degree the signals which govern their 
differentiation
304, 322, 331
 infrequently distinguish between human disease aetiologies, 
and the pattern of disease induced in animal models. This has led the field to become 
muddied in its approach to elucidate the signalling pathways which are important in 
these processes.  
 
The initial aim of this Thesis was to identify and establish within our laboratory 
divergent animal models which require regeneration of the epithelial compartments. 
To this end I have established and characterised the Choline Deficint Ethionine 
Supplemented (CDE) diet, and the 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine 
(DDC) as models of hepatocyte and cholangiocyte regeneration from HPCs 
respectively, both of these models have been used in the literature with great success 
however have never been considered as separate patterns of hepatic disease
6, 60, 63, 104, 
332
. Importantly establishing these two models in our lab confirmed our suspicions 
that despite HPC activation and the surrounding cellular and acellular niche being 
stereotypical in these models as described in human liver disease
90
 the niche 
structure is variable depending on disease pathology. During hepatocyte regeneration 
the HPC niche is highly homogenous, with examples of both macrophages and 
myofibroblasts contacting the HPC and as such both cell types can exert some 
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influence on the HPCs, however during biliary regeneration in our DDC model we 
find that there is a florid myofibroblast niche surrounding the emerging HPCs, which 
prevents the penetration of macrophages into site of regeneration and as such 
prevents them interacting with and influencing the HPCs. These observations are 
salient as niche distribution will obviously affect the accessibility of both small 
molecules and larger cell based therapies for liver disease – fields which are 
emerging within the literature
8, 333, 334
. Moreover the variability in niche could be 
indicative of more subtle changes and differences in these disease patterns, a factor 
which I have defined more clearly during the course of this thesis. 
 
The second aim of this work was to investigate whether or not there is a variation in 
the Notch signalling pathway during hepatocellular disease and epithelial 
regeneration. It is currently unknown what pathways are important in the lineage 
separation of HPCs during epithelial regeneration in this organ, as such we looked to 
the well described ontogeny of the liver to best inform which pathways could be 
important in the regeneration of the adult liver. This work demonstrates for the first 
time that during adult regeneration of the liver in diverse disease patterns hepatocytes 
or cholangiocytes require differential signalling cascades to be activated in order to 
assume the correct epithelial fate. 
 
During definitive hepatic development Notch signalling is required for appropriate 
specification of the biliary tree
220, 226, 335-338
. This signalling pathway has been 
described during biliary disease but until this work the functional significance of 
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Notch signalling has not been investigated
228, 339-342
. It is interesting then that 
regeneration of the biliary tree from a progenitor source appears at least superficially, 
to resemble the initial specification and ontogeny of the bile ducts. In this work we 
demonstrate that there is a high upregulation and activation of the Notch signalling 
pathway during biliary regeneration; however during regeneration of hepatocytes 




To evaluate the functional importance of the Notch signalling pathway during biliary 
regeneration, we inhibited Notch pathway in a range of experimental systems to 
investigate the role of Notch signalling on biliary specification. During development 
abrogation of the Notch signalling pathway is associated with retardation of biliary 
specification and patterning, in humans this abrogation leads to Alagilles 
syndrome
232, 339, 341
. Using a co-culture system of Jagged-1 expressing myofibroblasts 
and primary HPCs I have shown that the Notch signalling pathway is activated and 
that this activation can be inhibited though treatment with DAPT which prevents the 
receptor processing required Notch pathway activation. In this co-culture system 
DAPT reduces the activation of the Notch signalling pathway. This pathway 
reduction is associated with the reduction in biliary phenotype as demonstrated 
though loss of biliary transcription factors such as Hnf1β and Hnf6. 
 
Intriguingly during biliary regeneration I find that there is an establishment of 
mesenchymal stroma surrounding the HPC, this stromal component is redolent of the 
portal mesenchyme which has recently been described as the critical supplier of 
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Notch ligand Jagged-1 during development
216
. The administration of Notch pathway 
inhibitors in vivo results in the suppression of biliary phenotype though the loss of 
early biliary transcription factors. This results in the reduction of cholangiocytes in 
absolute terms though a mechanism which is not clear. What is clear however is that 
there is no change in the inflammatory niche during DAPT administration, and as 
such I suggest that the loss of biliary cells is not down to a lack of support from the 
surrounding myofibroblasts. Rather this DAPT treatment is affecting the 
proliferation and/or differentiation of the HPCs, potentially allowing them to enter a 
more hepatocyte like fate, however without a suitable lineage tracing model it is 
difficult to draw firm conclusions. 
 
Further to describing the requirement of Notch signalling during biliary damage and 
regeneration I have found that the Notch regulator Numb is expressed both within the 
healthy bile duct and progenitor cells destined to become hepatocytes, however is 
lost during biliary regeneration (presumably to facilitate the function of activated 
Notch signalling). Interestingly suppression of the Notch pathway in the liver 
appears critical for the correct homeostasis of the liver. Ectopic activation of the 
Notch signalling pathway in the liver through generating mice with a 
haploinsufficiency in the Fringe family of genes resulted in biliary proliferation in 
adult mice indicating suggesting that Notch suppression is necessary to prevent 
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Despite not completely understanding how Numb and Notch are interacting during 
biliary specification I have found that Numb is likely to be controlled, and 
maintained in the progenitor cells becoming hepatocytes through the canonical Wnt 
pathway – a mechanism which has been predicted in the literature, but few studies 
have addressed completely
188, 189
. To address the final aim of this work I have 
demonstrated that during hepatocyte regeneration from an HPC source the progenitor 
cells themselves express genes which are known to be upregulated in response to the 
canonical Wnt pathway, such as Axin2, Myc and Sox9 at higher levels than those 
progenitor cells undergoing biliary regeneration. This was coupled with the 
translocation of Ctnnb1 to the nucleus of these cells, supporting the notion that 
activation of the canonical Wnt pathway is important in the fate of these HPCs.  
 
Recombinant Wnt3a treatment of progenitor cells in vitro resulted in the activation of 
the Wnt pathway and translocation of phosphorylated Ctnnb1 to the cytoplasm and 
nucleus of primary HPCs. Wnt3a is described in the literature as a mitogen for both 
ES cell derived hepatocytes, but also as a critical factor during hepatic ontogeny
317, 
343
. This was associated with an increase in the expression of early hepatocyte gene 
Hnf4α, but also an increase in the expression of the Numb gene; indicating that 
canonical Wnt signalling may be crucial to exit biliary phenotype and differentiate 
into a hepatocyte. In other systems of epithelial restoration after damage the 
canonical Wnt signal has been shown to come from macrophages
98, 344
. Here I found 
that there is a spatial difference in the distribution of macrophages in the two patterns 
of hepatocellular and biliary disease. During regeneration of the bile ducts there is a 
thick bad of myofibroblasts and ECM which prevents the access of macrophages to 
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progenitor cells. During hepatocyte regeneration macrophages can form close 
associations with progenitor cells and express Wnt3a at higher levels than during 
biliary regeneration and as such activate the canonical Wnt pathway and influence 
hepatocellular phenotype.  
 
As the role of Wnt signalling on the HPC population is scant within the literature we 
sought to co-culture Wnt expressing macrophages with HPCs in vitro. In this system 
Wnt pathway target genes were up-regulated when cells were combined compared 
with maintaining the macrophages and HPCs as separate populations. Associated 
with this co-culture was a high level of hepatocyte specific gene activation. When we 
inhibited the Wnt signalling pathway in vitro we found that as well as a reduction in 
the classical Wnt target genes we also found a reduction in the specification of 
hepatocytes from HPCs, a paradigm which reflects the requirement of Wnt signalling 
in the specification of hepatocytes from foetal liver progenitor cells.  Intriguingly 
when we inhibited the Wnt signalling pathway in HPC/macrophage co-cultures we 
see an increase in the early biliary transcription factors. As it appears in vivo Wnt 
signalling is required to suppress Notch function via Numb then it could be likely 
that there is a liberation of biliary phenotype when the Wnt pathway and by 
extension Numb is repressed. 
 
The identification of Wnt expression macrophages and their physical association 
with HPCs in vivo led us to ask whether these cells alone are important for the 
specification of HPCs from progenitor cells. Using liposomal clodronate we were 
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able to ablate the macrophage population in the regenerating adult liver
326, 345
, and 
demonstrate that the HPCs acquired a more biliary phenotype, expressing higher 
levels of the cholangiocyte transcription factors than those animals which had intact 
macrophages. Moreover when we assessed the Wnt signalling pathway in HPCs 
from macrophage depleted animals and controls we found that there was a loss of 
Wnt pathway target expression, and also a loss of nuclear Ctnnb1 suggesting that 
there was a failure to activate the Wnt signalling cascade, and again highlighting this 
pathway as important in the appropriate specification of HPCs into hepatocytes. 
 
Although the Wnt signalling pathway is perturbed through macrophage ablation, 
many other pathways will also be altered though this cellular ablation. As such future 
lines of investigation to confirm these phenotypes will be required. One possibility is 
to use an appropriate Cre line, such as a Krt19CreER
85
 or Sox9-Cre ER
51
 crossed 
with Ctnnb1 activating or knockout alleles. The use of transgenic systems in the field 
of liver disease historically has been slow, and as such small molecule or antibody 
approaches to Wnt pathway modulation could be employed. The recent publication 
of an LRP5/6 specific blocking antibody has raised the possibility of blocking the 
canonical Wnt pathway tightly and specifically, but without perturbation of any other 
signalling cascade
346
. To address whether Wnt signalling is required for hepatocyte 
specification from HPCs these blocking antibodies could prove useful.  
 
My work also points to the role of phagocytosis of hepatocyte debris in the 
establishment of a high Wnt status within the macrophage population. Post 
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phagocytic macrophages express more Wnt3a than their un-fed counterparts. To 
investigate whether this is a phagocytosis specific effect this work is being explored 
further through the feeding of multiple cell types as well as non-biological substrates 
including latex beads and non-phagocytosed liposomes in the presence or absence of 
colchicine, an inhibitor of phagocytosis
347-349
. These data are in their infancy, and the 
work presented in this Thesis regarding the role of phagocytosis initiating the 
transcription and expression of Wnt is a tantalising suggestion as to how the 
inflammatory infiltrate is linked to the re-establishment of the correct epithelial 
components in a liver, or indeed numerous other tissues, as regeneration must 
function on a supply and demand basis.  
 
Ultimately this work is one of the first descriptions of the mechanisms by which 
HPCs can assume a differential biliary or hepatocyte fate during regeneration of the 
damaged liver. Here we describe that there is a differential spatial and signalling 
requirements within a progenitor niche; a process which has been historically 
described as homogenous throughout disease patterns. The diverse phenotypes of 
these diseases are characterised in table 6.1 and demonstrates the diverse nature of 
these pathways during different disease states.  
 
Furthermore this study describes a novel means by which Notch and Wnt signalling 
interact via Numb to establish correct lineage choice in the adult liver. These data 
demonstrate that appropriate fate, and as such regeneration may be achieved by 
environmental sensing though macrophages and that alteration of the inflammatory 
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milieu is critical in the correct specification of HPCs in vivo. Excitingly, but outwith 
the realms of this Thesis we have found in collaboration Prof. with Tania Roskams, 
Leuven that these data correlate with human diseases, and as such may represent an 
archetype in diverse hepatic regeneration, and as such may identify pathways which 
could be manipulated in order to modulate the outcome of adult liver disease. 
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Table 6.1 – A summary characterisation of hepatocellular and biliary 
regeneration in the liver. 
Characteristics of hepatocellular and biliary progenitor cells 
  
DDC - Biliary CDE - Hepatocellular 
EpCam, Dlk1 and panCK positive EpCam, Dlk1 and panCK positive 
Found as ill defined ducts near the portal 
tract 
Form thin infiltrating cords of cells which 
migrate into the parenchyma 
Express Hnf1β and Hnf6 Express Hnf4α and Hnf1α 
Are closely associated with 
myofibroblasts, but have macrophages 
surrounding this 
Are found closely associated with both 
macrophages and myofibroblasts 
Have a highly activated Notch pathway Low levels of Notch pathway activation 
Low expression of Numb High levels of Numb expression 
Low levels of Wnt expression and Wnt 
effector genes 

























 1.      World Health Organisation. Disease and injury country estimates, Burden of 
disease.  2009. 
http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/
index.html.  
Ref Type: Generic 
 2.      Baker,A.R.M.a.G.C. Health Service Quarterly, O.o.N. Statistics, ed.  59-60. 
2008.  Palgrave MacMillan.  
Ref Type: Generic 
 3.      Poovorawan,Y., Chongsrisawat,V., & Tangkijvanich,P. Problems and 
prevention of viral hepatitis in Thailand. J Med Assoc. Thai. 84 Suppl 1, S18-S25 
(2001). 
 4.      Tangkijvanich,P. et al. Hepatitis viruses and chronic liver disease. Southeast 
Asian J Trop. Med Public Health 30, 489-495 (1999). 
 5.      Carpentier,B., Gautier,A., & Legallais,C. Artificial and bioartificial liver 
devices: present and future. Gut 58, 1690-1702 (2009). 
 6.      Van Hul,N.K., barca-Quinones,J., Sempoux,C., Horsmans,Y., & Leclercq,I.A. 
Relation between liver progenitor cell expansion and extracellular matrix 
deposition in a CDE-induced murine model of chronic liver injury. Hepatology 
49, 1625-1635 (2009). 
 7.      Bird,T.G., Lorenzini,S., & Forbes,S.J. Activation of stem cells in hepatic 
diseases. Cell Tissue Res 331, 283-300 (2008). 
 8.      Stutchfield,B.M., Forbes,S.J., & Wigmore,S.J. Prospects for stem cell 
transplantation in the treatment of hepatic disease. Liver Transpl. 16, 827-836 
(2010). 
 9.      Iimuro,Y. & Fujimoto,J. TLRs, NF-kappaB, JNK, and Liver Regeneration. 
Gastroenterol Res Pract. 2010, (2010). 
 10.      Kung,J.W. & Forbes,S.J. Stem cells and liver repair. Curr Opin Biotechnol. 20, 
568-574 (2009). 
 11.      Adams,D.H. & Eksteen,B. Aberrant homing of mucosal T cells and extra-
intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 6, 
244-251 (2006). 
 12.      Friedman,S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic 
cells of the liver. Physiol Rev 88, 125-172 (2008). 





 14.      Burke,Z.D. et al. Liver zonation occurs through a beta-catenin-dependent, c-
Myc-independent mechanism. Gastroenterology 136, 2316-2324 (2009). 
 15.      Burke,Z.D. & Tosh,D. The Wnt/beta-catenin pathway: master regulator of 
liver zonation? Bioessays 28, 1072-1077 (2006). 
 16.      Yumoto,A.U. et al. Structural and functional features of bile canaliculi in 
adult rat hepatocyte spheroids. Liver 16, 61-66 (1996). 
 17.      Banales,J.M., Prieto,J., & Medina,J.F. Cholangiocyte anion exchange and 
biliary bicarbonate excretion. World J Gastroenterol 12, 3496-3511 (2006). 
 18.      Bogert,P.T. & LaRusso,N.F. Cholangiocyte biology. Curr Opin Gastroenterol 
23, 299-305 (2007). 
 19.      Gradilone,S.A. et al. Cholangiocyte cilia express TRPV4 and detect changes 
in luminal tonicity inducing bicarbonate secretion. Proc Natl Acad Sci U S A 104, 
19138-19143 (2007). 
 20.      Duncan,A.W., Dorrell,C., & Grompe,M. Stem cells and liver regeneration. 
Gastroenterology 137, 466-481 (2009). 
 21.      Michalopoulos,G.K. & DeFrances,M.C. Liver regeneration. Science 276, 60-
66 (1997). 
 22.      Forbes,S.J. et al. Tri-iodothyronine and a deleted form of hepatocyte 
growth factor act synergistically to enhance liver proliferation and enable in 
vivo retroviral gene transfer via the peripheral venous system. Gene Ther. 7, 
784-789 (2000). 
 23.      Forbes,S.J. et al. Retroviral gene transfer to the liver in vivo during tri-
iodothyronine induced hyperplasia. Gene Ther. 5, 552-555 (1998). 
 24.      Watt,F.M. & Jensen,K.B. Epidermal stem cell diversity and quiescence. 
EMBO Mol Med 1, 260-267 (2009). 
 25.      van der Flier,L.G. & Clevers,H. Stem cells, self-renewal, and differentiation 
in the intestinal epithelium. Annu Rev Physiol 71, 241-260 (2009). 
 26.      Medvinsky,A.L. & Dzierzak,E.A. Development of the definitive 
hematopoietic hierarchy in the mouse. Dev Comp Immunol 22, 289-301 (1998). 
 27.      Kazanis,I., Lathia,J., Moss,L., & ffrench-Constant,C. The neural stem cell 
microenvironment.(2008). 
 28.      Kee,K., Pera,R.A., & Turek,P.J. Testicular germline stem cells. Nat Rev Urol 
7, 94-100 (2010). 
 29.      Clayton,E. & Forbes,S.J. The isolation and in vitro expansion of hepatic Sca-




 30.      Rountree,C.B. et al. A CD133-expressing murine liver oval cell population 
with bilineage potential. Stem Cells 25, 2419-2429 (2007). 
 31.      Evarts,R.P., Nagy,P., Nakatsukasa,H., Marsden,E., & Thorgeirsson,S.S. In 
vivo differentiation of rat liver oval cells into hepatocytes. Cancer Research 
Cancer Res 49, 1541-1547 (1989). 
 32.      Holic,N. et al. Differential expression of the rat gamma-glutamyl 
transpeptidase gene promoters along with differentiation of hepatoblasts into 
biliary or hepatocytic lineage. The American Journal of Pathology Am. J. Pathol 
157, 537-548 (2000). 
 33.      Jelnes,P. et al. Remarkable heterogeneity displayed by oval cells in rat and 
mouse models of stem cell-mediated liver regeneration. Hepatology 45, 1462-
1470 (2007). 
 34.      Fausto,N., Campbell,J.S., Riehle,K.J., & FARBER,E. Liver regeneration; 
Similarities in the sequence of early histological changes induced in the liver of 
the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-
dimethylaminoazobenzene. Hepatology (Baltimore, Md. ); Cancer Research 
Hepatology M3 - 10. 1002/hep. 43; 16, S45-S53 (2006). 
 35.      Bralet,M.P., Branchereau,S., Brechot,C., & Ferry,N. Cell lineage study in the 
liver using retroviral mediated gene transfer. Evidence against the streaming of 
hepatocytes in normal liver. Am J Pathol 144, 896-905 (1994). 
 36.      Overturf,K., Al-Dhalimy,M., Ou,C.N., Finegold,M., & Grompe,M. Serial 
transplantation reveals the stem-cell-like regenerative potential of adult mouse 
hepatocytes. Am J Pathol 151, 1273-1280 (1997). 
 37.      Rhim,J.A., Sandgren,E.P., Degen,J.L., Palmiter,R.D., & Brinster,R.L. 
Replacement of diseased mouse liver by hepatic cell transplantation. Science 
263, 1149-1152 (1994). 
 38.      Overturf,K., Al-Dhalimy,M., Finegold,M., & Grompe,M. The repopulation 
potential of hepatocyte populations differing in size and prior mitotic 
expansion. Am J Pathol 155, 2135-2143 (1999). 
 39.      Michalopoulos,G.K., Barua,L., & Bowen,W.C. Transdifferentiation of rat 
hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. 
Hepatology 41, 535-544 (2005). 
 40.      Michalopoulos,G.K., Bowen,W.C., Mule,K., & Stolz,D.B. Histological 
organization in hepatocyte organoid cultures. Am J Pathol 159, 1877-1887 
(2001). 
 41.      Hay,D.C. Cadaveric hepatocytes repopulate diseased livers: life after death. 




 42.      Hay,D.C. et al. Efficient differentiation of hepatocytes from human 
embryonic stem cells exhibiting markers recapitulating liver development in 
vivo. Stem Cells 26, 894-902 (2008). 
 43.      Sharma,R., Greenhough,S., Medine,C.N., & Hay,D.C. Three-dimensional 
culture of human embryonic stem cell derived hepatic endoderm and its role in 
bioartificial liver construction. J Biomed. Biotechnol. 2010, 236147 (2010). 
 44.      Sullivan,G.J. et al. Generation of functional human hepatic endoderm from 
human induced pluripotent stem cells. Hepatology 51, 329-335 (2010). 
 45.      Payne,C.M. et al. Persistence of functional hepatocyte-like cells in immune-
compromised mice. Liver Int 31, 254-262 (2011). 
 46.      Masyuk,A.I. et al. Biliary exosomes influence cholangiocyte regulatory 
mechanisms and proliferation through interaction with primary cilia. Am J 
Physiol Gastrointest Liver Physiol 299, G990-G999 (2010). 
 47.      Fouassier,L. et al. Ezrin-radixin-moesin-binding phosphoprotein 50 is 
expressed at the apical membrane of rat liver epithelia. Hepatology 33, 166-176 
(2001). 
 48.      Terada,T., Ueyama,J., Ukita,Y., & Ohta,T. Protein expression of double-
stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in 
normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and 
intrahepatic cholangiocarcinoma. Liver 20, 450-457 (2000). 
 49.      Humphreys,E.H., Williams,K.T., Adams,D.H., & Afford,S.C. Primary and 
malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, 
but are insensitive to direct activation with exogenous Fas ligand. PLoS ONE 5, 
e14037 (2010). 
 50.      Williams,K.T. et al. C4b binding protein binds to CD154 preventing CD40 
mediated cholangiocyte apoptosis: a novel link between complement and 
epithelial cell survival. PLoS ONE 2, e159 (2007). 
 51.      Furuyama,K. et al. Continuous cell supply from a Sox9-expressing 
progenitor zone in adult liver, exocrine pancreas and intestine. Nat 
Genet(2010). 
 52.      Kinosita R Studies on the cancerogenic chemical substances. Trans Soc 
Pathol Jpn 27, 329-334 (1937). 
 53.      FARBER,E. Similarities in the sequence of early histological changes induced 
in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-
dimethylaminoazobenzene. Cancer Res 16, 142-148 (1956). 
 54.      Evarts,R.P., Nagy,P., Marsden,E., & Thorgeirsson,S.S. A precursor-product 
relationship exists between oval cells and hepatocytes in rat liver. 




 55.      Li,W.L. et al. Isolation and characterization of bipotent liver progenitor cells 
from adult mouse. Stem Cells 24, 322-332 (2006). 
 56.      Fujii,T. et al. Mouse model of carbon tetrachloride induced liver fibrosis: 
Histopathological changes and expression of CD133 and epidermal growth 
factor. BMC Gastroenterol 10, 79 (2010). 
 57.      Akhurst,B. et al. A modified choline-deficient, ethionine-supplemented diet 
protocol effectively induces oval cells in mouse liver. Hepatology 34, 519-522 
(2001). 
 58.      Knight,B. et al. Attenuated liver progenitor (oval) cell and fibrogenic 
responses to the choline deficient, ethionine supplemented diet in the BALB/c 
inbred strain of mice. J Hepatol 46, 134-141 (2007). 
 59.      Knight,B. et al. Liver inflammation and cytokine production, but not acute 
phase protein synthesis, accompany the adult liver progenitor (oval) cell 
response to chronic liver injury. Immunol Cell Biol 83, 364-374 (2005). 
 60.      Tirnitz-Parker,J.E., Tonkin,J.N., Knight,B., Olynyk,J.K., & Yeoh,G.C. Isolation, 
culture and immortalisation of hepatic oval cells from adult mice fed a choline-
deficient, ethionine-supplemented diet. Int J Biochem Cell Biol 39, 2226-2239 
(2007). 
 61.      Knight,B., Tirnitz-Parker,J.E., & Olynyk,J.K. C-kit inhibition by imatinib 
mesylate attenuates progenitor cell expansion and inhibits liver tumor 
formation in mice. Gastroenterology 135, 969-79, 979 (2008). 
 62.      Guest,I., Ilic,Z., & Sell,S. Age dependence of oval cell responses and bile 
duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, 
ethionine-supplemented diet. Hepatology 52, 1750-1757 (2010). 
 63.      Wang,X. et al. The origin and liver repopulating capacity of murine oval 
cells. Proc Natl Acad Sci U S A 100 Suppl 1, 11881-11888 (2003). 
 64.      Fickert,P. et al. The role of osteopontin and tumor necrosis factor alpha 
receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab 
Invest 90, 844-852 (2010). 
 65.      Fickert,P. et al. A new xenobiotic-induced mouse model of sclerosing 
cholangitis and biliary fibrosis. Am J Pathol 171, 525-536 (2007). 
 66.      Trauner,M. et al. New insights into autoimmune cholangitis through animal 
models. Dig. Dis. 28, 99-104 (2010). 
 67.      Alison,M.R., Golding,M.H., & Sarraf,C.E. Pluripotential liver stem cells: 
facultative stem cells located in the biliary tree. Cell Prolif. 29, 373-402 (1996). 
 68.      Theise,N.D. et al. The canals of Hering and hepatic stem cells in humans. 




 69.      Saxena,R., Theise,N.D., & Crawford,J.M. Microanatomy of the human liver-
exploring the hidden interfaces. Hepatology (Baltimore, Md. ) Hepatology M3 - 
10. 1002/hep. 30, 1339-1346 (1999). 
 70.      Paku,S., Schnur,J., Nagy,P., & Thorgeirsson,S.S. Origin and structural 
evolution of the early proliferating oval cells in rat liver. Am J Pathol 158, 1313-
1323 (2001). 
 71.      De,V.R. & Desmet,V. Ultrastructural characteristics of novel epithelial cell 
types identified in human pathologic liver specimens with chronic ductular 
reaction. Am J Pathol 140, 1441-1450 (1992). 
 72.      Mandache,E., Vidulescu,C., Gherghiceanu,M., Dragomir,P., & Popescu,L.M. 
Neoductular progenitor cells regenerate hepatocytes in severely damaged liver: 
a comparative ultrastructural study. J Cell Mol Med 6, 59-73 (2002). 
 73.      Fellous,T.G. et al. A methodological approach to tracing cell lineage in 
human epithelial tissues. Stem Cells 27, 1410-1420 (2009). 
 74.      Kofman,A.V. et al. Dose- and time-dependent oval cell reaction in 
acetaminophen-induced murine liver injury. Hepatology 41, 1252-1261 (2005). 
 75.      Schmelzer,E. & Reid,L.M. EpCAM expression in normal, non-pathological 
tissues. Front Biosci 13, 3096-3100 (2008). 
 76.      Jensen,C.H. et al. Transit-amplifying ductular (oval) cells and their 
hepatocytic progeny are characterized by a novel and distinctive expression of 
delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol 164, 1347-
1359 (2004). 
 77.      Suzuki,A. et al. Flow cytometric isolation and clonal identification of self-
renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 48, 
1964-1978 (2008). 
 78.      Dezso,K. et al. Thy-1 is expressed in hepatic myofibroblasts and not oval 
cells in stem cell-mediated liver regeneration. Am J Pathol 171, 1529-1537 
(2007). 
 79.      Petersen,B.E. et al. Bone marrow as a potential source of hepatic oval cells. 
Science 284, 1168-1170 (1999). 
 80.      Petersen,B.E. et al. Mouse A6-positive hepatic oval cells also express 
several hematopoietic stem cell markers. Hepatology 37, 632-640 (2003). 
 81.      varez-Dolado,M. et al. Fusion of bone-marrow-derived cells with Purkinje 
neurons, cardiomyocytes and hepatocytes. Nature 425, 968-973 (2003). 
 82.      Vassilopoulos,G. & Russell,D.W. Cell fusion: an alternative to stem cell 





 83.      Stock,P. et al. The generation of hepatocytes from mesenchymal stem cells 
and engraftment into murine liver. Nat Protoc. 5, 617-627 (2010). 
 84.      Li,W. et al. Differentiation of hepatocytoid cell induced from whole-bone-
marrow method isolated rat myeloid mesenchymal stem cells. World J 
Gastroenterol 12, 4866-4869 (2006). 
 85.      Means,A.L., Xu,Y., Zhao,A., Ray,K.C., & Gu,G. A CK19(CreERT) knockin 
mouse line allows for conditional DNA recombination in epithelial cells in 
multiple endodermal organs. Genesis. 46, 318-323 (2008). 
 86.      Sackett,S.D. et al. Foxl1 is a marker of bipotential hepatic progenitor cells in 
mice. Hepatology 49, 920-929 (2009). 
 87.      Sackett,S.D., Fulmer,J.T., Friedman,J.R., & Kaestner,K.H. Foxl1-Cre BAC 
transgenic mice: a new tool for gene ablation in the gastrointestinal 
mesenchyme. Genesis. 45, 518-522 (2007). 
 88.      Kazanis,I. et al. Quiescence and activation of stem and precursor cell 
populations in the subependymal zone of the mammalian brain are associated 
with distinct cellular and extracellular matrix signals. J Neurosci 30, 9771-9781 
(2010). 
 89.      Sato,T. et al. Paneth cells constitute the niche for Lgr5 stem cells in 
intestinal crypts. Nature(2010). 
 90.      Lorenzini,S. et al. Characterisation of a stereotypical cellular and 
extracellular adult liver progenitor cell niche in rodents and diseased human 
liver. Gut 59, 645-654 (2010). 
 91.      Schotanus,B.A. et al. Cross-species immunohistochemical investigation of 
the activation of the liver progenitor cell niche in different types of liver 
disease. Liver Int 29, 1241-1252 (2009). 
 92.      Henderson,N.C. & Iredale,J.P. Liver fibrosis: cellular mechanisms of 
progression and resolution. Clin Sci (Lond) 112, 265-280 (2007). 
 93.      Fallowfield,J.A. et al. Scar-associated macrophages are a major source of 
hepatic matrix metalloproteinase-13 and facilitate the resolution of murine 
hepatic fibrosis. J Immunol 178, 5288-5295 (2007). 
 94.      Kallis,Y.N. et al. Remodelling of extracellular matrix is a requirement for the 
hepatic progenitor cell response. Gut(2010). 
 95.      Yang,L. et al. Fate-Mapping Evidence that Hepatic Stellate Cells are 
Epithelial Progenitors in Adult Mouse Livers. Stem Cells(2008). 





 97.      He,W., Kang,Y.S., Dai,C., & Liu,Y. Blockade of Wnt/{beta}-Catenin Signaling 
by Paricalcitol Ameliorates Proteinuria and Kidney Injury. J Am Soc Nephrol. 22, 
90-103 (2011). 
 98.      Lin,S.L. et al. Macrophage Wnt7b is critical for kidney repair and 
regeneration. Proc Natl Acad Sci U S A 107, 4194-4199 (2010). 
 99.      Szondy,Z. et al. Transglutaminase 2-/- mice reveal a phagocytosis-
associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad 
Sci U S A 100, 7812-7817 (2003). 
 100.      Vernon-Wilson,E.F. et al. CD31 delays phagocyte membrane repolarization 
to promote efficient binding of apoptotic cells. J Leukoc. Biol 82, 1278-1288 
(2007). 
 101.      Brown,S. et al. Apoptosis disables CD31-mediated cell detachment from 
phagocytes promoting binding and engulfment. Nature 418, 200-203 (2002). 
 102.      Nguyen,L.N. et al. Transforming growth factor-beta differentially regulates 
oval cell and hepatocyte proliferation. Hepatology 45, 31-41 (2007). 
 103.      Jakubowski,A. et al. TWEAK induces liver progenitor cell proliferation. J Clin 
Invest 115, 2330-2340 (2005). 
 104.      Tirnitz-Parker,J.E. et al. Tumor necrosis factor-like weak inducer of 
apoptosis is a mitogen for liver progenitor cells. Hepatology 52, 291-302 (2010). 
 105.      Akhurst,B. et al. Differential lymphotoxin-beta and interferon gamma 
signaling during mouse liver regeneration induced by chronic and acute injury. 
Hepatology 41, 327-335 (2005). 
 106.      Knight,B. et al. Impaired preneoplastic changes and liver tumor formation 
in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192, 1809-
1818 (2000). 
 107.      Tumanov,A.V., Christiansen,P.A., & Fu,Y.X. The role of lymphotoxin 
receptor signaling in diseases. Curr Mol Med 7, 567-578 (2007). 
 108.      Subrata,L.S. et al. Hepatic expression of the tumor necrosis factor family 
member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: 
transcriptional control mechanisms in oval cells and hepatoma cell lines. Liver 
Int 25, 633-646 (2005). 
 109.      Yeoh,G.C. et al. Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 
signaling in liver progenitor cell migration and proliferation. Hepatology 45, 
486-494 (2007). 
 110.      Spee,B. et al. Characterisation of the activated liver progenitor cell niche, 





 111.      Zong,Y. et al. Notch signaling controls liver development by regulating 
biliary differentiation. Development M3 - 10. 1242/dev. 136, 1727-1739 (2009). 
 112.      Ma,G., Xiao,Y., & He,L. Recent progress in the study of Hedgehog signaling. 
J Genet Genomics 35, 129-137 (2008). 
 113.      Hayward,P., Kalmar,T., & Arias,A.M. Wnt/Notch signalling and information 
processing during development. Development 135, 411-424 (2008). 
 114.      Pownall,M.E., Tucker,A.S., Slack,J.M., & Isaacs,H.V. eFGF, Xcad3 and Hox 
genes form a molecular pathway that establishes the anteroposterior axis in 
Xenopus. Development 122, 3881-3892 (1996). 
 115.      Kelleher,F.C., Fennelly,D., & Rafferty,M. Common critical pathways in 
embryogenesis and cancer. Acta Oncol 45, 375-388 (2006). 
 116.      rtavanis-Tsakonas,S., Rand,M.D., & Lake,R.J. Notch signaling: cell fate 
control and signal integration in development. Science 284, 770-776 (1999). 
 117.      Kovall,R.A. & Blacklow,S.C. Mechanistic insights into Notch receptor 
signaling from structural and biochemical studies. Curr Top. Dev Biol 92, 31-71 
(2010). 
 118.      Logeat,F. et al. The Notch1 receptor is cleaved constitutively by a furin-like 
convertase. Proc Natl Acad Sci U S A 95, 8108-8112 (1998). 
 119.      Pan,D. & Rubin,G.M. Kuzbanian controls proteolytic processing of Notch 
and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. 
Cell 90, 271-280 (1997). 
 120.      Qi,H. et al. Processing of the notch ligand delta by the metalloprotease 
Kuzbanian. Science 283, 91-94 (1999). 
 121.      De Strooper,B. et al. A presenilin-1-dependent gamma-secretase-like 
protease mediates release of Notch intracellular domain. Nature Nature M3 - 
10. 398, 518-522 (1999). 
 122.      Ray,W.J. et al. Cell surface presenilin-1 participates in the gamma-
secretase-like proteolysis of Notch. J Biol Chem 274, 36801-36807 (1999). 
 123.      Artavanis-Tsakonas,S., Rand,M.D., & Lake,R.J. Notch signaling: cell fate 
control and signal integration in development. Science 284, 770-776 (1999). 
 124.      Kopan,R., Schroeter,E.H., Weintraub,H., & Nye,J.S. Signal transduction by 
activated mNotch: importance of proteolytic processing and its regulation by 
the extracellular domain. Proc Natl Acad Sci U S A 93, 1683-1688 (1996). 
 125.      Parks,A.L., Klueg,K.M., Stout,J.R., & Muskavitch,M.A. Ligand endocytosis 
drives receptor dissociation and activation in the Notch pathway. Development 




 126.      Parks,A.L. et al. Structure-function analysis of delta trafficking, receptor 
binding and signaling in Drosophila. Genetics 174, 1947-1961 (2006). 
 127.      Zhou,S. et al. SKIP, a CBF1-associated protein, interacts with the ankyrin 
repeat domain of NotchIC To facilitate NotchIC function. Mol Cell Biol 20, 2400-
2410 (2000). 
 128.      Okajima,T., Xu,A., Lei,L., & Irvine,K.D. Chaperone activity of protein O-
fucosyltransferase 1 promotes notch receptor folding. Science 307, 1599-1603 
(2005). 
 129.      Chitnis,A. Why is delta endocytosis required for effective activation of 
notch? Dev Dyn 235, 886-894 (2006). 
 130.      Le Borgne,R., Remaud,S., Hamel,S., & Schweisguth,F. Two distinct E3 
ubiquitin ligases have complementary functions in the regulation of delta and 
serrate signaling in Drosophila. PLoS Biol 3, (2005). 
 131.      Itoh,M. et al. Mind bomb is a ubiquitin ligase that is essential for efficient 
activation of Notch signaling by Delta. Dev Cell 4, 67-82 (2003). 
 132.      Commisso,C. & Boulianne,G.L. The NHR1 domain of Neuralized binds Delta 
and mediates Delta trafficking and Notch signaling. Mol Biol Cell 18, 1-13 
(2007). 
 133.      Commisso,C. & Boulianne,G.L. The neuralized homology repeat 1 domain of 
Drosophila neuralized mediates nuclear envelope association and delta-
dependent inhibition of nuclear import. J Mol Biol 375, 1125-1140 (2008). 
 134.      Wang,W. & Struhl,G. Drosophila Epsin mediates a select endocytic pathway 
that DSL ligands must enter to activate Notch. Development 131, 5367-5380 
(2004). 
 135.      Rooke,J., Pan,D., Xu,T., & Rubin,G.M. KUZ, a conserved metalloprotease-
disintegrin protein with two roles in Drosophila neurogenesis. Science 273, 
1227-1231 (1996). 
 136.      Mishra-Gorur,K., Rand,M.D., Perez-Villamil,B., & rtavanis-Tsakonas,S. 
Down-regulation of Delta by proteolytic processing. J Cell Biol 159, 313-324 
(2002). 
 137.      Delwig,A., Bland,C., Beem-Miller,M., Kimberly,P., & Rand,M.D. Endocytosis-
independent mechanisms of Delta ligand proteolysis. Exp Cell Res 312, 1345-
1360 (2006). 
 138.      Six,E. et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM 





 139.      LaVoie,M.J. & Selkoe,D.J. The Notch ligands, Jagged and Delta, are 
sequentially processed by alpha-secretase and presenilin/gamma-secretase and 
release signaling fragments. J Biol Chem 278, 34427-34437 (2003). 
 140.      Bland,C.E., Kimberly,P., & Rand,M.D. Notch-induced proteolysis and nuclear 
localization of the Delta ligand. J Biol Chem 278, 13607-13610 (2003). 
 141.      Zolkiewska,A. ADAM proteases: ligand processing and modulation of the 
Notch pathway. Cell Mol Life Sci 65, 2056-2068 (2008). 
 142.      Ladi,E. et al. The divergent DSL ligand Dll3 does not activate Notch signaling 
but cell autonomously attenuates signaling induced by other DSL ligands. J Cell 
Biol 170, 983-992 (2005). 
 143.      Bray,S.J., Takada,S., Harrison,E., Shen,S.C., & Ferguson-Smith,A.C. The 
atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch 
signalling in Drosophila. BMC Dev Biol 8, 11 (2008). 
 144.      Nueda,M.L. et al. The novel gene EGFL9/Dlk2, highly homologous to Dlk1, 
functions as a modulator of adipogenesis. J Mol Biol 367, 1270-1280 (2007). 
 145.      Nueda,M.L., Garcia-Ramirez,J.J., Laborda,J., & Baladron,V. dlk1 specifically 
interacts with insulin-like growth factor binding protein 1 to modulate 
adipogenesis of 3T3-L1 cells. J Mol Biol 379, 428-442 (2008). 
 146.      Haines,N. & Irvine,K.D. Glycosylation regulates Notch signalling. Nat Rev 
Mol Cell Biol 4, 786-797 (2003). 
 147.      Bruckner,K., Perez,L., Clausen,H., & Cohen,S. Glycosyltransferase activity of 
Fringe modulates Notch-Delta interactions. Nature 406, 411-415 (2000). 
 148.      Ryan,M.J. et al. Bile duct proliferation in <I>Jag1</I>/fringe heterozygous 
mice identifies candidate modifiers of the alagille syndrome hepatic phenotype. 
Hepatology M3 - 10. 1002/hep. 48, 1989-1997 (2008). 
 149.      Bray,S.J. Notch signalling: a simple pathway becomes complex. Nature 
Reviews. Molecular Cell Biology Nat. Rev. Mol. Cell Biol M3 - 10. 1038/nrm2009 
7, 678-689 (2006). 
 150.      Kovall,R.A. Structures of CSL, Notch and Mastermind proteins: piecing 
together an active transcription complex. Curr Opin Struct. Biol 17, 117-127 
(2007). 
 151.      Castella,P., Wagner,J.A., & Caudy,M. Regulation of hippocampal neuronal 
differentiation by the basic helix-loop-helix transcription factors HES-1 and 
MASH-1. J Neurosci Res 56, 229-240 (1999). 
 152.      Uda,M., Ishido,M., & Kami,K. Features and a possible role of Mash1-
immunoreactive cells in the dentate gyrus of the hippocampus in the adult rat. 




 153.      Yang,Q., Bermingham,N.A., Finegold,M.J., & Zoghbi,H.Y. Requirement of 
Math1 for secretory cell lineage commitment in the mouse intestine. Science 
294, 2155-2158 (2001). 
 154.      Shroyer,N.F., Wallis,D., Venken,K.J., Bellen,H.J., & Zoghbi,H.Y. Gfi1 functions 
downstream of Math1 to control intestinal secretory cell subtype allocation 
and differentiation. Genes Dev 19, 2412-2417 (2005). 
 155.      Brou,C. et al. Inhibition of the DNA-binding activity of Drosophila 
suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct 
protein-protein interaction with Drosophila hairless. Genes Dev 8, 2491-2503 
(1994). 
 156.      Barolo,S., Stone,T., Bang,A.G., & Posakony,J.W. Default repression and 
Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho 
and dCtBP to Suppressor of Hairless. Genes Dev 16, 1964-1976 (2002). 
 157.      Nagel,A.C. et al. Hairless-mediated repression of notch target genes 
requires the combined activity of Groucho and CtBP corepressors. Mol Cell Biol 
25, 10433-10441 (2005). 
 158.      Lai,E.C. Keeping a good pathway down: transcriptional repression of Notch 
pathway target genes by CSL proteins. EMBO Rep 3, 840-845 (2002). 
 159.      Kao,H.Y. et al. A histone deacetylase corepressor complex regulates the 
Notch signal transduction pathway. Genes Dev 12, 2269-2277 (1998). 
 160.      Oswald,F. et al. SHARP is a novel component of the Notch/RBP-Jkappa 
signalling pathway. EMBO J 21, 5417-5426 (2002). 
 161.      Oswald,F. et al. RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to 
silence Notch target genes. Mol Cell Biol 25, 10379-10390 (2005). 
 162.      Hsieh,J.J., Zhou,S., Chen,L., Young,D.B., & Hayward,S.D. CIR, a corepressor 
linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc 
Natl Acad Sci U S A 96, 23-28 (1999). 
 163.      Iso,T., Kedes,L., & Hamamori,Y. HES and HERP families: multiple effectors of 
the Notch signaling pathway. J Cell Physiol 194, 237-255 (2003). 
 164.      Iso,T. et al. HERP, a novel heterodimer partner of HES/E(spl) in Notch 
signaling. Mol Cell Biol 21, 6080-6089 (2001). 
 165.      Bai,G. et al. Id sustains Hes1 expression to inhibit precocious neurogenesis 
by releasing negative autoregulation of Hes1. Dev Cell 13, 283-297 (2007). 
 166.      Hirata,H. et al. Oscillatory expression of the bHLH factor Hes1 regulated by 
a negative feedback loop. Science 298, 840-843 (2002). 
 167.      Kovall,R.A. More complicated than it looks: assembly of Notch pathway 




 168.      Chitnis,A.B. The role of Notch in lateral inhibition and cell fate specification. 
Mol Cell Neurosci 6, 311-321 (1995). 
 169.      Skeath,J.B. & Carroll,S.B. Regulation of achaete-scute gene expression and 
sensory organ pattern formation in the Drosophila wing. Genes Dev 5, 984-995 
(1991). 
 170.      Heitzler,P., Bourouis,M., Ruel,L., Carteret,C., & Simpson,P. Genes of the 
Enhancer of split and achaete-scute complexes are required for a regulatory 
loop between Notch and Delta during lateral signalling in Drosophila. 
Development 122, 161-171 (1996). 
 171.      Heitzler,P. & Simpson,P. The choice of cell fate in the epidermis of 
Drosophila. Cell 64, 1083-1092 (1991). 
 172.      Simpson,P. et al. Delta, notch, and shaggy: elements of a lateral signaling 
pathway in Drosophila. Cold Spring Harb. Symp. Quant. Biol 57, 391-400 (1992). 
 173.      Busseau,I., Diederich,R.J., Xu,T., & rtavanis-Tsakonas,S. A member of the 
Notch group of interacting loci, deltex encodes a cytoplasmic basic protein. 
Genetics 136, 585-596 (1994). 
 174.      Kishi,N. et al. Murine homologs of deltex define a novel gene family 
involved in vertebrate Notch signaling and neurogenesis. Int J Dev Neurosci 19, 
21-35 (2001). 
 175.      Matsuno,K. et al. Human deltex is a conserved regulator of Notch signalling. 
Nat Genet 19, 74-78 (1998). 
 176.      Diederich,R.J., Matsuno,K., Hing,H., & rtavanis-Tsakonas,S. Cytosolic 
interaction between deltex and Notch ankyrin repeats implicates deltex in the 
Notch signaling pathway. Development 120, 473-481 (1994). 
 177.      Brennan,K. & Gardner,P. Notching up another pathway. Bioessays 24, 405-
410 (2002). 
 178.      Le Gall,M., De Mattei,C., & Giniger,E. Molecular separation of two signaling 
pathways for the receptor, Notch. Dev Biol 313, 556-567 (2008). 
 179.      Perry,W.L. et al. The itchy locus encodes a novel ubiquitin protein ligase 
that is disrupted in a18H mice. Nat Genet 18, 143-146 (1998). 
 180.      Hubbard,E.J., Wu,G., Kitajewski,J., & Greenwald,I. sel-10, a negative 
regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the 
CDC4 family of proteins. Genes Dev 11, 3182-3193 (1997). 
 181.      Frise,E., Knoblich,J.A., Younger-Shepherd,S., Jan,L.Y., & Jan,Y.N. The 
Drosophila Numb protein inhibits signaling of the Notch receptor during cell-





 182.      Zhong,W., Jiang,M.M., Weinmaster,G., Jan,L.Y., & Jan,Y.N. Differential 
expression of mammalian Numb, Numblike and Notch1 suggests distinct roles 
during mouse cortical neurogenesis. Development 124, 1887-1897 (1997). 
 183.      McGill,M.A. & McGlade,C.J. Mammalian numb proteins promote Notch1 
receptor ubiquitination and degradation of the Notch1 intracellular domain. J 
Biol Chem 278, 23196-23203 (2003). 
 184.      Nie,J. et al. LNX functions as a RING type E3 ubiquitin ligase that targets the 
cell fate determinant Numb for ubiquitin-dependent degradation. EMBO J 21, 
93-102 (2002). 
 185.      McGill,M.A., Dho,S.E., Weinmaster,G., & McGlade,C.J. Numb regulates 
post-endocytic trafficking and degradation of Notch1. J Biol Chem 284, 26427-
26438 (2009). 
 186.      Imai,T. et al. The neural RNA-binding protein Musashi1 translationally 
regulates mammalian numb gene expression by interacting with its mRNA. Mol 
Cell Biol 21, 3888-3900 (2001). 
 187.      Nagaya,M., Kubota,S., Suzuki,N., Akashi,K., & Mitaka,T. Thermoreversible 
gelation polymer induces the emergence of hepatic stem cells in the partially 
injured rat liver. Hepatology 43, 1053-1062 (2006). 
 188.      Katoh,M. & Katoh,M. NUMB is a break of WNT-Notch signaling cycle. Int J 
Mol Med 18, 517-521 (2006). 
 189.      Cheng,X., Huber,T.L., Chen,V.C., Gadue,P., & Keller,G.M. Numb mediates 
the interaction between Wnt and Notch to modulate primitive erythropoietic 
specification from the hemangioblast. Development 135, 3447-3458 (2008). 
 190.      Ro,H. & Dawid,I.B. Organizer restriction through modulation of Bozozok 
stability by the E3 ubiquitin ligase Lnx-like. Nat Cell Biol 11, 1121-1127 (2009). 
 191.      Wilson,A.A. & Kotton,D.N. Another notch in stem cell biology: Drosophila 
intestinal stem cells and the specification of cell fates. Bioessays 30, 107-109 
(2008). 
 192.      Kimble,J. & Crittenden,S.L. Germline proliferation and its control. 
WormBook1-14 (2005). 
 193.      Lowry,W.E. & Richter,L. Signaling in adult stem cells. Front Biosci 12, 3911-
3927 (2007). 
 194.      Andrews,P.W. Human embryonal carcinoma cells in culture do not 
synthesize fibronectin until they differentiate. Int J Cancer 30, 567-571 (1982). 
 195.      Fox,V. et al. Cell-cell signaling through NOTCH regulates human embryonic 




 196.      Nemir,M., Croquelois,A., Pedrazzini,T., & Radtke,F. Induction of 
cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling. 
Circ Res 98, 1471-1478 (2006). 
 197.      Lowell,S., Benchoua,A., Heavey,B., & Smith,A.G. Notch promotes neural 
lineage entry by pluripotent embryonic stem cells. PLoS Biol 4, (2006). 
 198.      Campos-Ortega,J.A. Genetic mechanisms of early neurogenesis in 
Drosophila melanogaster. Int Rev Cytol 124, 1-41 (1991). 
 199.      Campos-Ortega,J.A. & Knust,E. Molecular analysis of a cellular decision 
during embryonic development of Drosophila melanogaster: epidermogenesis 
or neurogenesis. Eur J Biochem 190, 1-10 (1990). 
 200.      de la Pompa,J.L. et al. Conservation of the Notch signalling pathway in 
mammalian neurogenesis. Development 124, 1139-1148 (1997). 
 201.      Wang,W. et al. Notch signaling regulates neuroepithelial stem cell 
maintenance and neuroblast formation in Drosophila optic lobe development. 
Dev Biol(2010). 
 202.      Hammerle,B. & Tejedor,F.J. A novel function of DELTA-NOTCH signalling 
mediates the transition from proliferation to neurogenesis in neural progenitor 
cells. PLoS ONE 2, (2007). 
 203.      Hartenstein,V., Younossi-Hartenstein,A., & Lekven,A. Delamination and 
division in the Drosophila neurectoderm: spatiotemporal pattern, cytoskeletal 
dynamics, and common control by neurogenic and segment polarity genes. Dev 
Biol 165, 480-499 (1994). 
 204.      Ge,W. et al. Notch signaling promotes astrogliogenesis via direct CSL-
mediated glial gene activation. J Neurosci Res 69, 848-860 (2002). 
 205.      Grandbarbe,L. et al. Delta-Notch signaling controls the generation of 
neurons/glia from neural stem cells in a stepwise process. Development 130, 
1391-1402 (2003). 
 206.      Engin,F. et al. Dimorphic effects of Notch signaling in bone homeostasis. 
Nat Med 14, 299-305 (2008). 
 207.      Hilton,M.J. et al. Notch signaling maintains bone marrow mesenchymal 
progenitors by suppressing osteoblast differentiation. Nat Med 14, 306-314 
(2008). 
 208.      Fuss,B. & Hoch,M. Notch signaling controls cell fate specification along the 
dorsoventral axis of the Drosophila gut. Curr Biol 12, 171-179 (2002). 
 209.      Scoville,D.H., Sato,T., He,X.C., & Li,L. Current view: intestinal stem cells and 




 210.      Barker,N. et al. Identification of stem cells in small intestine and colon by 
marker gene Lgr5. Nature 449, 1003-1007 (2007). 
 211.      van Es,J.H. & Clevers,H. Notch and Wnt inhibitors as potential new drugs 
for intestinal neoplastic disease. Trends Mol Med 11, 496-502 (2005). 
 212.      van Es,J.H. et al. Notch/gamma-secretase inhibition turns proliferative cells 
in intestinal crypts and adenomas into goblet cells. Nature Nature M3 - 10. 435, 
959-963 (2005). 
 213.      Jensen,J. et al. Control of endodermal endocrine development by Hes-1. 
Nat Genet 24, 36-44 (2000). 
 214.      Fre,S. et al. Notch signals control the fate of immature progenitor cells in 
the intestine. Nature 435, 964-968 (2005). 
 215.      Lozier,J., McCright,B., & Gridley,T. Notch signaling regulates bile duct 
morphogenesis in mice. PLoS ONE 3, (2008). 
 216.      Hofmann,J.J. et al. Jagged1 in the portal vein mesenchyme regulates 
intrahepatic bile duct development: insights into Alagille syndrome. 
Development 137, 4061-4072 (2010). 
 217.      Sparks,E.E., Huppert,K.A., Brown,M.A., Washington,M.K., & Huppert,S.S. 
Notch signaling regulates formation of the three-dimensional architecture of 
intrahepatic bile ducts in mice. Hepatology 51, 1391-1400 (2010). 
 218.      Lorent,K., Moore,J.C., Siekmann,A.F., Lawson,N., & Pack,M. Reiterative use 
of the notch signal during zebrafish intrahepatic biliary development. Dev Dyn 
239, 855-864 (2010). 
 219.      Lorent,K. et al. Inhibition of Jagged-mediated Notch signaling disrupts 
zebrafish biliary development and generates multi-organ defects compatible 
with an Alagille syndrome phenocopy. Development 131, 5753-5766 (2004). 
 220.      Zong,Y. et al. Notch signaling controls liver development by regulating 
biliary differentiation. Development 136, 1727-1739 (2009). 
 221.      Tanimizu,N., Nishikawa,M., Saito,H., Tsujimura,T., & Miyajima,A. Isolation 
of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 116, 1775-1786 
(2003). 
 222.      Tanimizu,N. et al. Expression of Dlk/Pref-1 defines a subpopulation in the 
oval cell compartment of rat liver. Gene Expr Patterns 5, 209-218 (2004). 
 223.      Tanimizu,N. & Miyajima,A. Notch signaling controls hepatoblast 
differentiation by altering the expression of liver-enriched transcription factors. 
J Cell Sci 117, 3165-3174 (2004). 
 224.      Hodkinson,P.S. et al. Mammalian NOTCH-1 activates beta1 integrins via the 




 225.      Nagy,P., Bisgaard,H.C., & Thorgeirsson,S.S. Expression of hepatic 
transcription factors during liver development and oval cell differentiation. J 
Cell Biol 126, 223-233 (1994). 
 226.      Yamasaki,H. et al. Suppression of C/EBPalpha expression in periportal 
hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 
and Hnf1b expression. Development 133, 4233-4243 (2006). 
 227.      Crosnier,C. et al. JAGGED1 gene expression during human embryogenesis 
elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 32, 
574-581 (2000). 
 228.      Fabris,L. et al. Analysis of Liver Repair Mechanisms in Alagille Syndrome and 
Biliary Atresia Reveals a Role for Notch Signaling. Am J Pathol M3 - 10. 
2353/ajpath. 2007. 171, 641-653 (2007). 
 229.      Oda,T. et al. Mutations in the human Jagged1 gene are responsible for 
Alagille syndrome. Nat Genet 16, 235-242 (1997). 
 230.      McDaniell,R. et al. NOTCH2 mutations cause Alagille syndrome, a 
heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 79, 
169-173 (2006). 
 231.      Loomes,K.M. et al. Bile duct proliferation in liver-specific Jag1 conditional 
knockout mice: effects of gene dosage. Hepatology 45, 323-330 (2007). 
 232.      McCright,B., Lozier,J., & Gridley,T. A mouse model of Alagille syndrome: 
Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 
1075-1082 (2002). 
 233.      Geisler,F. et al. Liver-specific inactivation of Notch2, but not Notch1, 
compromises intrahepatic bile duct development in mice. Hepatology 48, 607-
616 (2008). 
 234.      Gao,J. et al. Deregulated expression of Notch receptors in human 
hepatocellular carcinoma. Dig. Liver Dis. 40, 114-121 (2008). 
 235.      KÃ¶hler,C. et al. Expression of Notch-1 and its ligand Jagged-1 in rat liver 
during liver regeneration. Hepatology M3 - 10. 1002/hep. 39, 1056-1065 
(2004). 
 236.      Grigoryan,T., Wend,P., Klaus,A., & Birchmeier,W. Deciphering the function 
of canonical Wnt signals in development and disease: conditional loss- and 
gain-of-function mutations of beta-catenin in mice. Genes Dev 22, 2308-2341 
(2008). 
 237.      Wend,P., Holland,J.D., Ziebold,U., & Birchmeier,W. Wnt signaling in stem 
and cancer stem cells. Semin Cell Dev Biol 21, 855-863 (2010). 
 238.      Struhl,G. & Basler,K. Organizing activity of wingless protein in Drosophila. 




 239.      Dougan,S. & DiNardo,S. Drosophila wingless generates cell type diversity 
among engrailed expressing cells. Nature 360, 347-350 (1992). 
 240.      Miller,J.R. The Wnts. Genome Biol 3, REVIEWS3001 (2002). 
 241.      Clevers,H. Wnt/beta-catenin signaling in development and disease. Cell 
127, 469-480 (2006). 
 242.      Thompson,M.D. & Monga,S.P. WNT/beta-catenin signaling in liver health 
and disease. Hepatology 45, 1298-1305 (2007). 
 243.      Monga,S.P. Role of Wnt/beta-catenin signaling in liver metabolism and 
cancer. Int J Biochem Cell Biol(2009). 
 244.      Logan,C.Y. & Nusse,R. The Wnt signaling pathway in development and 
disease. Annu Rev Cell Dev Biol 20, 781-810 (2004). 
 245.      He,X., Semenov,M., Tamai,K., & Zeng,X. LDL receptor-related proteins 5 and 
6 in Wnt/beta-catenin signaling: arrows point the way. Development 131, 1663-
1677 (2004). 
 246.      Barker,N. & Clevers,H. Catenins, Wnt signaling and cancer. Bioessays 22, 
961-965 (2000). 
 247.      Reya,T. & Clevers,H. Wnt signalling in stem cells and cancer. Nature 434, 
843-850 (2005). 
 248.      Seifert,J.R. & Mlodzik,M. Frizzled/PCP signalling: a conserved mechanism 
regulating cell polarity and directed motility. Nat Rev Genet 8, 126-138 (2007). 
 249.      Wang,Y. & Nathans,J. Tissue/planar cell polarity in vertebrates: new 
insights and new questions. Development 134, 647-658 (2007). 
 250.      Willert,K. et al. Wnt proteins are lipid-modified and can act as stem cell 
growth factors. Nature 423, 448-452 (2003). 
 251.      Komekado,H., Yamamoto,H., Chiba,T., & Kikuchi,A. Glycosylation and 
palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. 
Genes Cells 12, 521-534 (2007). 
 252.      Hausmann,G., Banziger,C., & Basler,K. Helping Wingless take flight: how 
WNT proteins are secreted. Nat Rev Mol Cell Biol 8, 331-336 (2007). 
 253.      Cong,F., Schweizer,L., & Varmus,H. Wnt signals across the plasma 
membrane to activate the beta-catenin pathway by forming oligomers 
containing its receptors, Frizzled and LRP. Development 131, 5103-5115 (2004). 
 254.      Holmen,S.L., Robertson,S.A., Zylstra,C.R., & Williams,B.O. Wnt-independent 
activation of beta-catenin mediated by a Dkk1-Fz5 fusion protein. Biochem 




 255.      Tolwinski,N.S. et al. Wg/Wnt signal can be transmitted through 
arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. Dev Cell 4, 
407-418 (2003). 
 256.      Kimelman,D. & Xu,W. beta-catenin destruction complex: insights and 
questions from a structural perspective. Oncogene 25, 7482-7491 (2006). 
 257.      Bustos,V.H. et al. The first armadillo repeat is involved in the recognition 
and regulation of beta-catenin phosphorylation by protein kinase CK1. Proc 
Natl Acad Sci U S A 103, 19725-19730 (2006). 
 258.      Rubinfeld,B. et al. Binding of GSK3beta to the APC-beta-catenin complex 
and regulation of complex assembly. Science 272, 1023-1026 (1996). 
 259.      Munemitsu,S., Albert,I., Rubinfeld,B., & Polakis,P. Deletion of an amino-
terminal sequence beta-catenin in vivo and promotes hyperphosporylation of 
the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol 16, 
4088-4094 (1996). 
 260.      Jiang,J. & Struhl,G. Regulation of the Hedgehog and Wingless signalling 
pathways by the F-box/WD40-repeat protein Slimb. Nature 391, 493-496 
(1998). 
 261.      Marikawa,Y. & Elinson,R.P. beta-TrCP is a negative regulator of Wnt/beta-
catenin signaling pathway and dorsal axis formation in Xenopus embryos. Mech 
Dev 77, 75-80 (1998). 
 262.      Gao,Z.H., Seeling,J.M., Hill,V., Yochum,A., & Virshup,D.M. Casein kinase I 
phosphorylates and destabilizes the beta-catenin degradation complex. Proc 
Natl Acad Sci U S A 99, 1182-1187 (2002). 
 263.      Ha,N.C., Tonozuka,T., Stamos,J.L., Choi,H.J., & Weis,W.I. Mechanism of 
phosphorylation-dependent binding of APC to beta-catenin and its role in beta-
catenin degradation. Mol Cell 15, 511-521 (2004). 
 264.      Peterson-Nedry,W. et al. Unexpectedly robust assembly of the Axin 
destruction complex regulates Wnt/Wg signaling in Drosophila as revealed by 
analysis in vivo. Dev Biol 320, 226-241 (2008). 
 265.      Kremer,S.A., Erdeniz,N., Peterson-Nedry,W., Swanson,E.A., & Wehrli,M. In 
vivo analysis in Drosophila reveals differential requirements of contact residues 
in Axin for interactions with GSK3beta or beta-catenin. Dev Biol 337, 110-123 
(2010). 
 266.      Schwarz-Romond,T. et al. The DIX domain of Dishevelled confers Wnt 
signaling by dynamic polymerization. Nat Struct. Mol Biol 14, 484-492 (2007). 
 267.      Luo,W. et al. Axin contains three separable domains that confer 
intramolecular, homodimeric, and heterodimeric interactions involved in 




 268.      Tamai,K. et al. LDL-receptor-related proteins in Wnt signal transduction. 
Nature 407, 530-535 (2000). 
 269.      Zeng,X. et al. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 
phosphorylation/activation via frizzled, dishevelled and axin functions. 
Development 135, 367-375 (2008). 
 270.      MacDonald,B.T., Tamai,K., & He,X. Wnt/beta-catenin signaling: 
components, mechanisms, and diseases. Dev Cell 17, 9-26 (2009). 
 271.      Henderson,B.R. & Fagotto,F. The ins and outs of APC and beta-catenin 
nuclear transport. EMBO Rep 3, 834-839 (2002). 
 272.      Wu,X. et al. Rac1 activation controls nuclear localization of beta-catenin 
during canonical Wnt signaling. Cell 133, 340-353 (2008). 
 273.      Clevers,H. & van de,W.M. TCF/LEF factor earn their wings. Trends Genet 13, 
485-489 (1997). 
 274.      Brantjes,H., Barker,N., Van,E.J., & Clevers,H. TCF: Lady Justice casting the 
final verdict on the outcome of Wnt signalling. Biol Chem 383, 255-261 (2002). 
 275.      Hecht,A., Litterst,C.M., Huber,O., & Kemler,R. Functional characterization 
of multiple transactivating elements in beta-catenin, some of which interact 
with the TATA-binding protein in vitro. J Biol Chem 274, 18017-18025 (1999). 
 276.      Struhl,G. & Adachi,A. Nuclear access and action of notch in vivo. Cell Cell 
93, 649-660 (1998). 
 277.      Chen,G. & Courey,A.J. Groucho/TLE family proteins and transcriptional 
repression. Gene 249, 1-16 (2000). 
 278.      Nuthall,H.N., Joachim,K., & Stifani,S. Phosphorylation of serine 239 of 
Groucho/TLE1 by protein kinase CK2 is important for inhibition of neuronal 
differentiation. Mol Cell Biol 24, 8395-8407 (2004). 
 279.      Inestrosa,N.C. & Arenas,E. Emerging roles of Wnts in the adult nervous 
system. Nat Rev Neurosci 11, 77-86 (2010). 
 280.      Hur,E.M. & Zhou,F.Q. GSK3 signalling in neural development. Nat Rev 
Neurosci 11, 539-551 (2010). 
 281.      Chenn,A. & Walsh,C.A. Regulation of cerebral cortical size by control of cell 
cycle exit in neural precursors. Science 297, 365-369 (2002). 
 282.      Hirabayashi,Y. et al. The Wnt/beta-catenin pathway directs neuronal 
differentiation of cortical neural precursor cells. Development 131, 2791-2801 
(2004). 
 283.      Zhou,C.J., Borello,U., Rubenstein,J.L., & Pleasure,S.J. Neuronal production 




function in the canonical Wnt signaling pathway. Neuroscience 142, 1119-1131 
(2006). 
 284.      Jessberger,S. et al. Dentate gyrus-specific knockdown of adult neurogenesis 
impairs spatial and object recognition memory in adult rats. Learn. Mem. 16, 
147-154 (2009). 
 285.      Mao,Y. et al. Disrupted in schizophrenia 1 regulates neuronal progenitor 
proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136, 
1017-1031 (2009). 
 286.      Kuwabara,T. et al. Wnt-mediated activation of NeuroD1 and retro-elements 
during adult neurogenesis. Nat Neurosci 12, 1097-1105 (2009). 
 287.      Su,L.K. et al. Multiple intestinal neoplasia caused by a mutation in the 
murine homolog of the APC gene. Science 256, 668-670 (1992). 
 288.      Sansom,O.J. et al. Cyclin D1 is not an immediate target of beta-catenin 
following Apc loss in the intestine. J Biol Chem 280, 28463-28467 (2005). 
 289.      Andreu,P. et al. Crypt-restricted proliferation and commitment to the 
Paneth cell lineage following Apc loss in the mouse intestine. Development 132, 
1443-1451 (2005). 
 290.      Buchert,M. et al. Genetic dissection of differential signaling threshold 
requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet 6, 
e1000816 (2010). 
 291.      Muncan,V. et al. Rapid loss of intestinal crypts upon conditional deletion of 
the Wnt/Tcf-4 target gene c-Myc. Mol Cell Biol 26, 8418-8426 (2006). 
 292.      Sato,T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro 
without a mesenchymal niche. Nature 459, 262-265 (2009). 
 293.      Barker,N. et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and 
build long-lived gastric units in vitro. Cell Stem Cell 6, 25-36 (2010). 
 294.      Barker,N. et al. Very long-term self-renewal of small intestine, colon, and 
hair follicles from cycling Lgr5+ve stem cells. Cold Spring Harb. Symp. Quant. 
Biol 73, 351-356 (2008). 
 295.      Snippert,H.J. et al. Intestinal crypt homeostasis results from neutral 
competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134-144 
(2010). 
 296.      Gregorieff,A. & Clevers,H. Wnt signaling in the intestinal epithelium: from 
endoderm to cancer. Genes Dev 19, 877-890 (2005). 
 297.      Haegebarth,A. & Clevers,H. Wnt signaling, lgr5, and stem cells in the 




 298.      van der Flier,L.G. et al. Transcription factor achaete scute-like 2 controls 
intestinal stem cell fate. Cell 136, 903-912 (2009). 
 299.      Lin,G., Xu,N., & Xi,R. Paracrine Wingless signalling controls self-renewal of 
Drosophila intestinal stem cells. Nature 455, 1119-1123 (2008). 
 300.      Barker,N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. 
Nature 457, 608-611 (2009). 
 301.      Shorning,B.Y. et al. Lkb1 deficiency alters goblet and paneth cell 
differentiation in the small intestine. PLoS One 4, e4264 (2009). 
 302.      Sato,T. et al. Paneth cells constitute the niche for Lgr5 stem cells in 
intestinal crypts. Nature(2010). 
 303.      Zaret,K.S. & Grompe,M. Generation and regeneration of cells of the liver 
and pancreas. Science 322, 1490-1494 (2008). 
 304.      Shin,D. et al. Bmp and Fgf signaling are essential for liver specification in 
zebrafish. Development 134, 2041-2050 (2007). 
 305.      Nejak-Bowen,K. & Monga,S.P. Wnt/beta-catenin signaling in hepatic 
organogenesis. Organogenesis. 4, 92-99 (2008). 
 306.      Pilcher,K.E. & Krieg,P.A. Expression of the Wnt inhibitor, sFRP5, in the gut 
endoderm of Xenopus. Gene Expr Patterns 2, 369-372 (2002). 
 307.      Li,Y. et al. Sfrp5 coordinates foregut specification and morphogenesis by 
antagonizing both canonical and noncanonical Wnt11 signaling. Genes Dev 22, 
3050-3063 (2008). 
 308.      Ober,E.A., Verkade,H., Field,H.A., & Stainier,D.Y. Mesodermal Wnt2b 
signalling positively regulates liver specification. Nature 442, 688-691 (2006). 
 309.      Monga,S.P. et al. Beta-catenin antisense studies in embryonic liver cultures: 
role in proliferation, apoptosis, and lineage specification. Gastroenterology 124, 
202-216 (2003). 
 310.      Hussain,S.Z. et al. Wnt impacts growth and differentiation in ex vivo liver 
development. Exp Cell Res 292, 157-169 (2004). 
 311.      Apte,U. et al. beta-Catenin is critical for early postnatal liver growth. Am J 
Physiol Gastrointest Liver Physiol 292, G1578-G1585 (2007). 
 312.      Tan,X. et al. Beta-catenin deletion in hepatoblasts disrupts hepatic 
morphogenesis and survival during mouse development. Hepatology 47, 1667-
1679 (2008). 
 313.      Decaens,T. et al. Stabilization of beta-catenin affects mouse embryonic liver 




 314.      Tan,X., Behari,J., Cieply,B., Michalopoulos,G.K., & Monga,S.P. Conditional 
deletion of beta-catenin reveals its role in liver growth and regeneration. 
Gastroenterology 131, 1561-1572 (2006). 
 315.      Tan,X. et al. Epidermal growth factor receptor: a novel target of the 
Wnt/beta-catenin pathway in liver. Gastroenterology 129, 285-302 (2005). 
 316.      Goessling,W. et al. APC mutant zebrafish uncover a changing temporal 
requirement for wnt signaling in liver development. Dev Biol 320, 161-174 
(2008). 
 317.      Bi,Y. et al. Wnt antagonist SFRP3 inhibits the differentiation of mouse 
hepatic progenitor cells. J Cell Biochem 108, 295-303 (2009). 
 318.      Monga,S.P., Pediaditakis,P., Mule,K., Stolz,D.B., & Michalopoulos,G.K. 
Changes in WNT/beta-catenin pathway during regulated growth in rat liver 
regeneration. Hepatology 33, 1098-1109 (2001). 
 319.      Apte,U. et al. Beta-catenin activation promotes liver regeneration after 
acetaminophen-induced injury. Am J Pathol 175, 1056-1065 (2009). 
 320.      Apte,U. et al. Wnt/beta-catenin signaling mediates oval cell response in 
rodents. Hepatology 47, 288-295 (2008). 
 321.      Hu,M. et al. Wnt/beta-catenin signaling in murine hepatic transit amplifying 
progenitor cells. Gastroenterology 133, 1579-1591 (2007). 
 322.      Spee,B. et al. Characterisation of the liver progenitor cell niche in liver 
diseases: potential involvement of Wnt and Notch signalling. Gut 59, 247-257 
(2010). 
 323.      Bourd-Boittin,K. et al. CX3CL1/fractalkine shedding by human hepatic 
stellate cells: contribution to chronic inflammation in the liver. J Cell Mol Med 
13, 1526-1535 (2009). 
 324.      Zorn,A.M., Butler,K., & Gurdon,J.B. Anterior endomesoderm specification in 
Xenopus by Wnt/beta-catenin and TGF-beta signalling pathways. Dev Biol 209, 
282-297 (1999). 
 325.      Thompson,M.D. & Monga,S.P. WNT/beta-catenin signaling in liver health 
and disease. Hepatology 45, 1298-1305 (2007). 
 326.      Van,R.N. & Sanders,A. Liposome mediated depletion of macrophages: 
mechanism of action, preparation of liposomes and applications. J Immunol 
Methods 174, 83-93 (1994). 
 327.      Sodhi,D. et al. Morpholino oligonucleotide-triggered beta-catenin 





 328.      Apte,U. et al. Wnt/beta-catenin signaling mediates oval cell response in 
rodents. Hepatology 47, 288-295 (2008). 
 329.      Yovchev,M.I. et al. Identification of adult hepatic progenitor cells capable of 
repopulating injured rat liver. Hepatology 47, 636-647 (2008). 
 330.      Matthews,V.B. et al. Oncostatin M induces an acute phase response but 
does not modulate the growth or maturation-status of liver progenitor (oval) 
cells in culture. Exp Cell Res 306, 252-263 (2005). 
 331.      Schotanus,B.A. et al. Cross-species immunohistochemical investigation of 
the activation of the liver progenitor cell niche in different types of liver 
disease. Liver Int 29, 1241-1252 (2009). 
 332.      Tee,L.B., Smith,P.G., & Yeoh,G.C. Expression of alpha, mu and pi class 
glutathione S-transferases in oval and ductal cells in liver of rats placed on a 
choline-deficient, ethionine-supplemented diet. Carcinogenesis 13, 1879-1885 
(1992). 
 333.      Zhu,A.X. et al. Efficacy, safety, and potential biomarkers of sunitinib 
monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin 
Oncol 27, 3027-3035 (2009). 
 334.      Wei,W., Chua,M.S., Grepper,S., & So,S. Small molecule antagonists of 
Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. 
Int J Cancer 126, 2426-2436 (2010). 
 335.      Tanimizu,N. & Miyajima,A. Notch signaling controls hepatoblast 
differentiation by altering the expression of liver-enriched transcription factors. 
J Cell Sci M3 - 10. 1242/jcs. 117, 3165-3174 (2004). 
 336.      Nijjar,S.S., Crosby,H.A., Wallace,L., Hubscher,S.G., & Strain,A.J. Notch 
receptor expression in adult human liver: a possible role in bile duct formation 
and hepatic neovascularization. Hepatology 34, 1184-1192 (2001). 
 337.      Lopez-Terrada,D. et al. Histologic subtypes of hepatoblastoma are 
characterized by differential canonical Wnt and Notch pathway activation in 
DLK+ precursors. Hum Pathol 40, 783-794 (2009). 
 338.      Geisler,F. et al. Liver-specific inactivation of Notch2, but not Notch1, 
compromises intrahepatic bile duct development in mice. Hepatology 48, 607-
616 (2008). 
 339.      Yuan,Z.R., Kobayashi,N., & Kohsaka,T. Human Jagged 1 mutants cause liver 
defect in Alagille syndrome by overexpression of hepatocyte growth factor. J 
Mol Biol 356, 559-568 (2006). 
 340.      Sawitza,I., Kordes,C., Reister,S., & Haussinger,D. The niche of stellate cells 




 341.      Li,L. et al. Alagille syndrome is caused by mutations in human Jagged1, 
which encodes a ligand for Notch1. Nat Genet 16, 243-251 (1997). 
 342.      Flynn,D.M. et al. The role of Notch receptor expression in bile duct 
development and disease. J Pathol 204, 55-64 (2004). 
 343.      Hay,D.C. et al. Highly efficient differentiation of hESCs to functional hepatic 
endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A 105, 
12301-12306 (2008). 
 344.      Karner,C.M. et al. Wnt9b signaling regulates planar cell polarity and kidney 
tubule morphogenesis. Nat Genet 41, 793-799 (2009). 
 345.      Van,R.N. & Sanders,A. Kupffer cell depletion by liposome-delivered drugs: 
comparative activity of intracellular clodronate, propamidine, and 
ethylenediaminetetraacetic acid. Hepatology 23, 1239-1243 (1996). 
 346.      Ettenberg,S.A. et al. Inhibition of tumorigenesis driven by different Wnt 
proteins requires blockade of distinct ligand-binding regions by LRP6 
antibodies. Proc Natl Acad Sci U S A 107, 15473-15478 (2010). 
 347.      Sanui,H., Yoshida,S., Nomoto,K., Ohhara,R., & Adachi,Y. Peritoneal 
macrophages which phagocytose autologous polymorphonuclear leucocytes in 
guinea-pigs. I: induction by irritants and microorgansisms and inhibition by 
colchicine. Br. J Exp Pathol 63, 278-284 (1982). 
 348.      Reddy,S.M. et al. Phagocytosis of apoptotic cells by macrophages induces 
novel signaling events leading to cytokine-independent survival and inhibition 
of proliferation: activation of Akt and inhibition of extracellular signal-regulated 
kinases 1 and 2. J Immunol 169, 702-713 (2002). 
 349.      Kovacs,A.L. & Seglen,P.O. Inhibition of hepatocytic protein degradation by 















Appendix 1 – Publications 
arising from this Thesis 
 
 
